_unit_id,_created_at,_canary,_id,_started_at,_channel,_trust,_worker_id,_country,_region,_city,_ip,direction,b1,b2,direction_gold,e1,e2,relation,relex_relcos,sent_id,sentence,term1,term2,twrex
497999919,7/4/2014 11:45:30,,1314799758,7/4/2014 11:44:52,tremorgames,0.875,25257192,CAN,ON,North York,207.188.64.245,no_relation,69,11,,97,23,treats,0.956182887467515,907847-FS1-2,Effects of CHLORAMBUCIL and therapeutic decision in initial forms of CHRONIC LYMPHOCYTIC LEUKEMIA (stage A): results of a randomized clinical trial on 612 patients,CHRONIC LYMPHOCYTIC LEUKEMIA,CHLORAMBUCIL,RO-may_treat
497999919,7/4/2014 12:26:05,,1314827106,7/4/2014 12:25:18,clixsense,0.8073,15189335,GBR,I9,Dereham,86.157.163.112,CHLORAMBUCIL treats CHRONIC LYMPHOCYTIC LEUKEMIA,69,11,,97,23,treats,0.956182887467515,907847-FS1-2,Effects of CHLORAMBUCIL and therapeutic decision in initial forms of CHRONIC LYMPHOCYTIC LEUKEMIA (stage A): results of a randomized clinical trial on 612 patients,CHRONIC LYMPHOCYTIC LEUKEMIA,CHLORAMBUCIL,RO-may_treat
497999919,7/4/2014 12:28:26,,1314828631,7/4/2014 12:28:11,neodev,0.8048,11014534,GBR,H9,London,80.254.147.52,CHLORAMBUCIL treats CHRONIC LYMPHOCYTIC LEUKEMIA,69,11,,97,23,treats,0.956182887467515,907847-FS1-2,Effects of CHLORAMBUCIL and therapeutic decision in initial forms of CHRONIC LYMPHOCYTIC LEUKEMIA (stage A): results of a randomized clinical trial on 612 patients,CHRONIC LYMPHOCYTIC LEUKEMIA,CHLORAMBUCIL,RO-may_treat
497999920,7/4/2014 11:41:06,,1314797139,7/4/2014 11:40:55,neodev,0.9875,18517457,GBR,,,86.29.55.201,DEXAMETHASONE treats CUSHING SYNDROME,84,66,,100,79,treats,0.762492851663023,906631-FS1-2,"We tried to detect salivary cortisol level with drug loading test(DEXAMETHASONE for CUSHING SYNDROME, and ACTH for adrenal insufficiency) with time interval",CUSHING SYNDROME,DEXAMETHASONE,RO-may_diagnose
497999920,7/4/2014 11:53:15,,1314804500,7/4/2014 11:52:39,clixsense,0.902,27871219,NLD,7,Amsterdam,87.210.207.223,DEXAMETHASONE treats CUSHING SYNDROME,84,66,,100,79,treats,0.762492851663023,906631-FS1-2,"We tried to detect salivary cortisol level with drug loading test(DEXAMETHASONE for CUSHING SYNDROME, and ACTH for adrenal insufficiency) with time interval",CUSHING SYNDROME,DEXAMETHASONE,RO-may_diagnose
497999920,7/4/2014 12:21:16,,1314823803,7/4/2014 12:20:45,clixsense,0.775,27969116,NLD,,,91.213.37.165,no_relation,84,66,,100,79,treats,0.762492851663023,906631-FS1-2,"We tried to detect salivary cortisol level with drug loading test(DEXAMETHASONE for CUSHING SYNDROME, and ACTH for adrenal insufficiency) with time interval",CUSHING SYNDROME,DEXAMETHASONE,RO-may_diagnose
497999921,7/4/2014 11:35:38,,1314794176,7/4/2014 11:35:26,neodev,0.9875,18517457,GBR,,,86.29.55.201,HYDROCHLOROTHIAZIDE treats HYPERTENSION,164,79,,176,98,treats,0.911684611677103,907530-FS1-2,"b ,   c  Class:  beta-Adrenergic Blocking Agents 24:24; CV100 (VA)  Synonyms:  HYDROCHLOROTHIAZIDE and Propranolol Hydrochloride  Uses  Hypertension  Management of HYPERTENSION, alone or in combination with other antihypertensive agents",HYPERTENSION,HYDROCHLOROTHIAZIDE,RO-may_treat
497999921,7/4/2014 11:52:38,,1314804051,7/4/2014 11:52:14,clixsense,0.902,27871219,NLD,7,Amsterdam,87.210.207.223,HYDROCHLOROTHIAZIDE treats HYPERTENSION,164,79,,176,98,treats,0.911684611677103,907530-FS1-2,"b ,   c  Class:  beta-Adrenergic Blocking Agents 24:24; CV100 (VA)  Synonyms:  HYDROCHLOROTHIAZIDE and Propranolol Hydrochloride  Uses  Hypertension  Management of HYPERTENSION, alone or in combination with other antihypertensive agents",HYPERTENSION,HYDROCHLOROTHIAZIDE,RO-may_treat
497999921,7/4/2014 12:21:16,,1314823804,7/4/2014 12:20:45,clixsense,0.775,27969116,NLD,,,91.213.37.165,no_relation,164,79,,176,98,treats,0.911684611677103,907530-FS1-2,"b ,   c  Class:  beta-Adrenergic Blocking Agents 24:24; CV100 (VA)  Synonyms:  HYDROCHLOROTHIAZIDE and Propranolol Hydrochloride  Uses  Hypertension  Management of HYPERTENSION, alone or in combination with other antihypertensive agents",HYPERTENSION,HYDROCHLOROTHIAZIDE,RO-may_treat
497999922,7/4/2014 11:34:55,,1314793811,7/4/2014 11:34:45,neodev,0.9875,18517457,GBR,,,86.29.55.201,WARFARIN treats PULMONARY EMBOLISM,93,137,,111,145,treats,0.995037190209989,907168-FS1-2,Clinical trials are currently investigating the potential value of LMWHs in the treatment of PULMONARY EMBOLISM and as an alternative to WARFARIN in secondary prevention of DVT,PULMONARY EMBOLISM,WARFARIN,RO-may_prevent
497999922,7/4/2014 11:46:58,,1314800744,7/4/2014 11:46:32,tremorgames,0.875,25257192,CAN,ON,North York,207.188.64.245,WARFARIN treats PULMONARY EMBOLISM,93,137,,111,145,treats,0.995037190209989,907168-FS1-2,Clinical trials are currently investigating the potential value of LMWHs in the treatment of PULMONARY EMBOLISM and as an alternative to WARFARIN in secondary prevention of DVT,PULMONARY EMBOLISM,WARFARIN,RO-may_prevent
497999922,7/4/2014 12:17:15,,1314820749,7/4/2014 12:16:44,clixsense,0.775,27969116,NLD,,,91.213.37.165,no_relation,93,137,,111,145,treats,0.995037190209989,907168-FS1-2,Clinical trials are currently investigating the potential value of LMWHs in the treatment of PULMONARY EMBOLISM and as an alternative to WARFARIN in secondary prevention of DVT,PULMONARY EMBOLISM,WARFARIN,RO-may_prevent
497999923,7/4/2014 11:34:44,,1314793720,7/4/2014 11:34:30,neodev,0.9875,18517457,GBR,,,86.29.55.201,ADEFOVIR treats HBV,28,48,,31,56,treats,1,907937-FS1-2,Individuals Coinfected with HBV and HIV  Use of ADEFOVIR for the treatment of chronic HBV infection in patients with unrecognized or untreated HIV infection may result in emergence of HIV resistance,HBV,ADEFOVIR,RO-may_treat
497999923,7/4/2014 11:44:31,,1314799115,7/4/2014 11:43:56,tremorgames,0.875,25257192,CAN,ON,North York,207.188.64.245,ADEFOVIR treats HBV,28,48,,31,56,treats,1,907937-FS1-2,Individuals Coinfected with HBV and HIV  Use of ADEFOVIR for the treatment of chronic HBV infection in patients with unrecognized or untreated HIV infection may result in emergence of HIV resistance,HBV,ADEFOVIR,RO-may_treat
497999923,7/4/2014 11:52:13,,1314803824,7/4/2014 11:51:17,clixsense,0.902,27871219,NLD,7,Amsterdam,87.210.207.223,ADEFOVIR treats HBV,28,48,,31,56,treats,1,907937-FS1-2,Individuals Coinfected with HBV and HIV  Use of ADEFOVIR for the treatment of chronic HBV infection in patients with unrecognized or untreated HIV infection may result in emergence of HIV resistance,HBV,ADEFOVIR,RO-may_treat
497999924,7/4/2014 12:19:44,,1314822573,7/4/2014 12:19:02,clixsense,0.775,27969116,NLD,,,91.213.37.165,RUBELLA VACCINE treats RUBELLA,87,0,,94,15,treats,1,907308-FS1-2,RUBELLA VACCINE should continue to be used to immunize susceptible adult women against RUBELLA in order to further the goal of elimination of the congenital rubella syndrome,RUBELLA,RUBELLA VACCINE,RO-may_prevent
497999924,7/4/2014 12:28:26,,1314828630,7/4/2014 12:28:11,neodev,0.8048,11014534,GBR,H9,London,80.254.147.52,RUBELLA VACCINE treats RUBELLA,87,0,,94,15,treats,1,907308-FS1-2,RUBELLA VACCINE should continue to be used to immunize susceptible adult women against RUBELLA in order to further the goal of elimination of the congenital rubella syndrome,RUBELLA,RUBELLA VACCINE,RO-may_prevent
497999924,7/4/2014 12:30:15,,1314829741,7/4/2014 12:29:42,clixsense,0.8073,15189335,GBR,I9,Dereham,86.157.163.112,RUBELLA VACCINE treats RUBELLA,87,0,,94,15,treats,1,907308-FS1-2,RUBELLA VACCINE should continue to be used to immunize susceptible adult women against RUBELLA in order to further the goal of elimination of the congenital rubella syndrome,RUBELLA,RUBELLA VACCINE,RO-may_prevent
497999925,7/4/2014 11:33:42,,1314793176,7/4/2014 11:33:20,neodev,0.9875,18517457,GBR,,,86.29.55.201,PULMONARY EMBOLISM is location of TISSUE PLASMINOGEN ACTIVATOR,49,17,,67,45,is location of,0.557086014531156,907785-FS1-9,Urokinase versus TISSUE PLASMINOGEN ACTIVATOR in PULMONARY EMBOLISM,PULMONARY EMBOLISM,TISSUE PLASMINOGEN ACTIVATOR,RO-may_treat
497999925,7/4/2014 11:37:37,,1314795247,7/4/2014 11:36:54,clixsense,0.902,27871219,NLD,7,Amsterdam,87.210.207.223,no_relation,49,17,,67,45,is location of,0.557086014531156,907785-FS1-9,Urokinase versus TISSUE PLASMINOGEN ACTIVATOR in PULMONARY EMBOLISM,PULMONARY EMBOLISM,TISSUE PLASMINOGEN ACTIVATOR,RO-may_treat
497999925,7/4/2014 12:24:37,,1314826160,7/4/2014 12:24:14,clixsense,0.8073,15189335,GBR,I9,Dereham,86.157.163.112,no_relation,49,17,,67,45,is location of,0.557086014531156,907785-FS1-9,Urokinase versus TISSUE PLASMINOGEN ACTIVATOR in PULMONARY EMBOLISM,PULMONARY EMBOLISM,TISSUE PLASMINOGEN ACTIVATOR,RO-may_treat
497999926,7/4/2014 11:33:42,,1314793167,7/4/2014 11:33:20,neodev,0.9875,18517457,GBR,,,86.29.55.201,RHEUMATOID ARTHRITIS is diagnosed by DIFLUNISAL,67,53,,87,63,is diagnosed by,0.348742916231458,907638-FS1-13,"Palmer DG, Ferry DG, Gibbins BL et al. Ibuprofen and DIFLUNISAL in RHEUMATOID ARTHRITIS: a double-blind comparative trial",RHEUMATOID ARTHRITIS,DIFLUNISAL,RO-may_treat
497999926,7/4/2014 11:50:28,,1314802913,7/4/2014 11:50:08,clixsense,0.902,27871219,NLD,7,Amsterdam,87.210.207.223,no_relation,67,53,,87,63,is diagnosed by,0.348742916231458,907638-FS1-13,"Palmer DG, Ferry DG, Gibbins BL et al. Ibuprofen and DIFLUNISAL in RHEUMATOID ARTHRITIS: a double-blind comparative trial",RHEUMATOID ARTHRITIS,DIFLUNISAL,RO-may_treat
497999926,7/4/2014 12:17:44,,1314821084,7/4/2014 12:17:16,clixsense,0.775,27969116,NLD,,,91.213.37.165,no_relation,67,53,,87,63,is diagnosed by,0.348742916231458,907638-FS1-13,"Palmer DG, Ferry DG, Gibbins BL et al. Ibuprofen and DIFLUNISAL in RHEUMATOID ARTHRITIS: a double-blind comparative trial",RHEUMATOID ARTHRITIS,DIFLUNISAL,RO-may_treat
497999927,7/4/2014 11:51:16,,1314803346,7/4/2014 11:50:54,clixsense,0.902,27871219,NLD,7,Amsterdam,87.210.207.223,EPINEPHRINE treats ANAPHYLAXIS,52,80,,63,91,treats,1,907663-FS1-2,Allergic reactions are treated with antihistamines; ANAPHYLAXIS is treated with EPINEPHRINE with IV fluids and vasopressors if necessary (see  Anaphylaxis,ANAPHYLAXIS,EPINEPHRINE,RO-may_treat
497999927,7/4/2014 12:17:44,,1314821080,7/4/2014 12:17:16,clixsense,0.775,27969116,NLD,,,91.213.37.165,EPINEPHRINE treats ANAPHYLAXIS,52,80,,63,91,treats,1,907663-FS1-2,Allergic reactions are treated with antihistamines; ANAPHYLAXIS is treated with EPINEPHRINE with IV fluids and vasopressors if necessary (see  Anaphylaxis,ANAPHYLAXIS,EPINEPHRINE,RO-may_treat
497999927,7/4/2014 12:27:24,,1314828079,7/4/2014 12:27:01,neodev,0.8048,11014534,GBR,H9,London,80.254.147.52,EPINEPHRINE treats ANAPHYLAXIS,52,80,,63,91,treats,1,907663-FS1-2,Allergic reactions are treated with antihistamines; ANAPHYLAXIS is treated with EPINEPHRINE with IV fluids and vasopressors if necessary (see  Anaphylaxis,ANAPHYLAXIS,EPINEPHRINE,RO-may_treat
497999928,7/4/2014 11:40:06,,1314796503,7/4/2014 11:39:54,neodev,0.9875,18517457,GBR,,,86.29.55.201,ORLISTAT treats OBESITY,97,54,,104,62,treats,1,907526-FS1-2,"Evaluation of the safety and efficacy of sibutramine, ORLISTAT and metformin in the treatment of OBESITY",OBESITY,ORLISTAT,RO-may_treat
497999928,7/4/2014 12:18:18,,1314821515,7/4/2014 12:17:45,clixsense,0.775,27969116,NLD,,,91.213.37.165,ORLISTAT treats OBESITY,97,54,,104,62,treats,1,907526-FS1-2,"Evaluation of the safety and efficacy of sibutramine, ORLISTAT and metformin in the treatment of OBESITY",OBESITY,ORLISTAT,RO-may_treat
497999928,7/4/2014 12:26:52,,1314827769,7/4/2014 12:26:36,clixsense,0.8073,15189335,GBR,I9,Dereham,86.157.163.112,ORLISTAT treats OBESITY,97,54,,104,62,treats,1,907526-FS1-2,"Evaluation of the safety and efficacy of sibutramine, ORLISTAT and metformin in the treatment of OBESITY",OBESITY,ORLISTAT,RO-may_treat
497999929,7/4/2014 11:33:05,,1314792855,7/4/2014 11:32:44,neodev,0.9875,18517457,GBR,,,86.29.55.201,BUSULFAN treats CHRONIC MYELOGENOUS LEUKEMIA,92,64,,120,72,treats,0.956182887467515,907521-FS1-2,"Hehlman R, Heimpel H, Hasford J et al. Randomized comparison of BUSULFAN and hydroxyurea in CHRONIC MYELOGENOUS LEUKEMIA: prolongation of survival by hydroxyurea",CHRONIC MYELOGENOUS LEUKEMIA,BUSULFAN,RO-may_treat
497999929,7/4/2014 12:21:49,,1314824334,7/4/2014 12:21:17,clixsense,0.775,27969116,NLD,,,91.213.37.165,no_relation,92,64,,120,72,treats,0.956182887467515,907521-FS1-2,"Hehlman R, Heimpel H, Hasford J et al. Randomized comparison of BUSULFAN and hydroxyurea in CHRONIC MYELOGENOUS LEUKEMIA: prolongation of survival by hydroxyurea",CHRONIC MYELOGENOUS LEUKEMIA,BUSULFAN,RO-may_treat
497999929,7/4/2014 12:29:51,,1314829526,7/4/2014 12:29:35,neodev,0.8048,11014534,GBR,H9,London,80.254.147.52,no_relation,92,64,,120,72,treats,0.956182887467515,907521-FS1-2,"Hehlman R, Heimpel H, Hasford J et al. Randomized comparison of BUSULFAN and hydroxyurea in CHRONIC MYELOGENOUS LEUKEMIA: prolongation of survival by hydroxyurea",CHRONIC MYELOGENOUS LEUKEMIA,BUSULFAN,RO-may_treat
497999930,7/4/2014 12:24:53,,1314826365,7/4/2014 12:23:49,clixsense,0.775,27969116,NLD,,,91.213.37.165,no_relation,53,0,,78,25,causes,0.975900072948533,902653-FS1-4,"MYELODYSPLASTIC SYNDROMES (MDS) are characterized by HYPERCELLULAR BONE MARROW, peripheral cytopenia and an increased rate of intramedullary apoptosis",HYPERCELLULAR BONE MARROW,MYELODYSPLASTIC SYNDROMES,RO-disease_may_have_finding
497999930,7/4/2014 12:32:37,,1314831068,7/4/2014 12:32:02,clixsense,0.8073,15189335,GBR,I9,Dereham,86.157.163.112,MYELODYSPLASTIC SYNDROMES causes HYPERCELLULAR BONE MARROW,53,0,,78,25,causes,0.975900072948533,902653-FS1-4,"MYELODYSPLASTIC SYNDROMES (MDS) are characterized by HYPERCELLULAR BONE MARROW, peripheral cytopenia and an increased rate of intramedullary apoptosis",HYPERCELLULAR BONE MARROW,MYELODYSPLASTIC SYNDROMES,RO-disease_may_have_finding
497999930,7/4/2014 12:32:37,,1314831075,7/4/2014 12:32:04,rewardsspot,0.7879,24482174,GBR,H9,London,46.23.68.180,MYELODYSPLASTIC SYNDROMES causes HYPERCELLULAR BONE MARROW,53,0,,78,25,causes,0.975900072948533,902653-FS1-4,"MYELODYSPLASTIC SYNDROMES (MDS) are characterized by HYPERCELLULAR BONE MARROW, peripheral cytopenia and an increased rate of intramedullary apoptosis",HYPERCELLULAR BONE MARROW,MYELODYSPLASTIC SYNDROMES,RO-disease_may_have_finding
497999931,7/4/2014 11:39:29,,1314796213,7/4/2014 11:38:32,clixsense,0.902,27871219,NLD,7,Amsterdam,87.210.207.223,METHENAMINE treats URINARY INFECTIONS,52,14,,70,25,treats,1,907019-FS1-2,"The action of METHENAMINE, used in the treatment of URINARY INFECTIONS, is based on the release of formaldehyde in the body",URINARY INFECTIONS,METHENAMINE,RO-may_prevent
497999931,7/4/2014 11:40:34,,1314796795,7/4/2014 11:40:21,neodev,0.9875,18517457,GBR,,,86.29.55.201,METHENAMINE treats URINARY INFECTIONS,52,14,,70,25,treats,1,907019-FS1-2,"The action of METHENAMINE, used in the treatment of URINARY INFECTIONS, is based on the release of formaldehyde in the body",URINARY INFECTIONS,METHENAMINE,RO-may_prevent
497999931,7/4/2014 12:23:02,,1314825061,7/4/2014 12:22:39,clixsense,0.775,27969116,NLD,,,91.213.37.165,METHENAMINE treats URINARY INFECTIONS,52,14,,70,25,treats,1,907019-FS1-2,"The action of METHENAMINE, used in the treatment of URINARY INFECTIONS, is based on the release of formaldehyde in the body",URINARY INFECTIONS,METHENAMINE,RO-may_prevent
497999932,7/4/2014 11:40:22,,1314796682,7/4/2014 11:39:52,clixsense,0.902,27871219,NLD,7,Amsterdam,87.210.207.223,ASPIRIN treats MYOCARDIAL INFARCTION,272,209,,293,216,treats,0.943456353049726,907118-FS1-2,Studies in patients scheduled for percutaneous coronary intervention and those with unstable angina or non-Q-wave myocardial infarction have shown that a combination of intravenous GP IIb-IIIa inhibitors with ASPIRIN and heparin is associated with a reduction in death or MYOCARDIAL INFARCTION compared with therapy with aspirin and heparin alone,MYOCARDIAL INFARCTION,ASPIRIN,RO-may_prevent
497999932,7/4/2014 12:27:52,,1314828263,7/4/2014 12:26:53,clixsense,0.8073,15189335,GBR,I9,Dereham,86.157.163.112,ASPIRIN treats MYOCARDIAL INFARCTION,272,209,,293,216,treats,0.943456353049726,907118-FS1-2,Studies in patients scheduled for percutaneous coronary intervention and those with unstable angina or non-Q-wave myocardial infarction have shown that a combination of intravenous GP IIb-IIIa inhibitors with ASPIRIN and heparin is associated with a reduction in death or MYOCARDIAL INFARCTION compared with therapy with aspirin and heparin alone,MYOCARDIAL INFARCTION,ASPIRIN,RO-may_prevent
497999932,7/4/2014 12:28:59,,1314828920,7/4/2014 12:28:44,neodev,0.8048,11014534,GBR,H9,London,80.254.147.52,ASPIRIN treats MYOCARDIAL INFARCTION,272,209,,293,216,treats,0.943456353049726,907118-FS1-2,Studies in patients scheduled for percutaneous coronary intervention and those with unstable angina or non-Q-wave myocardial infarction have shown that a combination of intravenous GP IIb-IIIa inhibitors with ASPIRIN and heparin is associated with a reduction in death or MYOCARDIAL INFARCTION compared with therapy with aspirin and heparin alone,MYOCARDIAL INFARCTION,ASPIRIN,RO-may_prevent
497999933,7/4/2014 11:34:29,,1314793546,7/4/2014 11:34:04,neodev,0.9875,18517457,GBR,,,86.29.55.201,no_relation,43,14,,61,18,causes,0.762000762001143,902739-FS1-4,Many cases of DCIS are detected because of MICROCALCIFICATION on mammograms; 20% of screen-detected cancers are of this type,MICROCALCIFICATION,DCIS,RO-disease_may_have_finding
497999933,7/4/2014 12:22:37,,1314824848,7/4/2014 12:21:51,clixsense,0.775,27969116,NLD,,,91.213.37.165,no_relation,43,14,,61,18,causes,0.762000762001143,902739-FS1-4,Many cases of DCIS are detected because of MICROCALCIFICATION on mammograms; 20% of screen-detected cancers are of this type,MICROCALCIFICATION,DCIS,RO-disease_may_have_finding
497999933,7/4/2014 12:30:15,,1314829724,7/4/2014 12:29:52,neodev,0.8048,11014534,GBR,H9,London,80.254.147.52,MICROCALCIFICATION causes DCIS,43,14,,61,18,causes,0.762000762001143,902739-FS1-4,Many cases of DCIS are detected because of MICROCALCIFICATION on mammograms; 20% of screen-detected cancers are of this type,MICROCALCIFICATION,DCIS,RO-disease_may_have_finding
497999934,7/4/2014 12:27:00,,1314827880,7/4/2014 12:26:23,neodev,0.8048,11014534,GBR,H9,London,80.254.147.52,FUROSEMIDE treats EDEMA,85,62,,90,72,treats,0.995893206467704,907519-FS1-2,"34 ,   37 ,   54 ,   55 ,   56  Appears to be as effective as FUROSEMIDE in reducing EDEMA, body weight, and abdominal girth in patients with edema secondary to renal disease",EDEMA,FUROSEMIDE,RO-may_treat
497999934,7/4/2014 12:31:57,,1314830749,7/4/2014 12:31:21,clixsense,0.8073,15189335,GBR,I9,Dereham,86.157.163.112,FUROSEMIDE treats EDEMA,85,62,,90,72,treats,0.995893206467704,907519-FS1-2,"34 ,   37 ,   54 ,   55 ,   56  Appears to be as effective as FUROSEMIDE in reducing EDEMA, body weight, and abdominal girth in patients with edema secondary to renal disease",EDEMA,FUROSEMIDE,RO-may_treat
497999934,7/4/2014 12:33:17,,1314831536,7/4/2014 12:32:43,rewardsspot,0.7879,24482174,GBR,H9,London,46.23.68.180,FUROSEMIDE treats EDEMA,85,62,,90,72,treats,0.995893206467704,907519-FS1-2,"34 ,   37 ,   54 ,   55 ,   56  Appears to be as effective as FUROSEMIDE in reducing EDEMA, body weight, and abdominal girth in patients with edema secondary to renal disease",EDEMA,FUROSEMIDE,RO-may_treat
497999935,7/4/2014 12:14:57,,1314818942,7/4/2014 12:14:13,clixsense,0.775,27969116,NLD,,,91.213.37.165,MALIGNANT PLEURAL MESOTHELIOMA causes CHEST PAIN,105,17,,115,47,causes,0.98058067569092,902728-FS1-4,"In patients with MALIGNANT PLEURAL MESOTHELIOMA, radiotherapy is useful in the palliation of symptoms of CHEST PAIN and painful masses",CHEST PAIN,MALIGNANT PLEURAL MESOTHELIOMA,RO-disease_may_have_finding
497999935,7/4/2014 12:30:15,,1314829725,7/4/2014 12:29:52,neodev,0.8048,11014534,GBR,H9,London,80.254.147.52,MALIGNANT PLEURAL MESOTHELIOMA causes CHEST PAIN,105,17,,115,47,causes,0.98058067569092,902728-FS1-4,"In patients with MALIGNANT PLEURAL MESOTHELIOMA, radiotherapy is useful in the palliation of symptoms of CHEST PAIN and painful masses",CHEST PAIN,MALIGNANT PLEURAL MESOTHELIOMA,RO-disease_may_have_finding
497999935,7/4/2014 12:31:59,,1314830785,7/4/2014 12:31:30,rewardsspot,0.7879,24482174,GBR,H9,London,46.23.68.180,CHEST PAIN causes MALIGNANT PLEURAL MESOTHELIOMA,105,17,,115,47,causes,0.98058067569092,902728-FS1-4,"In patients with MALIGNANT PLEURAL MESOTHELIOMA, radiotherapy is useful in the palliation of symptoms of CHEST PAIN and painful masses",CHEST PAIN,MALIGNANT PLEURAL MESOTHELIOMA,RO-disease_may_have_finding
497999936,7/4/2014 11:35:25,,1314794029,7/4/2014 11:34:56,neodev,0.9875,18517457,GBR,,,86.29.55.201,no_relation,163,120,,174,134,is diagnosed by,0.424264068711929,907509-FS1-13,"Ayestaran A, Lopez R, Montoro JB et al. Pharmacokinetics of conventional formulation versus fat emulsion formulation of AMPHOTERICIN B in a group of patients with NEUTROPENIA",NEUTROPENIA,AMPHOTERICIN B,RO-may_treat
497999936,7/4/2014 12:22:37,,1314824843,7/4/2014 12:21:51,clixsense,0.775,27969116,NLD,,,91.213.37.165,AMPHOTERICIN B is diagnosed by NEUTROPENIA,163,120,,174,134,is diagnosed by,0.424264068711929,907509-FS1-13,"Ayestaran A, Lopez R, Montoro JB et al. Pharmacokinetics of conventional formulation versus fat emulsion formulation of AMPHOTERICIN B in a group of patients with NEUTROPENIA",NEUTROPENIA,AMPHOTERICIN B,RO-may_treat
497999936,7/4/2014 12:31:13,,1314830288,7/4/2014 12:30:50,neodev,0.8048,11014534,GBR,H9,London,80.254.147.52,no_relation,163,120,,174,134,is diagnosed by,0.424264068711929,907509-FS1-13,"Ayestaran A, Lopez R, Montoro JB et al. Pharmacokinetics of conventional formulation versus fat emulsion formulation of AMPHOTERICIN B in a group of patients with NEUTROPENIA",NEUTROPENIA,AMPHOTERICIN B,RO-may_treat
497999937,7/4/2014 11:34:55,,1314793814,7/4/2014 11:34:45,neodev,0.9875,18517457,GBR,,,86.29.55.201,AZATHIOPRINE treats ULCERATIVE COLITIS,163,87,,181,99,treats,0.995893206467704,907572-FS1-2,"1 ,   14 ,   15 ,   17 ,   18 ,   41  Administered concomitantly with corticosteroids, AZATHIOPRINE or mercaptopurine, and/or 5-aminosalicyclates in patients with ULCERATIVE COLITIS",ULCERATIVE COLITIS,AZATHIOPRINE,RO-may_treat
497999937,7/4/2014 12:29:20,,1314829180,7/4/2014 12:29:01,neodev,0.8048,11014534,GBR,H9,London,80.254.147.52,AZATHIOPRINE treats ULCERATIVE COLITIS,163,87,,181,99,treats,0.995893206467704,907572-FS1-2,"1 ,   14 ,   15 ,   17 ,   18 ,   41  Administered concomitantly with corticosteroids, AZATHIOPRINE or mercaptopurine, and/or 5-aminosalicyclates in patients with ULCERATIVE COLITIS",ULCERATIVE COLITIS,AZATHIOPRINE,RO-may_treat
497999937,7/4/2014 12:30:15,,1314829736,7/4/2014 12:29:42,clixsense,0.8073,15189335,GBR,I9,Dereham,86.157.163.112,AZATHIOPRINE treats ULCERATIVE COLITIS,163,87,,181,99,treats,0.995893206467704,907572-FS1-2,"1 ,   14 ,   15 ,   17 ,   18 ,   41  Administered concomitantly with corticosteroids, AZATHIOPRINE or mercaptopurine, and/or 5-aminosalicyclates in patients with ULCERATIVE COLITIS",ULCERATIVE COLITIS,AZATHIOPRINE,RO-may_treat
497999938,7/4/2014 11:40:54,,1314796982,7/4/2014 11:40:36,neodev,0.9875,18517457,GBR,,,86.29.55.201,METHYLPREDNISOLONE treats GVHD,16,51,,20,69,treats,0.577350269189626,907108-FS1-2,Prophylaxis for GVHD consisted of cyclosporine and METHYLPREDNISOLONE,GVHD,METHYLPREDNISOLONE,RO-may_prevent
497999938,7/4/2014 11:52:13,,1314803825,7/4/2014 11:51:17,clixsense,0.902,27871219,NLD,7,Amsterdam,87.210.207.223,no_relation,16,51,,20,69,treats,0.577350269189626,907108-FS1-2,Prophylaxis for GVHD consisted of cyclosporine and METHYLPREDNISOLONE,GVHD,METHYLPREDNISOLONE,RO-may_prevent
497999938,7/4/2014 12:14:12,,1314818450,7/4/2014 12:13:25,clixsense,0.775,27969116,NLD,,,91.213.37.165,METHYLPREDNISOLONE treats GVHD,16,51,,20,69,treats,0.577350269189626,907108-FS1-2,Prophylaxis for GVHD consisted of cyclosporine and METHYLPREDNISOLONE,GVHD,METHYLPREDNISOLONE,RO-may_prevent
497999939,7/4/2014 11:34:03,,1314793339,7/4/2014 11:33:44,neodev,0.9875,18517457,GBR,,,86.29.55.201,PANCREATIC ADENOCARCINOMA causes WEIGHT LOSS,63,164,,74,189,causes,0.975900072948533,902684-FS1-4,"Because duodenal and/or pancreatic cancer was suspected due to WEIGHT LOSS, the pancreatic and bile duct obstruction, and the increased risk of small intestine and PANCREATIC ADENOCARCINOMA in patients with PSJ, a pancreatoduodenectomy was performed",WEIGHT LOSS,PANCREATIC ADENOCARCINOMA,RO-disease_may_have_finding
497999939,7/4/2014 11:47:07,,1314800818,7/4/2014 11:46:45,clixsense,0.902,27871219,NLD,7,Amsterdam,87.210.207.223,WEIGHT LOSS causes PANCREATIC ADENOCARCINOMA,63,164,,74,189,causes,0.975900072948533,902684-FS1-4,"Because duodenal and/or pancreatic cancer was suspected due to WEIGHT LOSS, the pancreatic and bile duct obstruction, and the increased risk of small intestine and PANCREATIC ADENOCARCINOMA in patients with PSJ, a pancreatoduodenectomy was performed",WEIGHT LOSS,PANCREATIC ADENOCARCINOMA,RO-disease_may_have_finding
497999939,7/4/2014 12:19:44,,1314822568,7/4/2014 12:19:02,clixsense,0.775,27969116,NLD,,,91.213.37.165,no_relation,63,164,,74,189,causes,0.975900072948533,902684-FS1-4,"Because duodenal and/or pancreatic cancer was suspected due to WEIGHT LOSS, the pancreatic and bile duct obstruction, and the increased risk of small intestine and PANCREATIC ADENOCARCINOMA in patients with PSJ, a pancreatoduodenectomy was performed",WEIGHT LOSS,PANCREATIC ADENOCARCINOMA,RO-disease_may_have_finding
497999940,7/4/2014 11:39:24,,1314796153,7/4/2014 11:39:13,neodev,0.9875,18517457,GBR,,,86.29.55.201,no_relation,53,14,,73,25,treats,0.896258159530272,907846-FS1-2,Comparison of CEFTRIAXONE and traditional therapy of BACTERIAL MENINGITIS,BACTERIAL MENINGITIS,CEFTRIAXONE,RO-may_treat
497999940,7/4/2014 12:28:43,,1314828787,7/4/2014 12:28:27,neodev,0.8048,11014534,GBR,H9,London,80.254.147.52,no_relation,53,14,,73,25,treats,0.896258159530272,907846-FS1-2,Comparison of CEFTRIAXONE and traditional therapy of BACTERIAL MENINGITIS,BACTERIAL MENINGITIS,CEFTRIAXONE,RO-may_treat
497999940,7/4/2014 12:32:37,,1314831069,7/4/2014 12:32:02,clixsense,0.8073,15189335,GBR,I9,Dereham,86.157.163.112,CEFTRIAXONE treats BACTERIAL MENINGITIS,53,14,,73,25,treats,0.896258159530272,907846-FS1-2,Comparison of CEFTRIAXONE and traditional therapy of BACTERIAL MENINGITIS,BACTERIAL MENINGITIS,CEFTRIAXONE,RO-may_treat
497999941,7/4/2014 11:50:52,,1314803182,7/4/2014 11:50:29,clixsense,0.902,27871219,NLD,7,Amsterdam,87.210.207.223,ENDOMETRIAL CARCINOMA contraindicates POSTMENOPAUSAL BLEEDING,5,30,,28,51,contraindicates,0.308606699924184,902767-FS1-10,"With POSTMENOPAUSAL BLEEDING, ENDOMETRIAL CARCINOMA must always be ruled out",POSTMENOPAUSAL BLEEDING,ENDOMETRIAL CARCINOMA,RO-disease_may_have_finding
497999941,7/4/2014 12:20:44,,1314823400,7/4/2014 12:20:15,clixsense,0.775,27969116,NLD,,,91.213.37.165,no_relation,5,30,,28,51,contraindicates,0.308606699924184,902767-FS1-10,"With POSTMENOPAUSAL BLEEDING, ENDOMETRIAL CARCINOMA must always be ruled out",POSTMENOPAUSAL BLEEDING,ENDOMETRIAL CARCINOMA,RO-disease_may_have_finding
497999941,7/4/2014 12:30:36,,1314829937,7/4/2014 12:30:16,neodev,0.8048,11014534,GBR,H9,London,80.254.147.52,POSTMENOPAUSAL BLEEDING contraindicates ENDOMETRIAL CARCINOMA,5,30,,28,51,contraindicates,0.308606699924184,902767-FS1-10,"With POSTMENOPAUSAL BLEEDING, ENDOMETRIAL CARCINOMA must always be ruled out",POSTMENOPAUSAL BLEEDING,ENDOMETRIAL CARCINOMA,RO-disease_may_have_finding
497999942,7/4/2014 11:34:44,,1314793719,7/4/2014 11:34:30,neodev,0.9875,18517457,GBR,,,86.29.55.201,ROSIGLITAZONE treats TYPE 2 DIABETES MELLITUS,177,105,,201,118,treats,0.98058067569092,907629-FS1-2,"May be used in combination with metformin or a thiazolidinedione antidiabetic agent (e.g., pioglitazone, ROSIGLITAZONE) as an adjunct to diet and exercise for the management of TYPE 2 DIABETES MELLITUS in patients who do not achieve adequate glycemic control with diet, exercise, and monotherapy with metformin, a sulfonylurea, repaglinide, or a thiazolidinedione antidiabetic agent",TYPE 2 DIABETES MELLITUS,ROSIGLITAZONE,RO-may_treat
497999942,7/4/2014 11:38:09,,1314795491,7/4/2014 11:37:39,clixsense,0.902,27871219,NLD,7,Amsterdam,87.210.207.223,ROSIGLITAZONE treats TYPE 2 DIABETES MELLITUS,177,105,,201,118,treats,0.98058067569092,907629-FS1-2,"May be used in combination with metformin or a thiazolidinedione antidiabetic agent (e.g., pioglitazone, ROSIGLITAZONE) as an adjunct to diet and exercise for the management of TYPE 2 DIABETES MELLITUS in patients who do not achieve adequate glycemic control with diet, exercise, and monotherapy with metformin, a sulfonylurea, repaglinide, or a thiazolidinedione antidiabetic agent",TYPE 2 DIABETES MELLITUS,ROSIGLITAZONE,RO-may_treat
497999942,7/4/2014 12:28:23,,1314828601,7/4/2014 12:27:55,clixsense,0.8073,15189335,GBR,I9,Dereham,86.157.163.112,ROSIGLITAZONE treats TYPE 2 DIABETES MELLITUS,177,105,,201,118,treats,0.98058067569092,907629-FS1-2,"May be used in combination with metformin or a thiazolidinedione antidiabetic agent (e.g., pioglitazone, ROSIGLITAZONE) as an adjunct to diet and exercise for the management of TYPE 2 DIABETES MELLITUS in patients who do not achieve adequate glycemic control with diet, exercise, and monotherapy with metformin, a sulfonylurea, repaglinide, or a thiazolidinedione antidiabetic agent",TYPE 2 DIABETES MELLITUS,ROSIGLITAZONE,RO-may_treat
497999943,7/4/2014 11:48:09,,1314801466,7/4/2014 11:47:09,clixsense,0.902,27871219,NLD,7,Amsterdam,87.210.207.223,PHENYTOIN treats POST-TRAUMATIC EPILEPSY,64,11,,87,20,treats,1,907396-FS1-2,The use of PHENYTOIN in headache syndromes and in prevention of POST-TRAUMATIC EPILEPSY is discussed,POST-TRAUMATIC EPILEPSY,PHENYTOIN,RO-may_prevent
497999943,7/4/2014 12:15:31,,1314819454,7/4/2014 12:14:58,clixsense,0.775,27969116,NLD,,,91.213.37.165,PHENYTOIN treats POST-TRAUMATIC EPILEPSY,64,11,,87,20,treats,1,907396-FS1-2,The use of PHENYTOIN in headache syndromes and in prevention of POST-TRAUMATIC EPILEPSY is discussed,POST-TRAUMATIC EPILEPSY,PHENYTOIN,RO-may_prevent
497999943,7/4/2014 12:27:45,,1314828193,7/4/2014 12:27:25,neodev,0.8048,11014534,GBR,H9,London,80.254.147.52,PHENYTOIN treats POST-TRAUMATIC EPILEPSY,64,11,,87,20,treats,1,907396-FS1-2,The use of PHENYTOIN in headache syndromes and in prevention of POST-TRAUMATIC EPILEPSY is discussed,POST-TRAUMATIC EPILEPSY,PHENYTOIN,RO-may_prevent
497999944,7/4/2014 11:46:43,,1314800617,7/4/2014 11:46:08,clixsense,0.902,27871219,NLD,7,Amsterdam,87.210.207.223,GLIBENCLAMIDE treats MATURITY ONSET DIABETES,105,59,,128,72,treats,0.811107105653813,907865-FS1-2,A clinical comparison between glipizide (Glibenese ����渇�膩��臂�申�鰹申鐃順����鐃初���申���紮�申羝�申鐃緒申��LIBENCLAMIDEnclamide (Daonil ����渇�膩��臂�申�鰹申鐃順����鐃初���申���紮�申羝�申鐃緒申�渇�膩������括�鐃順�����鰹申鐃� tMATURITY ONSET DIABETESy onset diabetes: a controlled double-blind cross-over study,MATURITY ONSET DIABETES,GLIBENCLAMIDE,RO-may_treat
497999944,7/4/2014 12:32:23,,1314830965,7/4/2014 12:31:57,neodev,0.8048,11014534,GBR,H9,London,80.254.147.52,no_relation,105,59,,128,72,treats,0.811107105653813,907865-FS1-2,A clinical comparison between glipizide (Glibenese ����渇�膩��臂�申�鰹申鐃順����鐃初���申���紮�申羝�申鐃緒申��LIBENCLAMIDEnclamide (Daonil ����渇�膩��臂�申�鰹申鐃順����鐃初���申���紮�申羝�申鐃緒申�渇�膩������括�鐃順�����鰹申鐃� tMATURITY ONSET DIABETESy onset diabetes: a controlled double-blind cross-over study,MATURITY ONSET DIABETES,GLIBENCLAMIDE,RO-may_treat
497999944,7/4/2014 12:32:37,,1314831076,7/4/2014 12:32:04,rewardsspot,0.7879,24482174,GBR,H9,London,46.23.68.180,GLIBENCLAMIDE treats MATURITY ONSET DIABETES,105,59,,128,72,treats,0.811107105653813,907865-FS1-2,A clinical comparison between glipizide (Glibenese ����渇�膩��臂�申�鰹申鐃順����鐃初���申���紮�申羝�申鐃緒申��LIBENCLAMIDEnclamide (Daonil ����渇�膩��臂�申�鰹申鐃順����鐃初���申���紮�申羝�申鐃緒申�渇�膩������括�鐃順�����鰹申鐃� tMATURITY ONSET DIABETESy onset diabetes: a controlled double-blind cross-over study,MATURITY ONSET DIABETES,GLIBENCLAMIDE,RO-may_treat
497999945,7/4/2014 11:33:18,,1314792929,7/4/2014 11:33:06,neodev,0.9875,18517457,GBR,,,86.29.55.201,FOLIC ACID treats NEURAL TUBE DEFECTS,115,77,,134,87,treats,0.997054485501582,907088-FS1-2,"These areas include rubella virus as a cause of congenital rubella syndrome, FOLIC ACID as a preventive factor for NEURAL TUBE DEFECTS, cytomegalovirus infection as a cause of birth defects and developmental disabilities, and alcohol as a cause of fetal alcohol spectrum disorders",NEURAL TUBE DEFECTS,FOLIC ACID,RO-may_prevent
497999945,7/4/2014 12:27:52,,1314828256,7/4/2014 12:26:53,clixsense,0.8073,15189335,GBR,I9,Dereham,86.157.163.112,FOLIC ACID treats NEURAL TUBE DEFECTS,115,77,,134,87,treats,0.997054485501582,907088-FS1-2,"These areas include rubella virus as a cause of congenital rubella syndrome, FOLIC ACID as a preventive factor for NEURAL TUBE DEFECTS, cytomegalovirus infection as a cause of birth defects and developmental disabilities, and alcohol as a cause of fetal alcohol spectrum disorders",NEURAL TUBE DEFECTS,FOLIC ACID,RO-may_prevent
497999945,7/4/2014 12:29:34,,1314829301,7/4/2014 12:29:22,neodev,0.8048,11014534,GBR,H9,London,80.254.147.52,FOLIC ACID treats NEURAL TUBE DEFECTS,115,77,,134,87,treats,0.997054485501582,907088-FS1-2,"These areas include rubella virus as a cause of congenital rubella syndrome, FOLIC ACID as a preventive factor for NEURAL TUBE DEFECTS, cytomegalovirus infection as a cause of birth defects and developmental disabilities, and alcohol as a cause of fetal alcohol spectrum disorders",NEURAL TUBE DEFECTS,FOLIC ACID,RO-may_prevent
497999946,7/4/2014 11:39:39,,1314796296,7/4/2014 11:39:25,neodev,0.9875,18517457,GBR,,,86.29.55.201,AMPHOTERICIN B treats NEUTROPENIA,163,120,,174,134,treats,0.848528137423857,907509-FS1-2,"Ayestaran A, Lopez R, Montoro JB et al. Pharmacokinetics of conventional formulation versus fat emulsion formulation of AMPHOTERICIN B in a group of patients with NEUTROPENIA",NEUTROPENIA,AMPHOTERICIN B,RO-may_treat
497999946,7/4/2014 11:40:22,,1314796680,7/4/2014 11:39:52,clixsense,0.902,27871219,NLD,7,Amsterdam,87.210.207.223,AMPHOTERICIN B treats NEUTROPENIA,163,120,,174,134,treats,0.848528137423857,907509-FS1-2,"Ayestaran A, Lopez R, Montoro JB et al. Pharmacokinetics of conventional formulation versus fat emulsion formulation of AMPHOTERICIN B in a group of patients with NEUTROPENIA",NEUTROPENIA,AMPHOTERICIN B,RO-may_treat
497999946,7/4/2014 11:46:58,,1314800742,7/4/2014 11:46:32,tremorgames,0.875,25257192,CAN,ON,North York,207.188.64.245,AMPHOTERICIN B treats NEUTROPENIA,163,120,,174,134,treats,0.848528137423857,907509-FS1-2,"Ayestaran A, Lopez R, Montoro JB et al. Pharmacokinetics of conventional formulation versus fat emulsion formulation of AMPHOTERICIN B in a group of patients with NEUTROPENIA",NEUTROPENIA,AMPHOTERICIN B,RO-may_treat
497999947,7/4/2014 11:38:31,,1314795616,7/4/2014 11:38:09,clixsense,0.902,27871219,NLD,7,Amsterdam,87.210.207.223,BONE METASTASES causes PATHOLOGIC FRACTURE,189,100,,208,115,causes,0.904534033733291,902668-FS1-4,"Bone is a preferred site of metastasis for many solid tumors, and the complications associated with BONE METASTASES can result in significant skeletal morbidity including severe bone pain, PATHOLOGIC FRACTURE, spinal cord compression, and hypercalcemia of malignancy (HCM",PATHOLOGIC FRACTURE,BONE METASTASES,RO-disease_may_have_finding
497999947,7/4/2014 12:27:00,,1314827894,7/4/2014 12:26:23,neodev,0.8048,11014534,GBR,H9,London,80.254.147.52,BONE METASTASES causes PATHOLOGIC FRACTURE,189,100,,208,115,causes,0.904534033733291,902668-FS1-4,"Bone is a preferred site of metastasis for many solid tumors, and the complications associated with BONE METASTASES can result in significant skeletal morbidity including severe bone pain, PATHOLOGIC FRACTURE, spinal cord compression, and hypercalcemia of malignancy (HCM",PATHOLOGIC FRACTURE,BONE METASTASES,RO-disease_may_have_finding
497999947,7/4/2014 12:31:03,,1314830204,7/4/2014 12:30:37,clixsense,0.8073,15189335,GBR,I9,Dereham,86.157.163.112,BONE METASTASES causes PATHOLOGIC FRACTURE,189,100,,208,115,causes,0.904534033733291,902668-FS1-4,"Bone is a preferred site of metastasis for many solid tumors, and the complications associated with BONE METASTASES can result in significant skeletal morbidity including severe bone pain, PATHOLOGIC FRACTURE, spinal cord compression, and hypercalcemia of malignancy (HCM",PATHOLOGIC FRACTURE,BONE METASTASES,RO-disease_may_have_finding
497999948,7/4/2014 11:40:06,,1314796506,7/4/2014 11:39:54,neodev,0.9875,18517457,GBR,,,86.29.55.201,CUSHING SYNDROME is diagnosed by DEXAMETHASONE,84,66,,100,79,is diagnosed by,0.609994281330419,906631-FS1-13,"We tried to detect salivary cortisol level with drug loading test(DEXAMETHASONE for CUSHING SYNDROME, and ACTH for adrenal insufficiency) with time interval",CUSHING SYNDROME,DEXAMETHASONE,RO-may_diagnose
497999948,7/4/2014 11:49:13,,1314802147,7/4/2014 11:48:10,clixsense,0.902,27871219,NLD,7,Amsterdam,87.210.207.223,CUSHING SYNDROME is diagnosed by DEXAMETHASONE,84,66,,100,79,is diagnosed by,0.609994281330419,906631-FS1-13,"We tried to detect salivary cortisol level with drug loading test(DEXAMETHASONE for CUSHING SYNDROME, and ACTH for adrenal insufficiency) with time interval",CUSHING SYNDROME,DEXAMETHASONE,RO-may_diagnose
497999948,7/4/2014 12:26:05,,1314827097,7/4/2014 12:25:18,clixsense,0.8073,15189335,GBR,I9,Dereham,86.157.163.112,no_relation,84,66,,100,79,is diagnosed by,0.609994281330419,906631-FS1-13,"We tried to detect salivary cortisol level with drug loading test(DEXAMETHASONE for CUSHING SYNDROME, and ACTH for adrenal insufficiency) with time interval",CUSHING SYNDROME,DEXAMETHASONE,RO-may_diagnose
497999949,7/4/2014 11:38:31,,1314795615,7/4/2014 11:38:09,clixsense,0.902,27871219,NLD,7,Amsterdam,87.210.207.223,HEMOPHAGOCYTIC SYNDROME causes PANCYTOPENIA,78,0,,90,23,causes,0.991836598134176,902642-FS1-4,HEMOPHAGOCYTIC SYNDROME (HPS) is a life-threatening disorder characterized by PANCYTOPENIA and activation of macrophages,PANCYTOPENIA,HEMOPHAGOCYTIC SYNDROME,RO-disease_may_have_finding
497999949,7/4/2014 12:17:15,,1314820750,7/4/2014 12:16:44,clixsense,0.775,27969116,NLD,,,91.213.37.165,no_relation,78,0,,90,23,causes,0.991836598134176,902642-FS1-4,HEMOPHAGOCYTIC SYNDROME (HPS) is a life-threatening disorder characterized by PANCYTOPENIA and activation of macrophages,PANCYTOPENIA,HEMOPHAGOCYTIC SYNDROME,RO-disease_may_have_finding
497999949,7/4/2014 12:29:40,,1314829371,7/4/2014 12:29:02,clixsense,0.8073,15189335,GBR,I9,Dereham,86.157.163.112,HEMOPHAGOCYTIC SYNDROME causes PANCYTOPENIA,78,0,,90,23,causes,0.991836598134176,902642-FS1-4,HEMOPHAGOCYTIC SYNDROME (HPS) is a life-threatening disorder characterized by PANCYTOPENIA and activation of macrophages,PANCYTOPENIA,HEMOPHAGOCYTIC SYNDROME,RO-disease_may_have_finding
497999950,7/4/2014 11:39:53,,1314796395,7/4/2014 11:39:41,neodev,0.9875,18517457,GBR,,,86.29.55.201,LIGNOCAINE treats PAIN,116,172,,120,182,treats,0.995893206467704,907183-FS1-2,When administered intravenously in the dorsum of the hand the pain score and the number of patients who experienced PAIN was reduced significantly by mixing the agent with LIGNOCAINE when compared with a bolus injection,PAIN,LIGNOCAINE,RO-may_prevent
497999950,7/4/2014 12:31:56,,1314830747,7/4/2014 12:31:34,neodev,0.8048,11014534,GBR,H9,London,80.254.147.52,LIGNOCAINE treats PAIN,116,172,,120,182,treats,0.995893206467704,907183-FS1-2,When administered intravenously in the dorsum of the hand the pain score and the number of patients who experienced PAIN was reduced significantly by mixing the agent with LIGNOCAINE when compared with a bolus injection,PAIN,LIGNOCAINE,RO-may_prevent
497999950,7/4/2014 12:31:57,,1314830766,7/4/2014 12:31:21,clixsense,0.8073,15189335,GBR,I9,Dereham,86.157.163.112,LIGNOCAINE treats PAIN,116,172,,120,182,treats,0.995893206467704,907183-FS1-2,When administered intravenously in the dorsum of the hand the pain score and the number of patients who experienced PAIN was reduced significantly by mixing the agent with LIGNOCAINE when compared with a bolus injection,PAIN,LIGNOCAINE,RO-may_prevent
497999951,7/4/2014 11:41:46,,1314797518,7/4/2014 11:41:24,neodev,0.9875,18517457,GBR,,,86.29.55.201,THYROID DISORDERS is diagnosed by TRIIODOTHYRONINE,80,138,,97,154,is diagnosed by,0.940720868383597,906871-FS1-13,"The commonly used laboratory investigations for the diagnosis and management of THYROID DISORDERS are the thyroid hormones, thyroxine and TRIIODOTHYRONINE and the pituitary hormone, thyrotrophin (TSH",THYROID DISORDERS,TRIIODOTHYRONINE,RO-may_diagnose
497999951,7/4/2014 11:50:52,,1314803166,7/4/2014 11:50:29,clixsense,0.902,27871219,NLD,7,Amsterdam,87.210.207.223,THYROID DISORDERS is diagnosed by TRIIODOTHYRONINE,80,138,,97,154,is diagnosed by,0.940720868383597,906871-FS1-13,"The commonly used laboratory investigations for the diagnosis and management of THYROID DISORDERS are the thyroid hormones, thyroxine and TRIIODOTHYRONINE and the pituitary hormone, thyrotrophin (TSH",THYROID DISORDERS,TRIIODOTHYRONINE,RO-may_diagnose
497999951,7/4/2014 12:14:12,,1314818449,7/4/2014 12:13:25,clixsense,0.775,27969116,NLD,,,91.213.37.165,TRIIODOTHYRONINE is diagnosed by THYROID DISORDERS,80,138,,97,154,is diagnosed by,0.940720868383597,906871-FS1-13,"The commonly used laboratory investigations for the diagnosis and management of THYROID DISORDERS are the thyroid hormones, thyroxine and TRIIODOTHYRONINE and the pituitary hormone, thyrotrophin (TSH",THYROID DISORDERS,TRIIODOTHYRONINE,RO-may_diagnose
497999952,7/4/2014 12:24:53,,1314826382,7/4/2014 12:23:49,clixsense,0.775,27969116,NLD,,,91.213.37.165,no_relation,73,106,,97,114,treats,0.979795897113271,907345-FS1-2,"In order to evaluate the preventive effect of estrogen and vitamin D3 on POSTMENOPAUSAL BONE LOSS, either ESTROGEN (Premarin 0.625 mg/day) or vitamin D3 (Onealfa 1.0 micrograms/day) was administered to postmenopausal women",POSTMENOPAUSAL BONE LOSS,ESTROGEN,RO-may_prevent
497999952,7/4/2014 12:28:10,,1314828515,7/4/2014 12:27:46,neodev,0.8048,11014534,GBR,H9,London,80.254.147.52,ESTROGEN treats POSTMENOPAUSAL BONE LOSS,73,106,,97,114,treats,0.979795897113271,907345-FS1-2,"In order to evaluate the preventive effect of estrogen and vitamin D3 on POSTMENOPAUSAL BONE LOSS, either ESTROGEN (Premarin 0.625 mg/day) or vitamin D3 (Onealfa 1.0 micrograms/day) was administered to postmenopausal women",POSTMENOPAUSAL BONE LOSS,ESTROGEN,RO-may_prevent
497999952,7/4/2014 12:29:40,,1314829346,7/4/2014 12:29:02,clixsense,0.8073,15189335,GBR,I9,Dereham,86.157.163.112,ESTROGEN treats POSTMENOPAUSAL BONE LOSS,73,106,,97,114,treats,0.979795897113271,907345-FS1-2,"In order to evaluate the preventive effect of estrogen and vitamin D3 on POSTMENOPAUSAL BONE LOSS, either ESTROGEN (Premarin 0.625 mg/day) or vitamin D3 (Onealfa 1.0 micrograms/day) was administered to postmenopausal women",POSTMENOPAUSAL BONE LOSS,ESTROGEN,RO-may_prevent
497999953,7/4/2014 12:26:34,,1314827567,7/4/2014 12:26:06,clixsense,0.8073,15189335,GBR,I9,Dereham,86.157.163.112,DEXAMETHASONE treats HYPERCORTISOLISM,48,104,,64,117,treats,0.78086880944303,906657-FS1-2,"Very high plasma androgen levels or evidence of HYPERCORTISOLISM, which is not normally suppressible by DEXAMETHASONE, should lead to the search for a tumor or Cushing's syndrome",HYPERCORTISOLISM,DEXAMETHASONE,RO-may_diagnose
497999953,7/4/2014 12:32:37,,1314831058,7/4/2014 12:32:25,neodev,0.8048,11014534,GBR,H9,London,80.254.147.52,no_relation,48,104,,64,117,treats,0.78086880944303,906657-FS1-2,"Very high plasma androgen levels or evidence of HYPERCORTISOLISM, which is not normally suppressible by DEXAMETHASONE, should lead to the search for a tumor or Cushing's syndrome",HYPERCORTISOLISM,DEXAMETHASONE,RO-may_diagnose
497999953,7/4/2014 12:33:17,,1314831523,7/4/2014 12:32:43,rewardsspot,0.7879,24482174,GBR,H9,London,46.23.68.180,DEXAMETHASONE treats HYPERCORTISOLISM,48,104,,64,117,treats,0.78086880944303,906657-FS1-2,"Very high plasma androgen levels or evidence of HYPERCORTISOLISM, which is not normally suppressible by DEXAMETHASONE, should lead to the search for a tumor or Cushing's syndrome",HYPERCORTISOLISM,DEXAMETHASONE,RO-may_diagnose
497999954,7/4/2014 11:34:29,,1314793545,7/4/2014 11:34:04,neodev,0.9875,18517457,GBR,,,86.29.55.201,no_relation,48,104,,64,117,causes,0.312347523777212,906657-FS1-4,"Very high plasma androgen levels or evidence of HYPERCORTISOLISM, which is not normally suppressible by DEXAMETHASONE, should lead to the search for a tumor or Cushing's syndrome",HYPERCORTISOLISM,DEXAMETHASONE,RO-may_diagnose
497999954,7/4/2014 11:49:13,,1314802135,7/4/2014 11:48:10,clixsense,0.902,27871219,NLD,7,Amsterdam,87.210.207.223,no_relation,48,104,,64,117,causes,0.312347523777212,906657-FS1-4,"Very high plasma androgen levels or evidence of HYPERCORTISOLISM, which is not normally suppressible by DEXAMETHASONE, should lead to the search for a tumor or Cushing's syndrome",HYPERCORTISOLISM,DEXAMETHASONE,RO-may_diagnose
497999954,7/4/2014 12:14:57,,1314818941,7/4/2014 12:14:13,clixsense,0.775,27969116,NLD,,,91.213.37.165,no_relation,48,104,,64,117,causes,0.312347523777212,906657-FS1-4,"Very high plasma androgen levels or evidence of HYPERCORTISOLISM, which is not normally suppressible by DEXAMETHASONE, should lead to the search for a tumor or Cushing's syndrome",HYPERCORTISOLISM,DEXAMETHASONE,RO-may_diagnose
497999955,7/4/2014 11:47:07,,1314800821,7/4/2014 11:46:45,clixsense,0.902,27871219,NLD,7,Amsterdam,87.210.207.223,ISOTRETINOIN treats ACNE,37,61,,41,73,treats,0.983869910099907,907655-FS1-2,Association of suicide attempts with ACNE and treatment with ISOTRETINOIN: retrospective Swedish cohort study,ACNE,ISOTRETINOIN,RO-may_treat
497999955,7/4/2014 12:31:19,,1314830363,7/4/2014 12:31:05,clixsense,0.8073,15189335,GBR,I9,Dereham,86.157.163.112,ISOTRETINOIN treats ACNE,37,61,,41,73,treats,0.983869910099907,907655-FS1-2,Association of suicide attempts with ACNE and treatment with ISOTRETINOIN: retrospective Swedish cohort study,ACNE,ISOTRETINOIN,RO-may_treat
497999955,7/4/2014 12:32:23,,1314830962,7/4/2014 12:31:57,neodev,0.8048,11014534,GBR,H9,London,80.254.147.52,ISOTRETINOIN treats ACNE,37,61,,41,73,treats,0.983869910099907,907655-FS1-2,Association of suicide attempts with ACNE and treatment with ISOTRETINOIN: retrospective Swedish cohort study,ACNE,ISOTRETINOIN,RO-may_treat
497999956,7/4/2014 11:41:23,,1314797284,7/4/2014 11:41:07,neodev,0.9875,18517457,GBR,,,86.29.55.201,BUPIVACAINE causes PAIN,94,124,,98,135,causes,0.919145030018058,907397-FS1-4,There was no difference in the rate of regression of sensory anesthesia or the development of PAIN among patients receiving BUPIVACAINE alone or bupivacaine with fentanyl,PAIN,BUPIVACAINE,RO-may_prevent
497999956,7/4/2014 12:28:10,,1314828516,7/4/2014 12:27:46,neodev,0.8048,11014534,GBR,H9,London,80.254.147.52,no_relation,94,124,,98,135,causes,0.919145030018058,907397-FS1-4,There was no difference in the rate of regression of sensory anesthesia or the development of PAIN among patients receiving BUPIVACAINE alone or bupivacaine with fentanyl,PAIN,BUPIVACAINE,RO-may_prevent
497999956,7/4/2014 12:30:40,,1314829980,7/4/2014 12:30:22,rewardsspot,0.7879,24482174,GBR,H9,London,46.23.68.180,PAIN causes BUPIVACAINE,94,124,,98,135,causes,0.919145030018058,907397-FS1-4,There was no difference in the rate of regression of sensory anesthesia or the development of PAIN among patients receiving BUPIVACAINE alone or bupivacaine with fentanyl,PAIN,BUPIVACAINE,RO-may_prevent
497999957,7/4/2014 11:34:03,,1314793328,7/4/2014 11:33:44,neodev,0.9875,18517457,GBR,,,86.29.55.201,MONONUCLEOSIS causes SPLENIC RUPTURE,35,68,,50,81,causes,0.970494958830946,902649-FS1-4,We do not recommend observation of SPLENIC RUPTURE in patients with MONONUCLEOSIS because of the danger of delayed hemorrhage,SPLENIC RUPTURE,MONONUCLEOSIS,RO-disease_may_have_finding
497999957,7/4/2014 11:39:29,,1314796214,7/4/2014 11:38:32,clixsense,0.902,27871219,NLD,7,Amsterdam,87.210.207.223,MONONUCLEOSIS causes SPLENIC RUPTURE,35,68,,50,81,causes,0.970494958830946,902649-FS1-4,We do not recommend observation of SPLENIC RUPTURE in patients with MONONUCLEOSIS because of the danger of delayed hemorrhage,SPLENIC RUPTURE,MONONUCLEOSIS,RO-disease_may_have_finding
497999957,7/4/2014 12:19:00,,1314822053,7/4/2014 12:18:19,clixsense,0.775,27969116,NLD,,,91.213.37.165,no_relation,35,68,,50,81,causes,0.970494958830946,902649-FS1-4,We do not recommend observation of SPLENIC RUPTURE in patients with MONONUCLEOSIS because of the danger of delayed hemorrhage,SPLENIC RUPTURE,MONONUCLEOSIS,RO-disease_may_have_finding
497999958,7/4/2014 11:41:23,,1314797283,7/4/2014 11:41:07,neodev,0.9875,18517457,GBR,,,86.29.55.201,INVASIVE DUCTAL CARCINOMA causes SOLID PATTERN,39,4,,52,29,causes,0.975900072948533,902666-FS1-4,"The INVASIVE DUCTAL CARCINOMA showed a SOLID PATTERN, high nuclear and structural atypia and frequent mitotic figures, while the tubular adenoma consisted of a proliferation of small ducts lined by single layers of epithelial and myoepithelial cells with bland nuclei and inconspicuous nucleoli",SOLID PATTERN,INVASIVE DUCTAL CARCINOMA,RO-disease_may_have_finding
497999958,7/4/2014 11:45:30,,1314799745,7/4/2014 11:44:52,tremorgames,0.875,25257192,CAN,ON,North York,207.188.64.245,no_relation,39,4,,52,29,causes,0.975900072948533,902666-FS1-4,"The INVASIVE DUCTAL CARCINOMA showed a SOLID PATTERN, high nuclear and structural atypia and frequent mitotic figures, while the tubular adenoma consisted of a proliferation of small ducts lined by single layers of epithelial and myoepithelial cells with bland nuclei and inconspicuous nucleoli",SOLID PATTERN,INVASIVE DUCTAL CARCINOMA,RO-disease_may_have_finding
497999958,7/4/2014 12:18:18,,1314821516,7/4/2014 12:17:45,clixsense,0.775,27969116,NLD,,,91.213.37.165,no_relation,39,4,,52,29,causes,0.975900072948533,902666-FS1-4,"The INVASIVE DUCTAL CARCINOMA showed a SOLID PATTERN, high nuclear and structural atypia and frequent mitotic figures, while the tubular adenoma consisted of a proliferation of small ducts lined by single layers of epithelial and myoepithelial cells with bland nuclei and inconspicuous nucleoli",SOLID PATTERN,INVASIVE DUCTAL CARCINOMA,RO-disease_may_have_finding
497999959,7/4/2014 11:44:50,,1314799257,7/4/2014 11:44:32,tremorgames,0.875,25257192,CAN,ON,North York,207.188.64.245,PAPAVERINE treats ERECTILE DYSFUNCTION,118,87,,138,97,treats,0.983869910099907,906513-FS1-2,"In our experience, E1-PG intracavernous injection has proven to be more effective than PAPAVERINE in the treatment of ERECTILE DYSFUNCTION and therefore, added to its safety and degree of acceptance, we consider it a first choice approach in the diagnosis and treatment of erectile dysfunction in males",ERECTILE DYSFUNCTION,PAPAVERINE,RO-may_diagnose
497999959,7/4/2014 12:26:52,,1314827771,7/4/2014 12:26:36,clixsense,0.8073,15189335,GBR,I9,Dereham,86.157.163.112,PAPAVERINE treats ERECTILE DYSFUNCTION,118,87,,138,97,treats,0.983869910099907,906513-FS1-2,"In our experience, E1-PG intracavernous injection has proven to be more effective than PAPAVERINE in the treatment of ERECTILE DYSFUNCTION and therefore, added to its safety and degree of acceptance, we consider it a first choice approach in the diagnosis and treatment of erectile dysfunction in males",ERECTILE DYSFUNCTION,PAPAVERINE,RO-may_diagnose
497999959,7/4/2014 12:27:24,,1314828081,7/4/2014 12:27:01,neodev,0.8048,11014534,GBR,H9,London,80.254.147.52,PAPAVERINE treats ERECTILE DYSFUNCTION,118,87,,138,97,treats,0.983869910099907,906513-FS1-2,"In our experience, E1-PG intracavernous injection has proven to be more effective than PAPAVERINE in the treatment of ERECTILE DYSFUNCTION and therefore, added to its safety and degree of acceptance, we consider it a first choice approach in the diagnosis and treatment of erectile dysfunction in males",ERECTILE DYSFUNCTION,PAPAVERINE,RO-may_diagnose
497999960,7/4/2014 11:35:38,,1314794201,7/4/2014 11:35:26,neodev,0.9875,18517457,GBR,,,86.29.55.201,INSULIN treats HYPERGLYCEMIA,82,138,,95,145,treats,0.98058067569092,907915-FS1-2,"Beta cells are nonetheless destroyed (by unknown means), and the patient develops HYPERGLYCEMIA or ketoacidosis unless he or she receives INSULIN",HYPERGLYCEMIA,INSULIN,RO-may_treat
497999960,7/4/2014 11:37:37,,1314795230,7/4/2014 11:36:54,clixsense,0.902,27871219,NLD,7,Amsterdam,87.210.207.223,INSULIN treats HYPERGLYCEMIA,82,138,,95,145,treats,0.98058067569092,907915-FS1-2,"Beta cells are nonetheless destroyed (by unknown means), and the patient develops HYPERGLYCEMIA or ketoacidosis unless he or she receives INSULIN",HYPERGLYCEMIA,INSULIN,RO-may_treat
497999960,7/4/2014 12:20:14,,1314823004,7/4/2014 12:19:45,clixsense,0.775,27969116,NLD,,,91.213.37.165,INSULIN treats HYPERGLYCEMIA,82,138,,95,145,treats,0.98058067569092,907915-FS1-2,"Beta cells are nonetheless destroyed (by unknown means), and the patient develops HYPERGLYCEMIA or ketoacidosis unless he or she receives INSULIN",HYPERGLYCEMIA,INSULIN,RO-may_treat
497999961,7/4/2014 11:50:06,,1314802661,7/4/2014 11:49:14,clixsense,0.902,27871219,NLD,7,Amsterdam,87.210.207.223,IMIPRAMINE treats DEPRESSION,102,71,,112,81,treats,1,907634-FS1-2,A double-blind comparison of the efficacy and safety of paroxetine and IMIPRAMINE in the treatment of DEPRESSION with dementia,DEPRESSION,IMIPRAMINE,RO-may_treat
497999961,7/4/2014 12:15:31,,1314819448,7/4/2014 12:14:58,clixsense,0.775,27969116,NLD,,,91.213.37.165,IMIPRAMINE treats DEPRESSION,102,71,,112,81,treats,1,907634-FS1-2,A double-blind comparison of the efficacy and safety of paroxetine and IMIPRAMINE in the treatment of DEPRESSION with dementia,DEPRESSION,IMIPRAMINE,RO-may_treat
497999961,7/4/2014 12:30:35,,1314829901,7/4/2014 12:30:19,clixsense,0.8073,15189335,GBR,I9,Dereham,86.157.163.112,IMIPRAMINE treats DEPRESSION,102,71,,112,81,treats,1,907634-FS1-2,A double-blind comparison of the efficacy and safety of paroxetine and IMIPRAMINE in the treatment of DEPRESSION with dementia,DEPRESSION,IMIPRAMINE,RO-may_treat
497999962,7/4/2014 11:40:17,,1314796633,7/4/2014 11:40:07,neodev,0.9875,18517457,GBR,,,86.29.55.201,PROMETHAZINE treats VOMITING,289,369,,297,381,treats,0.981980506061966,907548-FS1-2,"b  Class:  Antihistamines 56:22.08; First Generation Antihistamines 4:04; A04AD (ATC)  Synonyms:  dimenhy DRINATE ; Anti-nauseant; Anti-nausee; Dimenhydrinate; Dinate; Gravergol; Gravol; Nauseatol; Travel  Uses  Motion Sickness  Used principally in the prevention and treatment of nausea, VOMITING, and/or vertigo associated with motion sickness, although scopolamine, PROMETHAZINE, or meclizine may be more effective",VOMITING,PROMETHAZINE,RO-may_treat
497999962,7/4/2014 12:16:42,,1314820336,7/4/2014 12:16:05,clixsense,0.775,27969116,NLD,,,91.213.37.165,no_relation,289,369,,297,381,treats,0.981980506061966,907548-FS1-2,"b  Class:  Antihistamines 56:22.08; First Generation Antihistamines 4:04; A04AD (ATC)  Synonyms:  dimenhy DRINATE ; Anti-nauseant; Anti-nausee; Dimenhydrinate; Dinate; Gravergol; Gravol; Nauseatol; Travel  Uses  Motion Sickness  Used principally in the prevention and treatment of nausea, VOMITING, and/or vertigo associated with motion sickness, although scopolamine, PROMETHAZINE, or meclizine may be more effective",VOMITING,PROMETHAZINE,RO-may_treat
497999962,7/4/2014 12:25:17,,1314826631,7/4/2014 12:24:38,clixsense,0.8073,15189335,GBR,I9,Dereham,86.157.163.112,PROMETHAZINE treats VOMITING,289,369,,297,381,treats,0.981980506061966,907548-FS1-2,"b  Class:  Antihistamines 56:22.08; First Generation Antihistamines 4:04; A04AD (ATC)  Synonyms:  dimenhy DRINATE ; Anti-nauseant; Anti-nausee; Dimenhydrinate; Dinate; Gravergol; Gravol; Nauseatol; Travel  Uses  Motion Sickness  Used principally in the prevention and treatment of nausea, VOMITING, and/or vertigo associated with motion sickness, although scopolamine, PROMETHAZINE, or meclizine may be more effective",VOMITING,PROMETHAZINE,RO-may_treat
497999963,7/4/2014 12:16:03,,1314819812,7/4/2014 12:15:33,clixsense,0.775,27969116,NLD,,,91.213.37.165,ERGONOVINE is diagnosed by VASOSPASTIC ANGINA,156,103,,174,113,is diagnosed by,0.975900072948533,906650-FS1-13,"These results suggest that the two provocative tests for coronary spasm that involve acetylcholine and ERGONOVINE are clinically useful in the diagnosis of VASOSPASTIC ANGINA, but testing with intracoronary ergonovine is needed when a spontaneous focal coronary spasm is relieved by the intracoronary injection of acetylcholine",VASOSPASTIC ANGINA,ERGONOVINE,RO-may_diagnose
497999963,7/4/2014 12:31:56,,1314830758,7/4/2014 12:31:34,neodev,0.8048,11014534,GBR,H9,London,80.254.147.52,VASOSPASTIC ANGINA is diagnosed by ERGONOVINE,156,103,,174,113,is diagnosed by,0.975900072948533,906650-FS1-13,"These results suggest that the two provocative tests for coronary spasm that involve acetylcholine and ERGONOVINE are clinically useful in the diagnosis of VASOSPASTIC ANGINA, but testing with intracoronary ergonovine is needed when a spontaneous focal coronary spasm is relieved by the intracoronary injection of acetylcholine",VASOSPASTIC ANGINA,ERGONOVINE,RO-may_diagnose
497999963,7/4/2014 12:33:13,,1314831449,7/4/2014 12:32:39,clixsense,0.8073,15189335,GBR,I9,Dereham,86.157.163.112,VASOSPASTIC ANGINA is diagnosed by ERGONOVINE,156,103,,174,113,is diagnosed by,0.975900072948533,906650-FS1-13,"These results suggest that the two provocative tests for coronary spasm that involve acetylcholine and ERGONOVINE are clinically useful in the diagnosis of VASOSPASTIC ANGINA, but testing with intracoronary ergonovine is needed when a spontaneous focal coronary spasm is relieved by the intracoronary injection of acetylcholine",VASOSPASTIC ANGINA,ERGONOVINE,RO-may_diagnose
497999964,7/4/2014 11:33:05,,1314792856,7/4/2014 11:32:44,neodev,0.9875,18517457,GBR,,,86.29.55.201,CHOLECALCIFEROL treats OSTEOPOROSIS,103,55,,115,70,treats,1,907503-FS1-2,Alendronate is used alone or in fixed combination with CHOLECALCIFEROL (vitamin D 3 ) for treatment of OSTEOPOROSIS in postmenopausal women,OSTEOPOROSIS,CHOLECALCIFEROL,RO-may_treat
497999964,7/4/2014 11:44:31,,1314799114,7/4/2014 11:43:56,tremorgames,0.875,25257192,CAN,ON,North York,207.188.64.245,CHOLECALCIFEROL treats OSTEOPOROSIS,103,55,,115,70,treats,1,907503-FS1-2,Alendronate is used alone or in fixed combination with CHOLECALCIFEROL (vitamin D 3 ) for treatment of OSTEOPOROSIS in postmenopausal women,OSTEOPOROSIS,CHOLECALCIFEROL,RO-may_treat
497999964,7/4/2014 12:25:29,,1314826773,7/4/2014 12:24:55,clixsense,0.775,27969116,NLD,,,91.213.37.165,CHOLECALCIFEROL treats OSTEOPOROSIS,103,55,,115,70,treats,1,907503-FS1-2,Alendronate is used alone or in fixed combination with CHOLECALCIFEROL (vitamin D 3 ) for treatment of OSTEOPOROSIS in postmenopausal women,OSTEOPOROSIS,CHOLECALCIFEROL,RO-may_treat
497999965,7/4/2014 11:33:18,,1314792928,7/4/2014 11:33:06,neodev,0.9875,18517457,GBR,,,86.29.55.201,FUROSEMIDE treats CHRONIC RENAL FAILURE,115,76,,136,86,treats,0.929981109950554,907701-FS1-2,"1]  Knauf H, Mutschler E. Diuretic effectiveness of hydrochlorothiazide and FUROSEMIDE alone and in combination in CHRONIC RENAL FAILURE",CHRONIC RENAL FAILURE,FUROSEMIDE,RO-may_treat
497999965,7/4/2014 12:26:09,,1314827168,7/4/2014 12:25:31,clixsense,0.775,27969116,NLD,,,91.213.37.165,FUROSEMIDE treats CHRONIC RENAL FAILURE,115,76,,136,86,treats,0.929981109950554,907701-FS1-2,"1]  Knauf H, Mutschler E. Diuretic effectiveness of hydrochlorothiazide and FUROSEMIDE alone and in combination in CHRONIC RENAL FAILURE",CHRONIC RENAL FAILURE,FUROSEMIDE,RO-may_treat
497999965,7/4/2014 12:31:33,,1314830529,7/4/2014 12:31:15,neodev,0.8048,11014534,GBR,H9,London,80.254.147.52,FUROSEMIDE treats CHRONIC RENAL FAILURE,115,76,,136,86,treats,0.929981109950554,907701-FS1-2,"1]  Knauf H, Mutschler E. Diuretic effectiveness of hydrochlorothiazide and FUROSEMIDE alone and in combination in CHRONIC RENAL FAILURE",CHRONIC RENAL FAILURE,FUROSEMIDE,RO-may_treat
497999966,7/4/2014 11:40:17,,1314796670,7/4/2014 11:40:07,neodev,0.9875,18517457,GBR,,,86.29.55.201,PULMONARY EMBOLISM treats TISSUE PLASMINOGEN ACTIVATOR,49,17,,67,45,treats,0.371390676354104,907785-FS1-2,Urokinase versus TISSUE PLASMINOGEN ACTIVATOR in PULMONARY EMBOLISM,PULMONARY EMBOLISM,TISSUE PLASMINOGEN ACTIVATOR,RO-may_treat
497999966,7/4/2014 11:44:50,,1314799260,7/4/2014 11:44:32,tremorgames,0.875,25257192,CAN,ON,North York,207.188.64.245,no_relation,49,17,,67,45,treats,0.371390676354104,907785-FS1-2,Urokinase versus TISSUE PLASMINOGEN ACTIVATOR in PULMONARY EMBOLISM,PULMONARY EMBOLISM,TISSUE PLASMINOGEN ACTIVATOR,RO-may_treat
497999966,7/4/2014 11:48:09,,1314801461,7/4/2014 11:47:09,clixsense,0.902,27871219,NLD,7,Amsterdam,87.210.207.223,TISSUE PLASMINOGEN ACTIVATOR treats PULMONARY EMBOLISM,49,17,,67,45,treats,0.371390676354104,907785-FS1-2,Urokinase versus TISSUE PLASMINOGEN ACTIVATOR in PULMONARY EMBOLISM,PULMONARY EMBOLISM,TISSUE PLASMINOGEN ACTIVATOR,RO-may_treat
497999967,7/4/2014 11:35:48,,1314794261,7/4/2014 11:35:40,neodev,0.9875,18517457,GBR,,,86.29.55.201,THYROXINE treats THYROID DEFICIENCY,180,126,,198,135,treats,0.635000635000953,907209-FS1-2,"In developing PTU-treated rats, the abnormalities completely disappeared after therapy with increasing physiological doses of THYROXINE; consequently they were directly related to THYROID DEFICIENCY and not to toxic effects of PTU",THYROID DEFICIENCY,THYROXINE,RO-may_prevent
497999967,7/4/2014 12:28:23,,1314828600,7/4/2014 12:27:55,clixsense,0.8073,15189335,GBR,I9,Dereham,86.157.163.112,THYROXINE treats THYROID DEFICIENCY,180,126,,198,135,treats,0.635000635000953,907209-FS1-2,"In developing PTU-treated rats, the abnormalities completely disappeared after therapy with increasing physiological doses of THYROXINE; consequently they were directly related to THYROID DEFICIENCY and not to toxic effects of PTU",THYROID DEFICIENCY,THYROXINE,RO-may_prevent
497999967,7/4/2014 12:31:24,,1314830432,7/4/2014 12:30:46,rewardsspot,0.7879,24482174,GBR,H9,London,46.23.68.180,THYROXINE treats THYROID DEFICIENCY,180,126,,198,135,treats,0.635000635000953,907209-FS1-2,"In developing PTU-treated rats, the abnormalities completely disappeared after therapy with increasing physiological doses of THYROXINE; consequently they were directly related to THYROID DEFICIENCY and not to toxic effects of PTU",THYROID DEFICIENCY,THYROXINE,RO-may_prevent
497999968,7/4/2014 12:26:09,,1314827179,7/4/2014 12:25:31,clixsense,0.775,27969116,NLD,,,91.213.37.165,ORLISTAT treats OBESITY,106,76,,113,84,treats,0.957826285221151,907616-FS1-2,"James WP, Avenell A, Broom J et al. A one-year trial to assess the value of ORLISTAT in the management of OBESITY",OBESITY,ORLISTAT,RO-may_treat
497999968,7/4/2014 12:30:36,,1314829928,7/4/2014 12:30:16,neodev,0.8048,11014534,GBR,H9,London,80.254.147.52,ORLISTAT treats OBESITY,106,76,,113,84,treats,0.957826285221151,907616-FS1-2,"James WP, Avenell A, Broom J et al. A one-year trial to assess the value of ORLISTAT in the management of OBESITY",OBESITY,ORLISTAT,RO-may_treat
497999968,7/4/2014 12:30:40,,1314829981,7/4/2014 12:30:22,rewardsspot,0.7879,24482174,GBR,H9,London,46.23.68.180,ORLISTAT treats OBESITY,106,76,,113,84,treats,0.957826285221151,907616-FS1-2,"James WP, Avenell A, Broom J et al. A one-year trial to assess the value of ORLISTAT in the management of OBESITY",OBESITY,ORLISTAT,RO-may_treat
497999969,7/4/2014 11:41:06,,1314797155,7/4/2014 11:40:55,neodev,0.9875,18517457,GBR,,,86.29.55.201,PRAVASTATIN treats HYPERCHOLESTEROLEMIA,87,71,,107,82,treats,0.991836598134176,907624-FS1-2,"Comparison of the efficacy, safety and tolerability of simvastatin and PRAVASTATIN for HYPERCHOLESTEROLEMIA",HYPERCHOLESTEROLEMIA,PRAVASTATIN,RO-may_treat
497999969,7/4/2014 12:31:13,,1314830290,7/4/2014 12:30:50,neodev,0.8048,11014534,GBR,H9,London,80.254.147.52,PRAVASTATIN treats HYPERCHOLESTEROLEMIA,87,71,,107,82,treats,0.991836598134176,907624-FS1-2,"Comparison of the efficacy, safety and tolerability of simvastatin and PRAVASTATIN for HYPERCHOLESTEROLEMIA",HYPERCHOLESTEROLEMIA,PRAVASTATIN,RO-may_treat
497999969,7/4/2014 12:31:19,,1314830364,7/4/2014 12:31:05,clixsense,0.8073,15189335,GBR,I9,Dereham,86.157.163.112,PRAVASTATIN treats HYPERCHOLESTEROLEMIA,87,71,,107,82,treats,0.991836598134176,907624-FS1-2,"Comparison of the efficacy, safety and tolerability of simvastatin and PRAVASTATIN for HYPERCHOLESTEROLEMIA",HYPERCHOLESTEROLEMIA,PRAVASTATIN,RO-may_treat
497999970,7/4/2014 11:39:39,,1314796299,7/4/2014 11:39:25,neodev,0.9875,18517457,GBR,,,86.29.55.201,KETOPROFEN treats RHEUMATOID ARTHRITIS,130,82,,150,92,treats,1,907589-FS1-2,"El-Ghobarey AF, Rennie JAN, Hadidi T et al. A comparative trial of large doses of KETOPROFEN and indomethacin in the treatment of RHEUMATOID ARTHRITIS",RHEUMATOID ARTHRITIS,KETOPROFEN,RO-may_treat
497999970,7/4/2014 12:29:34,,1314829310,7/4/2014 12:29:22,neodev,0.8048,11014534,GBR,H9,London,80.254.147.52,KETOPROFEN treats RHEUMATOID ARTHRITIS,130,82,,150,92,treats,1,907589-FS1-2,"El-Ghobarey AF, Rennie JAN, Hadidi T et al. A comparative trial of large doses of KETOPROFEN and indomethacin in the treatment of RHEUMATOID ARTHRITIS",RHEUMATOID ARTHRITIS,KETOPROFEN,RO-may_treat
497999970,7/4/2014 12:31:59,,1314830786,7/4/2014 12:31:30,rewardsspot,0.7879,24482174,GBR,H9,London,46.23.68.180,KETOPROFEN treats RHEUMATOID ARTHRITIS,130,82,,150,92,treats,1,907589-FS1-2,"El-Ghobarey AF, Rennie JAN, Hadidi T et al. A comparative trial of large doses of KETOPROFEN and indomethacin in the treatment of RHEUMATOID ARTHRITIS",RHEUMATOID ARTHRITIS,KETOPROFEN,RO-may_treat
497999971,7/4/2014 12:25:29,,1314826772,7/4/2014 12:24:55,clixsense,0.775,27969116,NLD,,,91.213.37.165,no_relation,50,96,,62,112,causes,0.348155311911396,902671-FS1-4,Evidence: ? Vigilant intraoperative management of HYPERTENSION is essential during resection of PHEOCHROMOCYTOMA,HYPERTENSION,PHEOCHROMOCYTOMA,RO-disease_may_have_finding
497999971,7/4/2014 12:30:49,,1314830060,7/4/2014 12:30:37,neodev,0.8048,11014534,GBR,H9,London,80.254.147.52,no_relation,50,96,,62,112,causes,0.348155311911396,902671-FS1-4,Evidence: ? Vigilant intraoperative management of HYPERTENSION is essential during resection of PHEOCHROMOCYTOMA,HYPERTENSION,PHEOCHROMOCYTOMA,RO-disease_may_have_finding
497999971,7/4/2014 12:31:03,,1314830223,7/4/2014 12:30:37,clixsense,0.8073,15189335,GBR,I9,Dereham,86.157.163.112,no_relation,50,96,,62,112,causes,0.348155311911396,902671-FS1-4,Evidence: ? Vigilant intraoperative management of HYPERTENSION is essential during resection of PHEOCHROMOCYTOMA,HYPERTENSION,PHEOCHROMOCYTOMA,RO-disease_may_have_finding
497999972,7/4/2014 12:20:14,,1314823003,7/4/2014 12:19:45,clixsense,0.775,27969116,NLD,,,91.213.37.165,no_relation,5,30,,28,51,causes,0.771516749810459,902767-FS1-4,"With POSTMENOPAUSAL BLEEDING, ENDOMETRIAL CARCINOMA must always be ruled out",POSTMENOPAUSAL BLEEDING,ENDOMETRIAL CARCINOMA,RO-disease_may_have_finding
497999972,7/4/2014 12:26:34,,1314827569,7/4/2014 12:26:06,clixsense,0.8073,15189335,GBR,I9,Dereham,86.157.163.112,ENDOMETRIAL CARCINOMA causes POSTMENOPAUSAL BLEEDING,5,30,,28,51,causes,0.771516749810459,902767-FS1-4,"With POSTMENOPAUSAL BLEEDING, ENDOMETRIAL CARCINOMA must always be ruled out",POSTMENOPAUSAL BLEEDING,ENDOMETRIAL CARCINOMA,RO-disease_may_have_finding
497999972,7/4/2014 12:30:49,,1314830054,7/4/2014 12:30:37,neodev,0.8048,11014534,GBR,H9,London,80.254.147.52,POSTMENOPAUSAL BLEEDING causes ENDOMETRIAL CARCINOMA,5,30,,28,51,causes,0.771516749810459,902767-FS1-4,"With POSTMENOPAUSAL BLEEDING, ENDOMETRIAL CARCINOMA must always be ruled out",POSTMENOPAUSAL BLEEDING,ENDOMETRIAL CARCINOMA,RO-disease_may_have_finding
497999973,7/4/2014 11:40:54,,1314796984,7/4/2014 11:40:36,neodev,0.9875,18517457,GBR,,,86.29.55.201,ERGOMETRINE treats VARIANT ANGINA,214,128,,228,139,treats,0.964901281354015,906931-FS1-2,"Studies were performed on isolated canine coronary artery segments to characterize the mechanism of the constrictor response of ERGOMETRINE (ergonovine), an agent used to induce coronary vasospasm in patients with VARIANT ANGINA",VARIANT ANGINA,ERGOMETRINE,RO-may_diagnose
497999973,7/4/2014 12:23:47,,1314825612,7/4/2014 12:23:04,clixsense,0.775,27969116,NLD,,,91.213.37.165,ERGOMETRINE treats VARIANT ANGINA,214,128,,228,139,treats,0.964901281354015,906931-FS1-2,"Studies were performed on isolated canine coronary artery segments to characterize the mechanism of the constrictor response of ERGOMETRINE (ergonovine), an agent used to induce coronary vasospasm in patients with VARIANT ANGINA",VARIANT ANGINA,ERGOMETRINE,RO-may_diagnose
497999973,7/4/2014 12:28:43,,1314828784,7/4/2014 12:28:27,neodev,0.8048,11014534,GBR,H9,London,80.254.147.52,ERGOMETRINE treats VARIANT ANGINA,214,128,,228,139,treats,0.964901281354015,906931-FS1-2,"Studies were performed on isolated canine coronary artery segments to characterize the mechanism of the constrictor response of ERGOMETRINE (ergonovine), an agent used to induce coronary vasospasm in patients with VARIANT ANGINA",VARIANT ANGINA,ERGOMETRINE,RO-may_diagnose
497999974,7/4/2014 11:46:30,,1314800479,7/4/2014 11:46:11,tremorgames,0.875,25257192,CAN,ON,North York,207.188.64.245,INTERFERON treats MULTIPLE MYELOMA,42,11,,58,21,treats,1,907873-FS1-2,The use of INTERFERON in the treatment of MULTIPLE MYELOMA,MULTIPLE MYELOMA,INTERFERON,RO-may_treat
497999974,7/4/2014 11:50:28,,1314802921,7/4/2014 11:50:08,clixsense,0.902,27871219,NLD,7,Amsterdam,87.210.207.223,INTERFERON treats MULTIPLE MYELOMA,42,11,,58,21,treats,1,907873-FS1-2,The use of INTERFERON in the treatment of MULTIPLE MYELOMA,MULTIPLE MYELOMA,INTERFERON,RO-may_treat
497999974,7/4/2014 12:23:02,,1314825048,7/4/2014 12:22:39,clixsense,0.775,27969116,NLD,,,91.213.37.165,INTERFERON treats MULTIPLE MYELOMA,42,11,,58,21,treats,1,907873-FS1-2,The use of INTERFERON in the treatment of MULTIPLE MYELOMA,MULTIPLE MYELOMA,INTERFERON,RO-may_treat
497999975,7/4/2014 12:29:51,,1314829535,7/4/2014 12:29:35,neodev,0.8048,11014534,GBR,H9,London,80.254.147.52,ITRACONAZOLE treats BLASTOMYCOSIS,14,51,,27,63,treats,1,907822-FS1-2,"Children with BLASTOMYCOSIS should be treated with ITRACONAZOLE, 5 to 7 mg/kg/day",BLASTOMYCOSIS,ITRACONAZOLE,RO-may_treat
497999975,7/4/2014 12:30:35,,1314829888,7/4/2014 12:30:19,clixsense,0.8073,15189335,GBR,I9,Dereham,86.157.163.112,ITRACONAZOLE treats BLASTOMYCOSIS,14,51,,27,63,treats,1,907822-FS1-2,"Children with BLASTOMYCOSIS should be treated with ITRACONAZOLE, 5 to 7 mg/kg/day",BLASTOMYCOSIS,ITRACONAZOLE,RO-may_treat
497999975,7/4/2014 12:34:03,,1314832014,7/4/2014 12:33:38,rewardsspot,0.7879,24482174,GBR,H9,London,46.23.68.180,ITRACONAZOLE treats BLASTOMYCOSIS,14,51,,27,63,treats,1,907822-FS1-2,"Children with BLASTOMYCOSIS should be treated with ITRACONAZOLE, 5 to 7 mg/kg/day",BLASTOMYCOSIS,ITRACONAZOLE,RO-may_treat
497999976,7/4/2014 11:39:24,,1314796151,7/4/2014 11:39:13,neodev,0.9875,18517457,GBR,,,86.29.55.201,GABAPENTIN treats PAIN,125,110,,129,120,treats,0.995893206467704,907864-FS1-2,"20 ,   21 ,   22 ,   23 ,   24 ,   25 ,   40 ,   41 ,   42 ,   43 ,   44 ,   45   40% of patients who receive GABAPENTIN for PAIN associated with diabetic neuropathy obtain good pain relief",PAIN,GABAPENTIN,RO-may_treat
497999976,7/4/2014 11:53:15,,1314804502,7/4/2014 11:52:39,clixsense,0.902,27871219,NLD,7,Amsterdam,87.210.207.223,GABAPENTIN treats PAIN,125,110,,129,120,treats,0.995893206467704,907864-FS1-2,"20 ,   21 ,   22 ,   23 ,   24 ,   25 ,   40 ,   41 ,   42 ,   43 ,   44 ,   45   40% of patients who receive GABAPENTIN for PAIN associated with diabetic neuropathy obtain good pain relief",PAIN,GABAPENTIN,RO-may_treat
497999976,7/4/2014 12:23:47,,1314825616,7/4/2014 12:23:04,clixsense,0.775,27969116,NLD,,,91.213.37.165,GABAPENTIN treats PAIN,125,110,,129,120,treats,0.995893206467704,907864-FS1-2,"20 ,   21 ,   22 ,   23 ,   24 ,   25 ,   40 ,   41 ,   42 ,   43 ,   44 ,   45   40% of patients who receive GABAPENTIN for PAIN associated with diabetic neuropathy obtain good pain relief",PAIN,GABAPENTIN,RO-may_treat
497999977,7/4/2014 11:46:09,,1314800288,7/4/2014 11:45:32,tremorgames,0.875,25257192,CAN,ON,North York,207.188.64.245,TERBINAFINE treats TINEA CAPITIS,140,108,,153,119,treats,0.995037190209989,907640-FS1-2,"Kullavanijaya P, Reangchainam S, Ungpakorn R. Randomized single-blind study of efficacy and tolerability of TERBINAFINE in the treatment of TINEA CAPITIS",TINEA CAPITIS,TERBINAFINE,RO-may_treat
497999977,7/4/2014 12:19:00,,1314822062,7/4/2014 12:18:19,clixsense,0.775,27969116,NLD,,,91.213.37.165,TERBINAFINE treats TINEA CAPITIS,140,108,,153,119,treats,0.995037190209989,907640-FS1-2,"Kullavanijaya P, Reangchainam S, Ungpakorn R. Randomized single-blind study of efficacy and tolerability of TERBINAFINE in the treatment of TINEA CAPITIS",TINEA CAPITIS,TERBINAFINE,RO-may_treat
497999977,7/4/2014 12:25:17,,1314826632,7/4/2014 12:24:38,clixsense,0.8073,15189335,GBR,I9,Dereham,86.157.163.112,TERBINAFINE treats TINEA CAPITIS,140,108,,153,119,treats,0.995037190209989,907640-FS1-2,"Kullavanijaya P, Reangchainam S, Ungpakorn R. Randomized single-blind study of efficacy and tolerability of TERBINAFINE in the treatment of TINEA CAPITIS",TINEA CAPITIS,TERBINAFINE,RO-may_treat
497999978,7/4/2014 12:29:00,,1314828928,7/4/2014 12:28:26,clixsense,0.8073,15189335,GBR,I9,Dereham,86.157.163.112,ONDANSETRON treats EMESIS,51,109,,57,120,treats,0.964901281354015,907273-FS1-2,Eight patients achieved good control of nausea and EMESIS with ondansetron alone while two patients required ONDANSETRON and diphenhydramine,EMESIS,ONDANSETRON,RO-may_prevent
497999978,7/4/2014 12:29:20,,1314829177,7/4/2014 12:29:01,neodev,0.8048,11014534,GBR,H9,London,80.254.147.52,ONDANSETRON treats EMESIS,51,109,,57,120,treats,0.964901281354015,907273-FS1-2,Eight patients achieved good control of nausea and EMESIS with ondansetron alone while two patients required ONDANSETRON and diphenhydramine,EMESIS,ONDANSETRON,RO-may_prevent
497999978,7/4/2014 12:31:24,,1314830434,7/4/2014 12:30:46,rewardsspot,0.7879,24482174,GBR,H9,London,46.23.68.180,ONDANSETRON treats EMESIS,51,109,,57,120,treats,0.964901281354015,907273-FS1-2,Eight patients achieved good control of nausea and EMESIS with ondansetron alone while two patients required ONDANSETRON and diphenhydramine,EMESIS,ONDANSETRON,RO-may_prevent
497999979,7/4/2014 11:38:09,,1314795486,7/4/2014 11:37:39,clixsense,0.902,27871219,NLD,7,Amsterdam,87.210.207.223,DCIS is diagnosed by MICROCALCIFICATION,43,14,,61,18,is diagnosed by,0.635000635000953,902739-FS1-13,Many cases of DCIS are detected because of MICROCALCIFICATION on mammograms; 20% of screen-detected cancers are of this type,MICROCALCIFICATION,DCIS,RO-disease_may_have_finding
497999979,7/4/2014 11:41:46,,1314797516,7/4/2014 11:41:24,neodev,0.9875,18517457,GBR,,,86.29.55.201,DCIS is diagnosed by MICROCALCIFICATION,43,14,,61,18,is diagnosed by,0.635000635000953,902739-FS1-13,Many cases of DCIS are detected because of MICROCALCIFICATION on mammograms; 20% of screen-detected cancers are of this type,MICROCALCIFICATION,DCIS,RO-disease_may_have_finding
497999979,7/4/2014 12:16:42,,1314820326,7/4/2014 12:16:05,clixsense,0.775,27969116,NLD,,,91.213.37.165,DCIS is diagnosed by MICROCALCIFICATION,43,14,,61,18,is diagnosed by,0.635000635000953,902739-FS1-13,Many cases of DCIS are detected because of MICROCALCIFICATION on mammograms; 20% of screen-detected cancers are of this type,MICROCALCIFICATION,DCIS,RO-disease_may_have_finding
497999980,7/4/2014 11:46:43,,1314800616,7/4/2014 11:46:08,clixsense,0.902,27871219,NLD,7,Amsterdam,87.210.207.223,ANTIARRHYTHMIC AGENTS treats DYSRHYTHMIA,0,45,,11,66,treats,1,907097-FS1-2,"DYSRHYTHMIA should be treated with atropine, ANTIARRHYTHMIC AGENTS, and a temporary pacemaker, in order to avoid lethal results",DYSRHYTHMIA,ANTIARRHYTHMIC AGENTS,RO-may_prevent
497999980,7/4/2014 12:21:49,,1314824314,7/4/2014 12:21:17,clixsense,0.775,27969116,NLD,,,91.213.37.165,ANTIARRHYTHMIC AGENTS treats DYSRHYTHMIA,0,45,,11,66,treats,1,907097-FS1-2,"DYSRHYTHMIA should be treated with atropine, ANTIARRHYTHMIC AGENTS, and a temporary pacemaker, in order to avoid lethal results",DYSRHYTHMIA,ANTIARRHYTHMIC AGENTS,RO-may_prevent
497999980,7/4/2014 12:28:59,,1314828917,7/4/2014 12:28:44,neodev,0.8048,11014534,GBR,H9,London,80.254.147.52,ANTIARRHYTHMIC AGENTS treats DYSRHYTHMIA,0,45,,11,66,treats,1,907097-FS1-2,"DYSRHYTHMIA should be treated with atropine, ANTIARRHYTHMIC AGENTS, and a temporary pacemaker, in order to avoid lethal results",DYSRHYTHMIA,ANTIARRHYTHMIC AGENTS,RO-may_prevent
497999981,7/4/2014 11:39:50,,1314796373,7/4/2014 11:39:30,clixsense,0.902,27871219,NLD,7,Amsterdam,87.210.207.223,PENTAMIDINE ISETHIONATE treats PNEUMOCYSTIS PNEUMONIA,101,68,,123,91,treats,0.953462589245592,907179-FS1-2,"In 1984, three patients died of severe hypoglycemia after receiving PENTAMIDINE ISETHIONATE to treat PNEUMOCYSTIS PNEUMONIA",PNEUMOCYSTIS PNEUMONIA,PENTAMIDINE ISETHIONATE,RO-may_prevent
497999981,7/4/2014 12:27:45,,1314828187,7/4/2014 12:27:25,neodev,0.8048,11014534,GBR,H9,London,80.254.147.52,PNEUMOCYSTIS PNEUMONIA treats PENTAMIDINE ISETHIONATE,101,68,,123,91,treats,0.953462589245592,907179-FS1-2,"In 1984, three patients died of severe hypoglycemia after receiving PENTAMIDINE ISETHIONATE to treat PNEUMOCYSTIS PNEUMONIA",PNEUMOCYSTIS PNEUMONIA,PENTAMIDINE ISETHIONATE,RO-may_prevent
497999981,7/4/2014 12:33:13,,1314831442,7/4/2014 12:32:39,clixsense,0.8073,15189335,GBR,I9,Dereham,86.157.163.112,PENTAMIDINE ISETHIONATE treats PNEUMOCYSTIS PNEUMONIA,101,68,,123,91,treats,0.953462589245592,907179-FS1-2,"In 1984, three patients died of severe hypoglycemia after receiving PENTAMIDINE ISETHIONATE to treat PNEUMOCYSTIS PNEUMONIA",PNEUMOCYSTIS PNEUMONIA,PENTAMIDINE ISETHIONATE,RO-may_prevent
497999982,7/4/2014 11:39:53,,1314796394,7/4/2014 11:39:41,neodev,0.9875,18517457,GBR,,,86.29.55.201,DEXAMETHASONE contraindicates HYPERCORTISOLISM,48,104,,64,117,contraindicates,0.468521285665818,906657-FS1-10,"Very high plasma androgen levels or evidence of HYPERCORTISOLISM, which is not normally suppressible by DEXAMETHASONE, should lead to the search for a tumor or Cushing's syndrome",HYPERCORTISOLISM,DEXAMETHASONE,RO-may_diagnose
497999982,7/4/2014 11:46:09,,1314800289,7/4/2014 11:45:32,tremorgames,0.875,25257192,CAN,ON,North York,207.188.64.245,DEXAMETHASONE contraindicates HYPERCORTISOLISM,48,104,,64,117,contraindicates,0.468521285665818,906657-FS1-10,"Very high plasma androgen levels or evidence of HYPERCORTISOLISM, which is not normally suppressible by DEXAMETHASONE, should lead to the search for a tumor or Cushing's syndrome",HYPERCORTISOLISM,DEXAMETHASONE,RO-may_diagnose
497999982,7/4/2014 11:50:06,,1314802683,7/4/2014 11:49:14,clixsense,0.902,27871219,NLD,7,Amsterdam,87.210.207.223,no_relation,48,104,,64,117,contraindicates,0.468521285665818,906657-FS1-10,"Very high plasma androgen levels or evidence of HYPERCORTISOLISM, which is not normally suppressible by DEXAMETHASONE, should lead to the search for a tumor or Cushing's syndrome",HYPERCORTISOLISM,DEXAMETHASONE,RO-may_diagnose
497999983,7/4/2014 11:52:38,,1314804047,7/4/2014 11:52:14,clixsense,0.902,27871219,NLD,7,Amsterdam,87.210.207.223,SIMVASTATIN treats HYPERCHOLESTEROLEMIA,53,107,,73,118,treats,1,907900-FS1-2,"Tikkanen MJ, Laakso M, Ilmonen M et al. Treatment of HYPERCHOLESTEROLEMIA and combined hyperlipidemia with SIMVASTATIN and gemfibrozil in patients with NIDDM",HYPERCHOLESTEROLEMIA,SIMVASTATIN,RO-may_treat
497999983,7/4/2014 12:20:44,,1314823401,7/4/2014 12:20:15,clixsense,0.775,27969116,NLD,,,91.213.37.165,no_relation,53,107,,73,118,treats,1,907900-FS1-2,"Tikkanen MJ, Laakso M, Ilmonen M et al. Treatment of HYPERCHOLESTEROLEMIA and combined hyperlipidemia with SIMVASTATIN and gemfibrozil in patients with NIDDM",HYPERCHOLESTEROLEMIA,SIMVASTATIN,RO-may_treat
497999983,7/4/2014 12:24:37,,1314826161,7/4/2014 12:24:14,clixsense,0.8073,15189335,GBR,I9,Dereham,86.157.163.112,SIMVASTATIN treats HYPERCHOLESTEROLEMIA,53,107,,73,118,treats,1,907900-FS1-2,"Tikkanen MJ, Laakso M, Ilmonen M et al. Treatment of HYPERCHOLESTEROLEMIA and combined hyperlipidemia with SIMVASTATIN and gemfibrozil in patients with NIDDM",HYPERCHOLESTEROLEMIA,SIMVASTATIN,RO-may_treat
497999984,7/4/2014 11:35:25,,1314794028,7/4/2014 11:34:56,neodev,0.9875,18517457,GBR,,,86.29.55.201,DIFLUNISAL treats RHEUMATOID ARTHRITIS,67,53,,87,63,treats,0.929981109950554,907638-FS1-2,"Palmer DG, Ferry DG, Gibbins BL et al. Ibuprofen and DIFLUNISAL in RHEUMATOID ARTHRITIS: a double-blind comparative trial",RHEUMATOID ARTHRITIS,DIFLUNISAL,RO-may_treat
497999984,7/4/2014 11:51:16,,1314803348,7/4/2014 11:50:54,clixsense,0.902,27871219,NLD,7,Amsterdam,87.210.207.223,DIFLUNISAL treats RHEUMATOID ARTHRITIS,67,53,,87,63,treats,0.929981109950554,907638-FS1-2,"Palmer DG, Ferry DG, Gibbins BL et al. Ibuprofen and DIFLUNISAL in RHEUMATOID ARTHRITIS: a double-blind comparative trial",RHEUMATOID ARTHRITIS,DIFLUNISAL,RO-may_treat
497999984,7/4/2014 12:16:03,,1314819793,7/4/2014 12:15:33,clixsense,0.775,27969116,NLD,,,91.213.37.165,no_relation,67,53,,87,63,treats,0.929981109950554,907638-FS1-2,"Palmer DG, Ferry DG, Gibbins BL et al. Ibuprofen and DIFLUNISAL in RHEUMATOID ARTHRITIS: a double-blind comparative trial",RHEUMATOID ARTHRITIS,DIFLUNISAL,RO-may_treat
497999985,7/4/2014 11:39:50,,1314796372,7/4/2014 11:39:30,clixsense,0.902,27871219,NLD,7,Amsterdam,87.210.207.223,no_relation,90,0,,102,5,causes,0.416025147168922,906474-FS1-4,"SMMCI has also been found as an isolated finding or together with other anomalies such as MICROCEPHALY, short stature, endocrine pathology, and choanal atresia",MICROCEPHALY,SMMCI,RO-has_manifestation
497999985,7/4/2014 11:40:34,,1314796796,7/4/2014 11:40:21,neodev,0.9875,18517457,GBR,,,86.29.55.201,no_relation,90,0,,102,5,causes,0.416025147168922,906474-FS1-4,"SMMCI has also been found as an isolated finding or together with other anomalies such as MICROCEPHALY, short stature, endocrine pathology, and choanal atresia",MICROCEPHALY,SMMCI,RO-has_manifestation
497999985,7/4/2014 12:31:33,,1314830533,7/4/2014 12:31:15,neodev,0.8048,11014534,GBR,H9,London,80.254.147.52,no_relation,90,0,,102,5,causes,0.416025147168922,906474-FS1-4,"SMMCI has also been found as an isolated finding or together with other anomalies such as MICROCEPHALY, short stature, endocrine pathology, and choanal atresia",MICROCEPHALY,SMMCI,RO-has_manifestation
497999986,7/4/2014 11:35:48,,1314794260,7/4/2014 11:35:40,neodev,0.9875,18517457,GBR,,,86.29.55.201,LANSOPRAZOLE treats GASTRIC ULCERS,46,74,,60,86,treats,0.917662935482247,907805-FS1-2,"cOmeprazole and lansoprazole are approved for GASTRIC ULCERS; omeprazole, LANSOPRAZOLE, and rabeprazole are approved for duodenal ulcers",GASTRIC ULCERS,LANSOPRAZOLE,RO-may_treat
497999986,7/4/2014 11:46:30,,1314800487,7/4/2014 11:46:11,tremorgames,0.875,25257192,CAN,ON,North York,207.188.64.245,no_relation,46,74,,60,86,treats,0.917662935482247,907805-FS1-2,"cOmeprazole and lansoprazole are approved for GASTRIC ULCERS; omeprazole, LANSOPRAZOLE, and rabeprazole are approved for duodenal ulcers",GASTRIC ULCERS,LANSOPRAZOLE,RO-may_treat
497999986,7/4/2014 12:29:00,,1314828929,7/4/2014 12:28:26,clixsense,0.8073,15189335,GBR,I9,Dereham,86.157.163.112,LANSOPRAZOLE treats GASTRIC ULCERS,46,74,,60,86,treats,0.917662935482247,907805-FS1-2,"cOmeprazole and lansoprazole are approved for GASTRIC ULCERS; omeprazole, LANSOPRAZOLE, and rabeprazole are approved for duodenal ulcers",GASTRIC ULCERS,LANSOPRAZOLE,RO-may_treat
498023341,7/4/2014 15:04:34,false,1314949832,7/4/2014 15:04:07,clixsense,0.7667,27969116,NLD,4,Veendam,185.12.216.74,no_relation,69,11,,97,23,treats,0.956182887467515,907847-FS1-2,Effects of CHLORAMBUCIL and therapeutic decision in initial forms of CHRONIC LYMPHOCYTIC LEUKEMIA (stage A): results of a randomized clinical trial on 612 patients,CHRONIC LYMPHOCYTIC LEUKEMIA,CHLORAMBUCIL,RO-may_treat
498023341,7/4/2014 15:19:28,false,1314961329,7/4/2014 15:19:07,clixsense,0.6246,15189335,GBR,I9,Dereham,86.157.163.112,CHLORAMBUCIL treats CHRONIC LYMPHOCYTIC LEUKEMIA,69,11,,97,23,treats,0.956182887467515,907847-FS1-2,Effects of CHLORAMBUCIL and therapeutic decision in initial forms of CHRONIC LYMPHOCYTIC LEUKEMIA (stage A): results of a randomized clinical trial on 612 patients,CHRONIC LYMPHOCYTIC LEUKEMIA,CHLORAMBUCIL,RO-may_treat
498023341,7/4/2014 15:31:15,false,1314971483,7/4/2014 15:31:00,prodege,0.6637,14848125,GBR,V2,Glasgow,86.130.194.252,CHLORAMBUCIL treats CHRONIC LYMPHOCYTIC LEUKEMIA,69,11,,97,23,treats,0.956182887467515,907847-FS1-2,Effects of CHLORAMBUCIL and therapeutic decision in initial forms of CHRONIC LYMPHOCYTIC LEUKEMIA (stage A): results of a randomized clinical trial on 612 patients,CHRONIC LYMPHOCYTIC LEUKEMIA,CHLORAMBUCIL,RO-may_treat
498023341,7/4/2014 15:47:18,false,1314983270,7/4/2014 15:46:47,bitcoinget,0.6363,21490602,USA,NJ,Dunellen,68.193.37.224,CHLORAMBUCIL treats CHRONIC LYMPHOCYTIC LEUKEMIA,69,11,,97,23,treats,0.956182887467515,907847-FS1-2,Effects of CHLORAMBUCIL and therapeutic decision in initial forms of CHRONIC LYMPHOCYTIC LEUKEMIA (stage A): results of a randomized clinical trial on 612 patients,CHRONIC LYMPHOCYTIC LEUKEMIA,CHLORAMBUCIL,RO-may_treat
498023341,7/4/2014 15:48:44,false,1314984514,7/4/2014 15:48:09,rewardsspot,0.6639,24482174,GBR,H9,London,146.185.23.27,CHLORAMBUCIL treats CHRONIC LYMPHOCYTIC LEUKEMIA,69,11,,97,23,treats,0.956182887467515,907847-FS1-2,Effects of CHLORAMBUCIL and therapeutic decision in initial forms of CHRONIC LYMPHOCYTIC LEUKEMIA (stage A): results of a randomized clinical trial on 612 patients,CHRONIC LYMPHOCYTIC LEUKEMIA,CHLORAMBUCIL,RO-may_treat
498023342,7/4/2014 15:01:47,false,1314947481,7/4/2014 15:01:19,clixsense,0.7667,27969116,NLD,4,Veendam,185.12.216.74,DEXAMETHASONE treats CUSHING SYNDROME,84,66,,100,79,treats,0.762492851663023,906631-FS1-2,"We tried to detect salivary cortisol level with drug loading test(DEXAMETHASONE for CUSHING SYNDROME, and ACTH for adrenal insufficiency) with time interval",CUSHING SYNDROME,DEXAMETHASONE,RO-may_diagnose
498023342,7/4/2014 15:10:53,false,1314955005,7/4/2014 15:10:35,clixsense,0.6479,6394333,GBR,,,86.29.240.182,no_relation,84,66,,100,79,treats,0.762492851663023,906631-FS1-2,"We tried to detect salivary cortisol level with drug loading test(DEXAMETHASONE for CUSHING SYNDROME, and ACTH for adrenal insufficiency) with time interval",CUSHING SYNDROME,DEXAMETHASONE,RO-may_diagnose
498023342,7/4/2014 15:28:09,false,1314968589,7/4/2014 15:27:46,prodege,0.6637,14848125,GBR,V2,Glasgow,86.130.194.252,DEXAMETHASONE treats CUSHING SYNDROME,84,66,,100,79,treats,0.762492851663023,906631-FS1-2,"We tried to detect salivary cortisol level with drug loading test(DEXAMETHASONE for CUSHING SYNDROME, and ACTH for adrenal insufficiency) with time interval",CUSHING SYNDROME,DEXAMETHASONE,RO-may_diagnose
498023342,7/4/2014 15:33:25,false,1314973357,7/4/2014 15:33:12,gptbanks,0.4263,18496428,USA,CA,Newhall,199.244.112.44,CUSHING SYNDROME treats DEXAMETHASONE,84,66,,100,79,treats,0.762492851663023,906631-FS1-2,"We tried to detect salivary cortisol level with drug loading test(DEXAMETHASONE for CUSHING SYNDROME, and ACTH for adrenal insufficiency) with time interval",CUSHING SYNDROME,DEXAMETHASONE,RO-may_diagnose
498023342,7/4/2014 15:48:15,false,1314984068,7/4/2014 15:47:54,bitcoinget,0.6363,21490602,USA,NJ,Dunellen,68.193.37.224,no_relation,84,66,,100,79,treats,0.762492851663023,906631-FS1-2,"We tried to detect salivary cortisol level with drug loading test(DEXAMETHASONE for CUSHING SYNDROME, and ACTH for adrenal insufficiency) with time interval",CUSHING SYNDROME,DEXAMETHASONE,RO-may_diagnose
498023343,7/4/2014 14:52:06,false,1314939514,7/4/2014 14:51:46,clixsense,0.8625,19803139,NLD,6,Veldhoven,212.61.84.196,HYDROCHLOROTHIAZIDE treats HYPERTENSION,164,79,,176,98,treats,0.911684611677103,907530-FS1-2,"b ,   c  Class:  beta-Adrenergic Blocking Agents 24:24; CV100 (VA)  Synonyms:  HYDROCHLOROTHIAZIDE and Propranolol Hydrochloride  Uses  Hypertension  Management of HYPERTENSION, alone or in combination with other antihypertensive agents",HYPERTENSION,HYDROCHLOROTHIAZIDE,RO-may_treat
498023343,7/4/2014 15:09:49,false,1314954246,7/4/2014 15:09:29,clixsense,0.6479,6394333,GBR,,,86.29.240.182,no_relation,164,79,,176,98,treats,0.911684611677103,907530-FS1-2,"b ,   c  Class:  beta-Adrenergic Blocking Agents 24:24; CV100 (VA)  Synonyms:  HYDROCHLOROTHIAZIDE and Propranolol Hydrochloride  Uses  Hypertension  Management of HYPERTENSION, alone or in combination with other antihypertensive agents",HYPERTENSION,HYDROCHLOROTHIAZIDE,RO-may_treat
498023343,7/4/2014 15:35:43,false,1314974989,7/4/2014 15:35:37,gptbanks,0.4263,18496428,USA,CA,Newhall,199.244.112.44,HYPERTENSION treats HYDROCHLOROTHIAZIDE,164,79,,176,98,treats,0.911684611677103,907530-FS1-2,"b ,   c  Class:  beta-Adrenergic Blocking Agents 24:24; CV100 (VA)  Synonyms:  HYDROCHLOROTHIAZIDE and Propranolol Hydrochloride  Uses  Hypertension  Management of HYPERTENSION, alone or in combination with other antihypertensive agents",HYPERTENSION,HYDROCHLOROTHIAZIDE,RO-may_treat
498023343,7/4/2014 15:40:13,false,1314978261,7/4/2014 15:39:41,bitcoinget,0.6363,21490602,USA,NJ,Dunellen,68.193.37.224,HYDROCHLOROTHIAZIDE treats HYPERTENSION,164,79,,176,98,treats,0.911684611677103,907530-FS1-2,"b ,   c  Class:  beta-Adrenergic Blocking Agents 24:24; CV100 (VA)  Synonyms:  HYDROCHLOROTHIAZIDE and Propranolol Hydrochloride  Uses  Hypertension  Management of HYPERTENSION, alone or in combination with other antihypertensive agents",HYPERTENSION,HYDROCHLOROTHIAZIDE,RO-may_treat
498023343,7/4/2014 15:48:03,false,1314983874,7/4/2014 15:47:37,rewardsspot,0.6639,24482174,GBR,H9,London,146.185.23.27,HYDROCHLOROTHIAZIDE treats HYPERTENSION,164,79,,176,98,treats,0.911684611677103,907530-FS1-2,"b ,   c  Class:  beta-Adrenergic Blocking Agents 24:24; CV100 (VA)  Synonyms:  HYDROCHLOROTHIAZIDE and Propranolol Hydrochloride  Uses  Hypertension  Management of HYPERTENSION, alone or in combination with other antihypertensive agents",HYPERTENSION,HYDROCHLOROTHIAZIDE,RO-may_treat
498023344,7/4/2014 14:47:13,false,1314935364,7/4/2014 14:47:02,prodege,0.8625,14890188,GBR,I2,Manchester,151.230.18.68,WARFARIN treats PULMONARY EMBOLISM,93,137,,111,145,treats,0.995037190209989,907168-FS1-2,Clinical trials are currently investigating the potential value of LMWHs in the treatment of PULMONARY EMBOLISM and as an alternative to WARFARIN in secondary prevention of DVT,PULMONARY EMBOLISM,WARFARIN,RO-may_prevent
498023344,7/4/2014 15:10:53,false,1314955015,7/4/2014 15:10:35,clixsense,0.6479,6394333,GBR,,,86.29.240.182,no_relation,93,137,,111,145,treats,0.995037190209989,907168-FS1-2,Clinical trials are currently investigating the potential value of LMWHs in the treatment of PULMONARY EMBOLISM and as an alternative to WARFARIN in secondary prevention of DVT,PULMONARY EMBOLISM,WARFARIN,RO-may_prevent
498023344,7/4/2014 15:29:47,false,1314970022,7/4/2014 15:29:23,prodege,0.6637,14848125,GBR,V2,Glasgow,86.130.194.252,WARFARIN treats PULMONARY EMBOLISM,93,137,,111,145,treats,0.995037190209989,907168-FS1-2,Clinical trials are currently investigating the potential value of LMWHs in the treatment of PULMONARY EMBOLISM and as an alternative to WARFARIN in secondary prevention of DVT,PULMONARY EMBOLISM,WARFARIN,RO-may_prevent
498023344,7/4/2014 15:46:47,false,1314982861,7/4/2014 15:45:55,bitcoinget,0.6363,21490602,USA,NJ,Dunellen,68.193.37.224,no_relation,93,137,,111,145,treats,0.995037190209989,907168-FS1-2,Clinical trials are currently investigating the potential value of LMWHs in the treatment of PULMONARY EMBOLISM and as an alternative to WARFARIN in secondary prevention of DVT,PULMONARY EMBOLISM,WARFARIN,RO-may_prevent
498023344,7/4/2014 15:48:44,false,1314984522,7/4/2014 15:48:09,rewardsspot,0.6639,24482174,GBR,H9,London,146.185.23.27,WARFARIN treats PULMONARY EMBOLISM,93,137,,111,145,treats,0.995037190209989,907168-FS1-2,Clinical trials are currently investigating the potential value of LMWHs in the treatment of PULMONARY EMBOLISM and as an alternative to WARFARIN in secondary prevention of DVT,PULMONARY EMBOLISM,WARFARIN,RO-may_prevent
498023345,7/4/2014 14:47:00,false,1314935072,7/4/2014 14:46:49,prodege,0.8625,14890188,GBR,I2,Manchester,151.230.18.68,ADEFOVIR treats HBV,28,48,,31,56,treats,1,907937-FS1-2,Individuals Coinfected with HBV and HIV  Use of ADEFOVIR for the treatment of chronic HBV infection in patients with unrecognized or untreated HIV infection may result in emergence of HIV resistance,HBV,ADEFOVIR,RO-may_treat
498023345,7/4/2014 14:51:25,false,1314938996,7/4/2014 14:51:02,clixsense,0.8625,19803139,NLD,6,Veldhoven,212.61.84.196,ADEFOVIR treats HBV,28,48,,31,56,treats,1,907937-FS1-2,Individuals Coinfected with HBV and HIV  Use of ADEFOVIR for the treatment of chronic HBV infection in patients with unrecognized or untreated HIV infection may result in emergence of HIV resistance,HBV,ADEFOVIR,RO-may_treat
498023345,7/4/2014 14:56:00,false,1314942582,7/4/2014 14:55:15,clixsense,0.7667,27969116,NLD,4,Veendam,185.12.216.74,ADEFOVIR treats HBV,28,48,,31,56,treats,1,907937-FS1-2,Individuals Coinfected with HBV and HIV  Use of ADEFOVIR for the treatment of chronic HBV infection in patients with unrecognized or untreated HIV infection may result in emergence of HIV resistance,HBV,ADEFOVIR,RO-may_treat
498023345,7/4/2014 15:08:51,false,1314953484,7/4/2014 15:08:03,clixsense,0.6479,6394333,GBR,,,86.29.240.182,no_relation,28,48,,31,56,treats,1,907937-FS1-2,Individuals Coinfected with HBV and HIV  Use of ADEFOVIR for the treatment of chronic HBV infection in patients with unrecognized or untreated HIV infection may result in emergence of HIV resistance,HBV,ADEFOVIR,RO-may_treat
498023345,7/4/2014 15:28:47,false,1314969143,7/4/2014 15:28:22,prodege,0.6637,14848125,GBR,V2,Glasgow,86.130.194.252,ADEFOVIR treats HBV,28,48,,31,56,treats,1,907937-FS1-2,Individuals Coinfected with HBV and HIV  Use of ADEFOVIR for the treatment of chronic HBV infection in patients with unrecognized or untreated HIV infection may result in emergence of HIV resistance,HBV,ADEFOVIR,RO-may_treat
498023346,7/4/2014 14:48:00,false,1314936203,7/4/2014 14:47:49,prodege,0.8625,14890188,GBR,I2,Manchester,151.230.18.68,RUBELLA VACCINE treats RUBELLA,87,0,,94,15,treats,1,907308-FS1-2,RUBELLA VACCINE should continue to be used to immunize susceptible adult women against RUBELLA in order to further the goal of elimination of the congenital rubella syndrome,RUBELLA,RUBELLA VACCINE,RO-may_prevent
498023346,7/4/2014 15:14:48,false,1314957596,7/4/2014 15:14:26,clixsense,0.6479,6394333,GBR,,,86.29.240.182,no_relation,87,0,,94,15,treats,1,907308-FS1-2,RUBELLA VACCINE should continue to be used to immunize susceptible adult women against RUBELLA in order to further the goal of elimination of the congenital rubella syndrome,RUBELLA,RUBELLA VACCINE,RO-may_prevent
498023346,7/4/2014 15:19:28,false,1314961330,7/4/2014 15:19:07,clixsense,0.6246,15189335,GBR,I9,Dereham,86.157.163.112,RUBELLA VACCINE treats RUBELLA,87,0,,94,15,treats,1,907308-FS1-2,RUBELLA VACCINE should continue to be used to immunize susceptible adult women against RUBELLA in order to further the goal of elimination of the congenital rubella syndrome,RUBELLA,RUBELLA VACCINE,RO-may_prevent
498023346,7/4/2014 15:29:47,false,1314970019,7/4/2014 15:29:23,prodege,0.6637,14848125,GBR,V2,Glasgow,86.130.194.252,no_relation,87,0,,94,15,treats,1,907308-FS1-2,RUBELLA VACCINE should continue to be used to immunize susceptible adult women against RUBELLA in order to further the goal of elimination of the congenital rubella syndrome,RUBELLA,RUBELLA VACCINE,RO-may_prevent
498023346,7/4/2014 15:33:38,false,1314973618,7/4/2014 15:33:26,gptbanks,0.4263,18496428,USA,CA,Newhall,199.244.112.44,RUBELLA VACCINE treats RUBELLA,87,0,,94,15,treats,1,907308-FS1-2,RUBELLA VACCINE should continue to be used to immunize susceptible adult women against RUBELLA in order to further the goal of elimination of the congenital rubella syndrome,RUBELLA,RUBELLA VACCINE,RO-may_prevent
498023348,7/4/2014 14:47:29,false,1314935563,7/4/2014 14:47:15,clixsense,0.8625,19803139,NLD,6,Veldhoven,212.61.84.196,no_relation,49,17,,67,45,is location of,0.557086014531156,907785-FS1-9,Urokinase versus TISSUE PLASMINOGEN ACTIVATOR in PULMONARY EMBOLISM,PULMONARY EMBOLISM,TISSUE PLASMINOGEN ACTIVATOR,RO-may_treat
498023348,7/4/2014 14:50:10,false,1314938001,7/4/2014 14:49:59,prodege,0.8625,14890188,GBR,I2,Manchester,151.230.18.68,TISSUE PLASMINOGEN ACTIVATOR is location of PULMONARY EMBOLISM,49,17,,67,45,is location of,0.557086014531156,907785-FS1-9,Urokinase versus TISSUE PLASMINOGEN ACTIVATOR in PULMONARY EMBOLISM,PULMONARY EMBOLISM,TISSUE PLASMINOGEN ACTIVATOR,RO-may_treat
498023348,7/4/2014 15:04:06,false,1314949513,7/4/2014 15:03:34,clixsense,0.7667,27969116,NLD,4,Veendam,185.12.216.74,TISSUE PLASMINOGEN ACTIVATOR is location of PULMONARY EMBOLISM,49,17,,67,45,is location of,0.557086014531156,907785-FS1-9,Urokinase versus TISSUE PLASMINOGEN ACTIVATOR in PULMONARY EMBOLISM,PULMONARY EMBOLISM,TISSUE PLASMINOGEN ACTIVATOR,RO-may_treat
498023348,7/4/2014 15:21:36,false,1314963062,7/4/2014 15:21:19,clixsense,0.6246,15189335,GBR,I9,Dereham,86.157.163.112,no_relation,49,17,,67,45,is location of,0.557086014531156,907785-FS1-9,Urokinase versus TISSUE PLASMINOGEN ACTIVATOR in PULMONARY EMBOLISM,PULMONARY EMBOLISM,TISSUE PLASMINOGEN ACTIVATOR,RO-may_treat
498023348,7/4/2014 15:33:31,false,1314973419,7/4/2014 15:33:01,prodege,0.6637,14848125,GBR,V2,Glasgow,86.130.194.252,no_relation,49,17,,67,45,is location of,0.557086014531156,907785-FS1-9,Urokinase versus TISSUE PLASMINOGEN ACTIVATOR in PULMONARY EMBOLISM,PULMONARY EMBOLISM,TISSUE PLASMINOGEN ACTIVATOR,RO-may_treat
498023349,7/4/2014 14:45:47,false,1314933878,7/4/2014 14:45:19,clixsense,0.8625,19803139,NLD,6,Veldhoven,212.61.84.196,no_relation,67,53,,87,63,is diagnosed by,0.348742916231458,907638-FS1-13,"Palmer DG, Ferry DG, Gibbins BL et al. Ibuprofen and DIFLUNISAL in RHEUMATOID ARTHRITIS: a double-blind comparative trial",RHEUMATOID ARTHRITIS,DIFLUNISAL,RO-may_treat
498023349,7/4/2014 14:46:31,false,1314934760,7/4/2014 14:46:16,prodege,0.8625,14890188,GBR,I2,Manchester,151.230.18.68,RHEUMATOID ARTHRITIS is diagnosed by DIFLUNISAL,67,53,,87,63,is diagnosed by,0.348742916231458,907638-FS1-13,"Palmer DG, Ferry DG, Gibbins BL et al. Ibuprofen and DIFLUNISAL in RHEUMATOID ARTHRITIS: a double-blind comparative trial",RHEUMATOID ARTHRITIS,DIFLUNISAL,RO-may_treat
498023349,7/4/2014 15:00:10,false,1314945895,7/4/2014 14:59:45,clixsense,0.7667,27969116,NLD,4,Veendam,185.12.216.74,no_relation,67,53,,87,63,is diagnosed by,0.348742916231458,907638-FS1-13,"Palmer DG, Ferry DG, Gibbins BL et al. Ibuprofen and DIFLUNISAL in RHEUMATOID ARTHRITIS: a double-blind comparative trial",RHEUMATOID ARTHRITIS,DIFLUNISAL,RO-may_treat
498023349,7/4/2014 15:11:16,false,1314955262,7/4/2014 15:10:54,clixsense,0.6479,6394333,GBR,,,86.29.240.182,no_relation,67,53,,87,63,is diagnosed by,0.348742916231458,907638-FS1-13,"Palmer DG, Ferry DG, Gibbins BL et al. Ibuprofen and DIFLUNISAL in RHEUMATOID ARTHRITIS: a double-blind comparative trial",RHEUMATOID ARTHRITIS,DIFLUNISAL,RO-may_treat
498023349,7/4/2014 15:30:11,false,1314970372,7/4/2014 15:30:02,gptbanks,0.4263,18496428,USA,CA,Newhall,199.244.112.44,RHEUMATOID ARTHRITIS is diagnosed by DIFLUNISAL,67,53,,87,63,is diagnosed by,0.348742916231458,907638-FS1-13,"Palmer DG, Ferry DG, Gibbins BL et al. Ibuprofen and DIFLUNISAL in RHEUMATOID ARTHRITIS: a double-blind comparative trial",RHEUMATOID ARTHRITIS,DIFLUNISAL,RO-may_treat
498023350,7/4/2014 14:50:40,false,1314938330,7/4/2014 14:50:19,clixsense,0.8625,19803139,NLD,6,Veldhoven,212.61.84.196,ANAPHYLAXIS treats EPINEPHRINE,52,80,,63,91,treats,1,907663-FS1-2,Allergic reactions are treated with antihistamines; ANAPHYLAXIS is treated with EPINEPHRINE with IV fluids and vasopressors if necessary (see  Anaphylaxis,ANAPHYLAXIS,EPINEPHRINE,RO-may_treat
498023350,7/4/2014 15:11:47,false,1314955633,7/4/2014 15:11:32,clixsense,0.6479,6394333,GBR,,,86.29.240.182,no_relation,52,80,,63,91,treats,1,907663-FS1-2,Allergic reactions are treated with antihistamines; ANAPHYLAXIS is treated with EPINEPHRINE with IV fluids and vasopressors if necessary (see  Anaphylaxis,ANAPHYLAXIS,EPINEPHRINE,RO-may_treat
498023350,7/4/2014 15:24:34,false,1314965430,7/4/2014 15:24:22,clixsense,0.6246,15189335,GBR,I9,Dereham,86.157.163.112,EPINEPHRINE treats ANAPHYLAXIS,52,80,,63,91,treats,1,907663-FS1-2,Allergic reactions are treated with antihistamines; ANAPHYLAXIS is treated with EPINEPHRINE with IV fluids and vasopressors if necessary (see  Anaphylaxis,ANAPHYLAXIS,EPINEPHRINE,RO-may_treat
498023350,7/4/2014 15:27:45,false,1314968045,7/4/2014 15:27:14,prodege,0.6637,14848125,GBR,V2,Glasgow,86.130.194.252,EPINEPHRINE treats ANAPHYLAXIS,52,80,,63,91,treats,1,907663-FS1-2,Allergic reactions are treated with antihistamines; ANAPHYLAXIS is treated with EPINEPHRINE with IV fluids and vasopressors if necessary (see  Anaphylaxis,ANAPHYLAXIS,EPINEPHRINE,RO-may_treat
498023350,7/4/2014 15:36:34,false,1314975650,7/4/2014 15:36:18,gptbanks,0.4263,18496428,USA,CA,Newhall,199.244.112.44,ANAPHYLAXIS treats EPINEPHRINE,52,80,,63,91,treats,1,907663-FS1-2,Allergic reactions are treated with antihistamines; ANAPHYLAXIS is treated with EPINEPHRINE with IV fluids and vasopressors if necessary (see  Anaphylaxis,ANAPHYLAXIS,EPINEPHRINE,RO-may_treat
498023351,7/4/2014 14:59:03,false,1314944963,7/4/2014 14:58:40,clixsense,0.7667,27969116,NLD,4,Veendam,185.12.216.74,ORLISTAT treats OBESITY,97,54,,104,62,treats,1,907526-FS1-2,"Evaluation of the safety and efficacy of sibutramine, ORLISTAT and metformin in the treatment of OBESITY",OBESITY,ORLISTAT,RO-may_treat
498023351,7/4/2014 15:24:34,false,1314965432,7/4/2014 15:24:22,clixsense,0.6246,15189335,GBR,I9,Dereham,86.157.163.112,ORLISTAT treats OBESITY,97,54,,104,62,treats,1,907526-FS1-2,"Evaluation of the safety and efficacy of sibutramine, ORLISTAT and metformin in the treatment of OBESITY",OBESITY,ORLISTAT,RO-may_treat
498023351,7/4/2014 15:44:38,false,1314981129,7/4/2014 15:44:14,bitcoinget,0.6363,21490602,USA,NJ,Dunellen,68.193.37.224,ORLISTAT treats OBESITY,97,54,,104,62,treats,1,907526-FS1-2,"Evaluation of the safety and efficacy of sibutramine, ORLISTAT and metformin in the treatment of OBESITY",OBESITY,ORLISTAT,RO-may_treat
498023351,7/4/2014 15:48:03,false,1314983879,7/4/2014 15:47:37,rewardsspot,0.6639,24482174,GBR,H9,London,146.185.23.27,ORLISTAT treats OBESITY,97,54,,104,62,treats,1,907526-FS1-2,"Evaluation of the safety and efficacy of sibutramine, ORLISTAT and metformin in the treatment of OBESITY",OBESITY,ORLISTAT,RO-may_treat
498023351,7/4/2014 15:52:06,false,1314987239,7/4/2014 15:51:58,neodev,0.5875,25804244,USA,IL,Chicago,99.198.108.116,OBESITY treats ORLISTAT,97,54,,104,62,treats,1,907526-FS1-2,"Evaluation of the safety and efficacy of sibutramine, ORLISTAT and metformin in the treatment of OBESITY",OBESITY,ORLISTAT,RO-may_treat
498023352,7/4/2014 14:47:48,false,1314935969,7/4/2014 14:47:34,prodege,0.8625,14890188,GBR,I2,Manchester,151.230.18.68,BUSULFAN treats CHRONIC MYELOGENOUS LEUKEMIA,92,64,,120,72,treats,0.956182887467515,907521-FS1-2,"Hehlman R, Heimpel H, Hasford J et al. Randomized comparison of BUSULFAN and hydroxyurea in CHRONIC MYELOGENOUS LEUKEMIA: prolongation of survival by hydroxyurea",CHRONIC MYELOGENOUS LEUKEMIA,BUSULFAN,RO-may_treat
498023352,7/4/2014 14:58:38,false,1314944726,7/4/2014 14:58:17,clixsense,0.7667,27969116,NLD,4,Veendam,185.12.216.74,no_relation,92,64,,120,72,treats,0.956182887467515,907521-FS1-2,"Hehlman R, Heimpel H, Hasford J et al. Randomized comparison of BUSULFAN and hydroxyurea in CHRONIC MYELOGENOUS LEUKEMIA: prolongation of survival by hydroxyurea",CHRONIC MYELOGENOUS LEUKEMIA,BUSULFAN,RO-may_treat
498023352,7/4/2014 15:20:36,false,1314962354,7/4/2014 15:19:53,clixsense,0.6246,15189335,GBR,I9,Dereham,86.157.163.112,BUSULFAN treats CHRONIC MYELOGENOUS LEUKEMIA,92,64,,120,72,treats,0.956182887467515,907521-FS1-2,"Hehlman R, Heimpel H, Hasford J et al. Randomized comparison of BUSULFAN and hydroxyurea in CHRONIC MYELOGENOUS LEUKEMIA: prolongation of survival by hydroxyurea",CHRONIC MYELOGENOUS LEUKEMIA,BUSULFAN,RO-may_treat
498023352,7/4/2014 15:31:15,false,1314971467,7/4/2014 15:31:00,prodege,0.6637,14848125,GBR,V2,Glasgow,86.130.194.252,BUSULFAN treats CHRONIC MYELOGENOUS LEUKEMIA,92,64,,120,72,treats,0.956182887467515,907521-FS1-2,"Hehlman R, Heimpel H, Hasford J et al. Randomized comparison of BUSULFAN and hydroxyurea in CHRONIC MYELOGENOUS LEUKEMIA: prolongation of survival by hydroxyurea",CHRONIC MYELOGENOUS LEUKEMIA,BUSULFAN,RO-may_treat
498023352,7/4/2014 15:47:18,false,1314983271,7/4/2014 15:46:47,bitcoinget,0.6363,21490602,USA,NJ,Dunellen,68.193.37.224,BUSULFAN treats CHRONIC MYELOGENOUS LEUKEMIA,92,64,,120,72,treats,0.956182887467515,907521-FS1-2,"Hehlman R, Heimpel H, Hasford J et al. Randomized comparison of BUSULFAN and hydroxyurea in CHRONIC MYELOGENOUS LEUKEMIA: prolongation of survival by hydroxyurea",CHRONIC MYELOGENOUS LEUKEMIA,BUSULFAN,RO-may_treat
498023353,7/4/2014 14:46:52,false,1314935008,7/4/2014 14:46:32,clixsense,0.8625,19803139,NLD,6,Veldhoven,212.61.84.196,no_relation,53,0,,78,25,causes,0.975900072948533,902653-FS1-4,"MYELODYSPLASTIC SYNDROMES (MDS) are characterized by HYPERCELLULAR BONE MARROW, peripheral cytopenia and an increased rate of intramedullary apoptosis",HYPERCELLULAR BONE MARROW,MYELODYSPLASTIC SYNDROMES,RO-disease_may_have_finding
498023353,7/4/2014 14:49:09,false,1314937115,7/4/2014 14:48:53,prodege,0.8625,14890188,GBR,I2,Manchester,151.230.18.68,no_relation,53,0,,78,25,causes,0.975900072948533,902653-FS1-4,"MYELODYSPLASTIC SYNDROMES (MDS) are characterized by HYPERCELLULAR BONE MARROW, peripheral cytopenia and an increased rate of intramedullary apoptosis",HYPERCELLULAR BONE MARROW,MYELODYSPLASTIC SYNDROMES,RO-disease_may_have_finding
498023353,7/4/2014 15:11:31,false,1314955500,7/4/2014 15:11:17,clixsense,0.6479,6394333,GBR,,,86.29.240.182,no_relation,53,0,,78,25,causes,0.975900072948533,902653-FS1-4,"MYELODYSPLASTIC SYNDROMES (MDS) are characterized by HYPERCELLULAR BONE MARROW, peripheral cytopenia and an increased rate of intramedullary apoptosis",HYPERCELLULAR BONE MARROW,MYELODYSPLASTIC SYNDROMES,RO-disease_may_have_finding
498023353,7/4/2014 15:22:47,false,1314964014,7/4/2014 15:22:20,clixsense,0.6246,15189335,GBR,I9,Dereham,86.157.163.112,HYPERCELLULAR BONE MARROW causes MYELODYSPLASTIC SYNDROMES,53,0,,78,25,causes,0.975900072948533,902653-FS1-4,"MYELODYSPLASTIC SYNDROMES (MDS) are characterized by HYPERCELLULAR BONE MARROW, peripheral cytopenia and an increased rate of intramedullary apoptosis",HYPERCELLULAR BONE MARROW,MYELODYSPLASTIC SYNDROMES,RO-disease_may_have_finding
498023353,7/4/2014 15:29:21,false,1314969541,7/4/2014 15:28:48,prodege,0.6637,14848125,GBR,V2,Glasgow,86.130.194.252,MYELODYSPLASTIC SYNDROMES causes HYPERCELLULAR BONE MARROW,53,0,,78,25,causes,0.975900072948533,902653-FS1-4,"MYELODYSPLASTIC SYNDROMES (MDS) are characterized by HYPERCELLULAR BONE MARROW, peripheral cytopenia and an increased rate of intramedullary apoptosis",HYPERCELLULAR BONE MARROW,MYELODYSPLASTIC SYNDROMES,RO-disease_may_have_finding
498023354,7/4/2014 14:50:17,false,1314938083,7/4/2014 14:49:52,clixsense,0.8625,19803139,NLD,6,Veldhoven,212.61.84.196,METHENAMINE treats URINARY INFECTIONS,52,14,,70,25,treats,1,907019-FS1-2,"The action of METHENAMINE, used in the treatment of URINARY INFECTIONS, is based on the release of formaldehyde in the body",URINARY INFECTIONS,METHENAMINE,RO-may_prevent
498023354,7/4/2014 14:56:21,false,1314942898,7/4/2014 14:56:01,clixsense,0.7667,27969116,NLD,4,Veendam,185.12.216.74,METHENAMINE treats URINARY INFECTIONS,52,14,,70,25,treats,1,907019-FS1-2,"The action of METHENAMINE, used in the treatment of URINARY INFECTIONS, is based on the release of formaldehyde in the body",URINARY INFECTIONS,METHENAMINE,RO-may_prevent
498023354,7/4/2014 15:14:24,false,1314957303,7/4/2014 15:14:06,clixsense,0.6479,6394333,GBR,,,86.29.240.182,no_relation,52,14,,70,25,treats,1,907019-FS1-2,"The action of METHENAMINE, used in the treatment of URINARY INFECTIONS, is based on the release of formaldehyde in the body",URINARY INFECTIONS,METHENAMINE,RO-may_prevent
498023354,7/4/2014 15:25:15,false,1314965918,7/4/2014 15:25:04,clixsense,0.6246,15189335,GBR,I9,Dereham,86.157.163.112,METHENAMINE treats URINARY INFECTIONS,52,14,,70,25,treats,1,907019-FS1-2,"The action of METHENAMINE, used in the treatment of URINARY INFECTIONS, is based on the release of formaldehyde in the body",URINARY INFECTIONS,METHENAMINE,RO-may_prevent
498023354,7/4/2014 15:31:47,false,1314972052,7/4/2014 15:31:32,prodege,0.6637,14848125,GBR,V2,Glasgow,86.130.194.252,METHENAMINE treats URINARY INFECTIONS,52,14,,70,25,treats,1,907019-FS1-2,"The action of METHENAMINE, used in the treatment of URINARY INFECTIONS, is based on the release of formaldehyde in the body",URINARY INFECTIONS,METHENAMINE,RO-may_prevent
498023355,7/4/2014 14:48:19,false,1314936440,7/4/2014 14:47:57,clixsense,0.8625,19803139,NLD,6,Veldhoven,212.61.84.196,ASPIRIN treats MYOCARDIAL INFARCTION,272,209,,293,216,treats,0.943456353049726,907118-FS1-2,Studies in patients scheduled for percutaneous coronary intervention and those with unstable angina or non-Q-wave myocardial infarction have shown that a combination of intravenous GP IIb-IIIa inhibitors with ASPIRIN and heparin is associated with a reduction in death or MYOCARDIAL INFARCTION compared with therapy with aspirin and heparin alone,MYOCARDIAL INFARCTION,ASPIRIN,RO-may_prevent
498023355,7/4/2014 14:49:09,false,1314937114,7/4/2014 14:48:53,prodege,0.8625,14890188,GBR,I2,Manchester,151.230.18.68,ASPIRIN treats MYOCARDIAL INFARCTION,272,209,,293,216,treats,0.943456353049726,907118-FS1-2,Studies in patients scheduled for percutaneous coronary intervention and those with unstable angina or non-Q-wave myocardial infarction have shown that a combination of intravenous GP IIb-IIIa inhibitors with ASPIRIN and heparin is associated with a reduction in death or MYOCARDIAL INFARCTION compared with therapy with aspirin and heparin alone,MYOCARDIAL INFARCTION,ASPIRIN,RO-may_prevent
498023355,7/4/2014 14:57:27,false,1314943766,7/4/2014 14:56:46,clixsense,0.7667,27969116,NLD,4,Veendam,185.12.216.74,ASPIRIN treats MYOCARDIAL INFARCTION,272,209,,293,216,treats,0.943456353049726,907118-FS1-2,Studies in patients scheduled for percutaneous coronary intervention and those with unstable angina or non-Q-wave myocardial infarction have shown that a combination of intravenous GP IIb-IIIa inhibitors with ASPIRIN and heparin is associated with a reduction in death or MYOCARDIAL INFARCTION compared with therapy with aspirin and heparin alone,MYOCARDIAL INFARCTION,ASPIRIN,RO-may_prevent
498023355,7/4/2014 15:19:51,false,1314961713,7/4/2014 15:19:30,clixsense,0.6246,15189335,GBR,I9,Dereham,86.157.163.112,ASPIRIN treats MYOCARDIAL INFARCTION,272,209,,293,216,treats,0.943456353049726,907118-FS1-2,Studies in patients scheduled for percutaneous coronary intervention and those with unstable angina or non-Q-wave myocardial infarction have shown that a combination of intravenous GP IIb-IIIa inhibitors with ASPIRIN and heparin is associated with a reduction in death or MYOCARDIAL INFARCTION compared with therapy with aspirin and heparin alone,MYOCARDIAL INFARCTION,ASPIRIN,RO-may_prevent
498023355,7/4/2014 15:30:13,false,1314970351,7/4/2014 15:30:01,prodege,0.6637,14848125,GBR,V2,Glasgow,86.130.194.252,ASPIRIN treats MYOCARDIAL INFARCTION,272,209,,293,216,treats,0.943456353049726,907118-FS1-2,Studies in patients scheduled for percutaneous coronary intervention and those with unstable angina or non-Q-wave myocardial infarction have shown that a combination of intravenous GP IIb-IIIa inhibitors with ASPIRIN and heparin is associated with a reduction in death or MYOCARDIAL INFARCTION compared with therapy with aspirin and heparin alone,MYOCARDIAL INFARCTION,ASPIRIN,RO-may_prevent
498023356,7/4/2014 14:52:30,false,1314939761,7/4/2014 14:52:07,clixsense,0.8625,19803139,NLD,6,Veldhoven,212.61.84.196,DCIS causes MICROCALCIFICATION,43,14,,61,18,causes,0.762000762001143,902739-FS1-4,Many cases of DCIS are detected because of MICROCALCIFICATION on mammograms; 20% of screen-detected cancers are of this type,MICROCALCIFICATION,DCIS,RO-disease_may_have_finding
498023356,7/4/2014 15:00:10,false,1314945872,7/4/2014 14:59:45,clixsense,0.7667,27969116,NLD,4,Veendam,185.12.216.74,no_relation,43,14,,61,18,causes,0.762000762001143,902739-FS1-4,Many cases of DCIS are detected because of MICROCALCIFICATION on mammograms; 20% of screen-detected cancers are of this type,MICROCALCIFICATION,DCIS,RO-disease_may_have_finding
498023356,7/4/2014 15:11:16,false,1314955263,7/4/2014 15:10:54,clixsense,0.6479,6394333,GBR,,,86.29.240.182,no_relation,43,14,,61,18,causes,0.762000762001143,902739-FS1-4,Many cases of DCIS are detected because of MICROCALCIFICATION on mammograms; 20% of screen-detected cancers are of this type,MICROCALCIFICATION,DCIS,RO-disease_may_have_finding
498023356,7/4/2014 15:20:36,false,1314962355,7/4/2014 15:19:53,clixsense,0.6246,15189335,GBR,I9,Dereham,86.157.163.112,DCIS causes MICROCALCIFICATION,43,14,,61,18,causes,0.762000762001143,902739-FS1-4,Many cases of DCIS are detected because of MICROCALCIFICATION on mammograms; 20% of screen-detected cancers are of this type,MICROCALCIFICATION,DCIS,RO-disease_may_have_finding
498023356,7/4/2014 15:31:11,false,1314971428,7/4/2014 15:31:06,gptbanks,0.4263,18496428,USA,CA,Newhall,199.244.112.44,MICROCALCIFICATION causes DCIS,43,14,,61,18,causes,0.762000762001143,902739-FS1-4,Many cases of DCIS are detected because of MICROCALCIFICATION on mammograms; 20% of screen-detected cancers are of this type,MICROCALCIFICATION,DCIS,RO-disease_may_have_finding
498023357,7/4/2014 14:46:31,false,1314934744,7/4/2014 14:46:16,prodege,0.8625,14890188,GBR,I2,Manchester,151.230.18.68,FUROSEMIDE treats EDEMA,85,62,,90,72,treats,0.995893206467704,907519-FS1-2,"34 ,   37 ,   54 ,   55 ,   56  Appears to be as effective as FUROSEMIDE in reducing EDEMA, body weight, and abdominal girth in patients with edema secondary to renal disease",EDEMA,FUROSEMIDE,RO-may_treat
498023357,7/4/2014 15:00:37,false,1314946295,7/4/2014 15:00:11,clixsense,0.7667,27969116,NLD,4,Veendam,185.12.216.74,FUROSEMIDE treats EDEMA,85,62,,90,72,treats,0.995893206467704,907519-FS1-2,"34 ,   37 ,   54 ,   55 ,   56  Appears to be as effective as FUROSEMIDE in reducing EDEMA, body weight, and abdominal girth in patients with edema secondary to renal disease",EDEMA,FUROSEMIDE,RO-may_treat
498023357,7/4/2014 15:33:38,false,1314973620,7/4/2014 15:33:26,gptbanks,0.4263,18496428,USA,CA,Newhall,199.244.112.44,EDEMA treats FUROSEMIDE,85,62,,90,72,treats,0.995893206467704,907519-FS1-2,"34 ,   37 ,   54 ,   55 ,   56  Appears to be as effective as FUROSEMIDE in reducing EDEMA, body weight, and abdominal girth in patients with edema secondary to renal disease",EDEMA,FUROSEMIDE,RO-may_treat
498023357,7/4/2014 15:43:34,false,1314980419,7/4/2014 15:43:01,bitcoinget,0.6363,21490602,USA,NJ,Dunellen,68.193.37.224,FUROSEMIDE treats EDEMA,85,62,,90,72,treats,0.995893206467704,907519-FS1-2,"34 ,   37 ,   54 ,   55 ,   56  Appears to be as effective as FUROSEMIDE in reducing EDEMA, body weight, and abdominal girth in patients with edema secondary to renal disease",EDEMA,FUROSEMIDE,RO-may_treat
498023357,7/4/2014 15:51:57,false,1314987130,7/4/2014 15:51:47,neodev,0.5875,25804244,USA,IL,Chicago,99.198.108.116,EDEMA treats FUROSEMIDE,85,62,,90,72,treats,0.995893206467704,907519-FS1-2,"34 ,   37 ,   54 ,   55 ,   56  Appears to be as effective as FUROSEMIDE in reducing EDEMA, body weight, and abdominal girth in patients with edema secondary to renal disease",EDEMA,FUROSEMIDE,RO-may_treat
498023358,7/4/2014 14:49:28,false,1314937465,7/4/2014 14:49:11,prodege,0.8625,14890188,GBR,I2,Manchester,151.230.18.68,MALIGNANT PLEURAL MESOTHELIOMA causes CHEST PAIN,105,17,,115,47,causes,0.98058067569092,902728-FS1-4,"In patients with MALIGNANT PLEURAL MESOTHELIOMA, radiotherapy is useful in the palliation of symptoms of CHEST PAIN and painful masses",CHEST PAIN,MALIGNANT PLEURAL MESOTHELIOMA,RO-disease_may_have_finding
498023358,7/4/2014 14:51:25,false,1314938997,7/4/2014 14:51:02,clixsense,0.8625,19803139,NLD,6,Veldhoven,212.61.84.196,MALIGNANT PLEURAL MESOTHELIOMA causes CHEST PAIN,105,17,,115,47,causes,0.98058067569092,902728-FS1-4,"In patients with MALIGNANT PLEURAL MESOTHELIOMA, radiotherapy is useful in the palliation of symptoms of CHEST PAIN and painful masses",CHEST PAIN,MALIGNANT PLEURAL MESOTHELIOMA,RO-disease_may_have_finding
498023358,7/4/2014 15:04:06,false,1314949516,7/4/2014 15:03:34,clixsense,0.7667,27969116,NLD,4,Veendam,185.12.216.74,no_relation,105,17,,115,47,causes,0.98058067569092,902728-FS1-4,"In patients with MALIGNANT PLEURAL MESOTHELIOMA, radiotherapy is useful in the palliation of symptoms of CHEST PAIN and painful masses",CHEST PAIN,MALIGNANT PLEURAL MESOTHELIOMA,RO-disease_may_have_finding
498023358,7/4/2014 15:10:10,false,1314954451,7/4/2014 15:09:50,clixsense,0.6479,6394333,GBR,,,86.29.240.182,no_relation,105,17,,115,47,causes,0.98058067569092,902728-FS1-4,"In patients with MALIGNANT PLEURAL MESOTHELIOMA, radiotherapy is useful in the palliation of symptoms of CHEST PAIN and painful masses",CHEST PAIN,MALIGNANT PLEURAL MESOTHELIOMA,RO-disease_may_have_finding
498023358,7/4/2014 15:32:23,false,1314972495,7/4/2014 15:31:49,prodege,0.6637,14848125,GBR,V2,Glasgow,86.130.194.252,MALIGNANT PLEURAL MESOTHELIOMA causes CHEST PAIN,105,17,,115,47,causes,0.98058067569092,902728-FS1-4,"In patients with MALIGNANT PLEURAL MESOTHELIOMA, radiotherapy is useful in the palliation of symptoms of CHEST PAIN and painful masses",CHEST PAIN,MALIGNANT PLEURAL MESOTHELIOMA,RO-disease_may_have_finding
498023359,7/4/2014 15:11:47,false,1314955628,7/4/2014 15:11:32,clixsense,0.6479,6394333,GBR,,,86.29.240.182,no_relation,163,120,,174,134,is diagnosed by,0.424264068711929,907509-FS1-13,"Ayestaran A, Lopez R, Montoro JB et al. Pharmacokinetics of conventional formulation versus fat emulsion formulation of AMPHOTERICIN B in a group of patients with NEUTROPENIA",NEUTROPENIA,AMPHOTERICIN B,RO-may_treat
498023359,7/4/2014 15:25:02,false,1314965713,7/4/2014 15:24:37,clixsense,0.6246,15189335,GBR,I9,Dereham,86.157.163.112,NEUTROPENIA is diagnosed by AMPHOTERICIN B,163,120,,174,134,is diagnosed by,0.424264068711929,907509-FS1-13,"Ayestaran A, Lopez R, Montoro JB et al. Pharmacokinetics of conventional formulation versus fat emulsion formulation of AMPHOTERICIN B in a group of patients with NEUTROPENIA",NEUTROPENIA,AMPHOTERICIN B,RO-may_treat
498023359,7/4/2014 15:32:23,false,1314972494,7/4/2014 15:31:49,prodege,0.6637,14848125,GBR,V2,Glasgow,86.130.194.252,NEUTROPENIA is diagnosed by AMPHOTERICIN B,163,120,,174,134,is diagnosed by,0.424264068711929,907509-FS1-13,"Ayestaran A, Lopez R, Montoro JB et al. Pharmacokinetics of conventional formulation versus fat emulsion formulation of AMPHOTERICIN B in a group of patients with NEUTROPENIA",NEUTROPENIA,AMPHOTERICIN B,RO-may_treat
498023359,7/4/2014 15:37:00,false,1314975966,7/4/2014 15:36:36,gptbanks,0.4263,18496428,USA,CA,Newhall,199.244.112.44,NEUTROPENIA is diagnosed by AMPHOTERICIN B,163,120,,174,134,is diagnosed by,0.424264068711929,907509-FS1-13,"Ayestaran A, Lopez R, Montoro JB et al. Pharmacokinetics of conventional formulation versus fat emulsion formulation of AMPHOTERICIN B in a group of patients with NEUTROPENIA",NEUTROPENIA,AMPHOTERICIN B,RO-may_treat
498023359,7/4/2014 15:42:10,false,1314979523,7/4/2014 15:41:20,bitcoinget,0.6363,21490602,USA,NJ,Dunellen,68.193.37.224,no_relation,163,120,,174,134,is diagnosed by,0.424264068711929,907509-FS1-13,"Ayestaran A, Lopez R, Montoro JB et al. Pharmacokinetics of conventional formulation versus fat emulsion formulation of AMPHOTERICIN B in a group of patients with NEUTROPENIA",NEUTROPENIA,AMPHOTERICIN B,RO-may_treat
498023360,7/4/2014 14:49:58,false,1314937826,7/4/2014 14:49:42,prodege,0.8625,14890188,GBR,I2,Manchester,151.230.18.68,AZATHIOPRINE treats ULCERATIVE COLITIS,163,87,,181,99,treats,0.995893206467704,907572-FS1-2,"1 ,   14 ,   15 ,   17 ,   18 ,   41  Administered concomitantly with corticosteroids, AZATHIOPRINE or mercaptopurine, and/or 5-aminosalicyclates in patients with ULCERATIVE COLITIS",ULCERATIVE COLITIS,AZATHIOPRINE,RO-may_treat
498023360,7/4/2014 14:50:40,false,1314938311,7/4/2014 14:50:19,clixsense,0.8625,19803139,NLD,6,Veldhoven,212.61.84.196,no_relation,163,87,,181,99,treats,0.995893206467704,907572-FS1-2,"1 ,   14 ,   15 ,   17 ,   18 ,   41  Administered concomitantly with corticosteroids, AZATHIOPRINE or mercaptopurine, and/or 5-aminosalicyclates in patients with ULCERATIVE COLITIS",ULCERATIVE COLITIS,AZATHIOPRINE,RO-may_treat
498023360,7/4/2014 14:58:38,false,1314944725,7/4/2014 14:58:17,clixsense,0.7667,27969116,NLD,4,Veendam,185.12.216.74,AZATHIOPRINE treats ULCERATIVE COLITIS,163,87,,181,99,treats,0.995893206467704,907572-FS1-2,"1 ,   14 ,   15 ,   17 ,   18 ,   41  Administered concomitantly with corticosteroids, AZATHIOPRINE or mercaptopurine, and/or 5-aminosalicyclates in patients with ULCERATIVE COLITIS",ULCERATIVE COLITIS,AZATHIOPRINE,RO-may_treat
498023360,7/4/2014 15:34:12,false,1314974133,7/4/2014 15:33:45,prodege,0.6637,14848125,GBR,V2,Glasgow,86.130.194.252,AZATHIOPRINE treats ULCERATIVE COLITIS,163,87,,181,99,treats,0.995893206467704,907572-FS1-2,"1 ,   14 ,   15 ,   17 ,   18 ,   41  Administered concomitantly with corticosteroids, AZATHIOPRINE or mercaptopurine, and/or 5-aminosalicyclates in patients with ULCERATIVE COLITIS",ULCERATIVE COLITIS,AZATHIOPRINE,RO-may_treat
498023360,7/4/2014 15:36:07,false,1314975307,7/4/2014 15:36:00,gptbanks,0.4263,18496428,USA,CA,Newhall,199.244.112.44,AZATHIOPRINE treats ULCERATIVE COLITIS,163,87,,181,99,treats,0.995893206467704,907572-FS1-2,"1 ,   14 ,   15 ,   17 ,   18 ,   41  Administered concomitantly with corticosteroids, AZATHIOPRINE or mercaptopurine, and/or 5-aminosalicyclates in patients with ULCERATIVE COLITIS",ULCERATIVE COLITIS,AZATHIOPRINE,RO-may_treat
498023361,7/4/2014 14:48:00,false,1314936179,7/4/2014 14:47:49,prodege,0.8625,14890188,GBR,I2,Manchester,151.230.18.68,METHYLPREDNISOLONE treats GVHD,16,51,,20,69,treats,0.577350269189626,907108-FS1-2,Prophylaxis for GVHD consisted of cyclosporine and METHYLPREDNISOLONE,GVHD,METHYLPREDNISOLONE,RO-may_prevent
498023361,7/4/2014 15:21:17,false,1314962897,7/4/2014 15:21:05,clixsense,0.6246,15189335,GBR,I9,Dereham,86.157.163.112,METHYLPREDNISOLONE treats GVHD,16,51,,20,69,treats,0.577350269189626,907108-FS1-2,Prophylaxis for GVHD consisted of cyclosporine and METHYLPREDNISOLONE,GVHD,METHYLPREDNISOLONE,RO-may_prevent
498023361,7/4/2014 15:32:37,false,1314972750,7/4/2014 15:32:24,prodege,0.6637,14848125,GBR,V2,Glasgow,86.130.194.252,METHYLPREDNISOLONE treats GVHD,16,51,,20,69,treats,0.577350269189626,907108-FS1-2,Prophylaxis for GVHD consisted of cyclosporine and METHYLPREDNISOLONE,GVHD,METHYLPREDNISOLONE,RO-may_prevent
498023361,7/4/2014 15:40:58,false,1314978747,7/4/2014 15:40:14,bitcoinget,0.6363,21490602,USA,NJ,Dunellen,68.193.37.224,METHYLPREDNISOLONE treats GVHD,16,51,,20,69,treats,0.577350269189626,907108-FS1-2,Prophylaxis for GVHD consisted of cyclosporine and METHYLPREDNISOLONE,GVHD,METHYLPREDNISOLONE,RO-may_prevent
498023361,7/4/2014 15:52:06,false,1314987216,7/4/2014 15:51:58,neodev,0.5875,25804244,USA,IL,Chicago,99.198.108.116,METHYLPREDNISOLONE treats GVHD,16,51,,20,69,treats,0.577350269189626,907108-FS1-2,Prophylaxis for GVHD consisted of cyclosporine and METHYLPREDNISOLONE,GVHD,METHYLPREDNISOLONE,RO-may_prevent
498023362,7/4/2014 14:49:41,false,1314937650,7/4/2014 14:49:29,prodege,0.8625,14890188,GBR,I2,Manchester,151.230.18.68,PANCREATIC ADENOCARCINOMA causes WEIGHT LOSS,63,164,,74,189,causes,0.975900072948533,902684-FS1-4,"Because duodenal and/or pancreatic cancer was suspected due to WEIGHT LOSS, the pancreatic and bile duct obstruction, and the increased risk of small intestine and PANCREATIC ADENOCARCINOMA in patients with PSJ, a pancreatoduodenectomy was performed",WEIGHT LOSS,PANCREATIC ADENOCARCINOMA,RO-disease_may_have_finding
498023362,7/4/2014 15:26:33,false,1314967018,7/4/2014 15:26:02,clixsense,0.6246,15189335,GBR,I9,Dereham,86.157.163.112,PANCREATIC ADENOCARCINOMA causes WEIGHT LOSS,63,164,,74,189,causes,0.975900072948533,902684-FS1-4,"Because duodenal and/or pancreatic cancer was suspected due to WEIGHT LOSS, the pancreatic and bile duct obstruction, and the increased risk of small intestine and PANCREATIC ADENOCARCINOMA in patients with PSJ, a pancreatoduodenectomy was performed",WEIGHT LOSS,PANCREATIC ADENOCARCINOMA,RO-disease_may_have_finding
498023362,7/4/2014 15:29:21,false,1314969544,7/4/2014 15:28:48,prodege,0.6637,14848125,GBR,V2,Glasgow,86.130.194.252,PANCREATIC ADENOCARCINOMA causes WEIGHT LOSS,63,164,,74,189,causes,0.975900072948533,902684-FS1-4,"Because duodenal and/or pancreatic cancer was suspected due to WEIGHT LOSS, the pancreatic and bile duct obstruction, and the increased risk of small intestine and PANCREATIC ADENOCARCINOMA in patients with PSJ, a pancreatoduodenectomy was performed",WEIGHT LOSS,PANCREATIC ADENOCARCINOMA,RO-disease_may_have_finding
498023362,7/4/2014 15:35:51,false,1314975127,7/4/2014 15:35:45,gptbanks,0.4263,18496428,USA,CA,Newhall,199.244.112.44,WEIGHT LOSS causes PANCREATIC ADENOCARCINOMA,63,164,,74,189,causes,0.975900072948533,902684-FS1-4,"Because duodenal and/or pancreatic cancer was suspected due to WEIGHT LOSS, the pancreatic and bile duct obstruction, and the increased risk of small intestine and PANCREATIC ADENOCARCINOMA in patients with PSJ, a pancreatoduodenectomy was performed",WEIGHT LOSS,PANCREATIC ADENOCARCINOMA,RO-disease_may_have_finding
498023362,7/4/2014 15:46:47,false,1314982876,7/4/2014 15:45:55,bitcoinget,0.6363,21490602,USA,NJ,Dunellen,68.193.37.224,PANCREATIC ADENOCARCINOMA causes WEIGHT LOSS,63,164,,74,189,causes,0.975900072948533,902684-FS1-4,"Because duodenal and/or pancreatic cancer was suspected due to WEIGHT LOSS, the pancreatic and bile duct obstruction, and the increased risk of small intestine and PANCREATIC ADENOCARCINOMA in patients with PSJ, a pancreatoduodenectomy was performed",WEIGHT LOSS,PANCREATIC ADENOCARCINOMA,RO-disease_may_have_finding
498023363,7/4/2014 15:15:45,false,1314958258,7/4/2014 15:15:34,clixsense,0.6479,6394333,GBR,,,86.29.240.182,no_relation,53,14,,73,25,treats,0.896258159530272,907846-FS1-2,Comparison of CEFTRIAXONE and traditional therapy of BACTERIAL MENINGITIS,BACTERIAL MENINGITIS,CEFTRIAXONE,RO-may_treat
498023363,7/4/2014 15:24:20,false,1314965218,7/4/2014 15:24:09,clixsense,0.6246,15189335,GBR,I9,Dereham,86.157.163.112,CEFTRIAXONE treats BACTERIAL MENINGITIS,53,14,,73,25,treats,0.896258159530272,907846-FS1-2,Comparison of CEFTRIAXONE and traditional therapy of BACTERIAL MENINGITIS,BACTERIAL MENINGITIS,CEFTRIAXONE,RO-may_treat
498023363,7/4/2014 15:33:25,false,1314973343,7/4/2014 15:33:12,gptbanks,0.4263,18496428,USA,CA,Newhall,199.244.112.44,CEFTRIAXONE treats BACTERIAL MENINGITIS,53,14,,73,25,treats,0.896258159530272,907846-FS1-2,Comparison of CEFTRIAXONE and traditional therapy of BACTERIAL MENINGITIS,BACTERIAL MENINGITIS,CEFTRIAXONE,RO-may_treat
498023363,7/4/2014 15:47:52,false,1314983770,7/4/2014 15:47:19,bitcoinget,0.6363,21490602,USA,NJ,Dunellen,68.193.37.224,CEFTRIAXONE treats BACTERIAL MENINGITIS,53,14,,73,25,treats,0.896258159530272,907846-FS1-2,Comparison of CEFTRIAXONE and traditional therapy of BACTERIAL MENINGITIS,BACTERIAL MENINGITIS,CEFTRIAXONE,RO-may_treat
498023363,7/4/2014 15:52:22,false,1314987466,7/4/2014 15:52:07,neodev,0.5875,25804244,USA,IL,Chicago,99.198.108.116,CEFTRIAXONE treats BACTERIAL MENINGITIS,53,14,,73,25,treats,0.896258159530272,907846-FS1-2,Comparison of CEFTRIAXONE and traditional therapy of BACTERIAL MENINGITIS,BACTERIAL MENINGITIS,CEFTRIAXONE,RO-may_treat
498023364,7/4/2014 14:54:12,false,1314941137,7/4/2014 14:53:35,clixsense,0.7667,27969116,NLD,4,Veendam,185.12.216.74,no_relation,5,30,,28,51,contraindicates,0.308606699924184,902767-FS1-10,"With POSTMENOPAUSAL BLEEDING, ENDOMETRIAL CARCINOMA must always be ruled out",POSTMENOPAUSAL BLEEDING,ENDOMETRIAL CARCINOMA,RO-disease_may_have_finding
498023364,7/4/2014 15:14:04,false,1314957093,7/4/2014 15:13:34,clixsense,0.6479,6394333,GBR,,,86.29.240.182,no_relation,5,30,,28,51,contraindicates,0.308606699924184,902767-FS1-10,"With POSTMENOPAUSAL BLEEDING, ENDOMETRIAL CARCINOMA must always be ruled out",POSTMENOPAUSAL BLEEDING,ENDOMETRIAL CARCINOMA,RO-disease_may_have_finding
498023364,7/4/2014 15:26:55,false,1314967303,7/4/2014 15:26:34,clixsense,0.6246,15189335,GBR,I9,Dereham,86.157.163.112,ENDOMETRIAL CARCINOMA contraindicates POSTMENOPAUSAL BLEEDING,5,30,,28,51,contraindicates,0.308606699924184,902767-FS1-10,"With POSTMENOPAUSAL BLEEDING, ENDOMETRIAL CARCINOMA must always be ruled out",POSTMENOPAUSAL BLEEDING,ENDOMETRIAL CARCINOMA,RO-disease_may_have_finding
498023364,7/4/2014 15:30:57,false,1314971229,7/4/2014 15:30:21,gptbanks,0.4263,18496428,USA,CA,Newhall,199.244.112.44,POSTMENOPAUSAL BLEEDING contraindicates ENDOMETRIAL CARCINOMA,5,30,,28,51,contraindicates,0.308606699924184,902767-FS1-10,"With POSTMENOPAUSAL BLEEDING, ENDOMETRIAL CARCINOMA must always be ruled out",POSTMENOPAUSAL BLEEDING,ENDOMETRIAL CARCINOMA,RO-disease_may_have_finding
498023364,7/4/2014 15:45:11,false,1314981641,7/4/2014 15:44:40,bitcoinget,0.6363,21490602,USA,NJ,Dunellen,68.193.37.224,no_relation,5,30,,28,51,contraindicates,0.308606699924184,902767-FS1-10,"With POSTMENOPAUSAL BLEEDING, ENDOMETRIAL CARCINOMA must always be ruled out",POSTMENOPAUSAL BLEEDING,ENDOMETRIAL CARCINOMA,RO-disease_may_have_finding
498023365,7/4/2014 14:47:13,false,1314935353,7/4/2014 14:47:02,prodege,0.8625,14890188,GBR,I2,Manchester,151.230.18.68,ROSIGLITAZONE treats TYPE 2 DIABETES MELLITUS,177,105,,201,118,treats,0.98058067569092,907629-FS1-2,"May be used in combination with metformin or a thiazolidinedione antidiabetic agent (e.g., pioglitazone, ROSIGLITAZONE) as an adjunct to diet and exercise for the management of TYPE 2 DIABETES MELLITUS in patients who do not achieve adequate glycemic control with diet, exercise, and monotherapy with metformin, a sulfonylurea, repaglinide, or a thiazolidinedione antidiabetic agent",TYPE 2 DIABETES MELLITUS,ROSIGLITAZONE,RO-may_treat
498023365,7/4/2014 14:52:06,false,1314939517,7/4/2014 14:51:46,clixsense,0.8625,19803139,NLD,6,Veldhoven,212.61.84.196,ROSIGLITAZONE treats TYPE 2 DIABETES MELLITUS,177,105,,201,118,treats,0.98058067569092,907629-FS1-2,"May be used in combination with metformin or a thiazolidinedione antidiabetic agent (e.g., pioglitazone, ROSIGLITAZONE) as an adjunct to diet and exercise for the management of TYPE 2 DIABETES MELLITUS in patients who do not achieve adequate glycemic control with diet, exercise, and monotherapy with metformin, a sulfonylurea, repaglinide, or a thiazolidinedione antidiabetic agent",TYPE 2 DIABETES MELLITUS,ROSIGLITAZONE,RO-may_treat
498023365,7/4/2014 15:15:33,false,1314958171,7/4/2014 15:15:15,clixsense,0.6479,6394333,GBR,,,86.29.240.182,no_relation,177,105,,201,118,treats,0.98058067569092,907629-FS1-2,"May be used in combination with metformin or a thiazolidinedione antidiabetic agent (e.g., pioglitazone, ROSIGLITAZONE) as an adjunct to diet and exercise for the management of TYPE 2 DIABETES MELLITUS in patients who do not achieve adequate glycemic control with diet, exercise, and monotherapy with metformin, a sulfonylurea, repaglinide, or a thiazolidinedione antidiabetic agent",TYPE 2 DIABETES MELLITUS,ROSIGLITAZONE,RO-may_treat
498023365,7/4/2014 15:21:17,false,1314962907,7/4/2014 15:21:05,clixsense,0.6246,15189335,GBR,I9,Dereham,86.157.163.112,ROSIGLITAZONE treats TYPE 2 DIABETES MELLITUS,177,105,,201,118,treats,0.98058067569092,907629-FS1-2,"May be used in combination with metformin or a thiazolidinedione antidiabetic agent (e.g., pioglitazone, ROSIGLITAZONE) as an adjunct to diet and exercise for the management of TYPE 2 DIABETES MELLITUS in patients who do not achieve adequate glycemic control with diet, exercise, and monotherapy with metformin, a sulfonylurea, repaglinide, or a thiazolidinedione antidiabetic agent",TYPE 2 DIABETES MELLITUS,ROSIGLITAZONE,RO-may_treat
498023365,7/4/2014 15:30:11,false,1314970358,7/4/2014 15:30:02,gptbanks,0.4263,18496428,USA,CA,Newhall,199.244.112.44,ROSIGLITAZONE treats TYPE 2 DIABETES MELLITUS,177,105,,201,118,treats,0.98058067569092,907629-FS1-2,"May be used in combination with metformin or a thiazolidinedione antidiabetic agent (e.g., pioglitazone, ROSIGLITAZONE) as an adjunct to diet and exercise for the management of TYPE 2 DIABETES MELLITUS in patients who do not achieve adequate glycemic control with diet, exercise, and monotherapy with metformin, a sulfonylurea, repaglinide, or a thiazolidinedione antidiabetic agent",TYPE 2 DIABETES MELLITUS,ROSIGLITAZONE,RO-may_treat
498023366,7/4/2014 15:01:47,false,1314947476,7/4/2014 15:01:19,clixsense,0.7667,27969116,NLD,4,Veendam,185.12.216.74,no_relation,64,11,,87,20,treats,1,907396-FS1-2,The use of PHENYTOIN in headache syndromes and in prevention of POST-TRAUMATIC EPILEPSY is discussed,POST-TRAUMATIC EPILEPSY,PHENYTOIN,RO-may_prevent
498023366,7/4/2014 15:08:51,false,1314953530,7/4/2014 15:08:03,clixsense,0.6479,6394333,GBR,,,86.29.240.182,no_relation,64,11,,87,20,treats,1,907396-FS1-2,The use of PHENYTOIN in headache syndromes and in prevention of POST-TRAUMATIC EPILEPSY is discussed,POST-TRAUMATIC EPILEPSY,PHENYTOIN,RO-may_prevent
498023366,7/4/2014 15:23:15,false,1314964385,7/4/2014 15:22:51,clixsense,0.6246,15189335,GBR,I9,Dereham,86.157.163.112,PHENYTOIN treats POST-TRAUMATIC EPILEPSY,64,11,,87,20,treats,1,907396-FS1-2,The use of PHENYTOIN in headache syndromes and in prevention of POST-TRAUMATIC EPILEPSY is discussed,POST-TRAUMATIC EPILEPSY,PHENYTOIN,RO-may_prevent
498023366,7/4/2014 15:35:58,false,1314975210,7/4/2014 15:35:52,gptbanks,0.4263,18496428,USA,CA,Newhall,199.244.112.44,PHENYTOIN treats POST-TRAUMATIC EPILEPSY,64,11,,87,20,treats,1,907396-FS1-2,The use of PHENYTOIN in headache syndromes and in prevention of POST-TRAUMATIC EPILEPSY is discussed,POST-TRAUMATIC EPILEPSY,PHENYTOIN,RO-may_prevent
498023366,7/4/2014 15:41:19,false,1314978960,7/4/2014 15:40:59,bitcoinget,0.6363,21490602,USA,NJ,Dunellen,68.193.37.224,PHENYTOIN treats POST-TRAUMATIC EPILEPSY,64,11,,87,20,treats,1,907396-FS1-2,The use of PHENYTOIN in headache syndromes and in prevention of POST-TRAUMATIC EPILEPSY is discussed,POST-TRAUMATIC EPILEPSY,PHENYTOIN,RO-may_prevent
498023367,7/4/2014 14:45:17,false,1314933495,7/4/2014 14:45:02,prodege,0.8625,14890188,GBR,I2,Manchester,151.230.18.68,no_relation,105,59,,128,72,treats,0.811107105653813,907865-FS1-2,A clinical comparison between glipizide (Glibenese ����渇�膩��臂�申�鰹申鐃順����鐃初���申���紮�申羝�申鐃緒申��LIBENCLAMIDEnclamide (Daonil ����渇�膩��臂�申�鰹申鐃順����鐃初���申���紮�申羝�申鐃緒申�渇�膩������括�鐃順�����鰹申鐃� tMATURITY ONSET DIABETESy onset diabetes: a controlled double-blind cross-over study,MATURITY ONSET DIABETES,GLIBENCLAMIDE,RO-may_treat
498023367,7/4/2014 14:51:45,false,1314939323,7/4/2014 14:51:28,clixsense,0.8625,19803139,NLD,6,Veldhoven,212.61.84.196,no_relation,105,59,,128,72,treats,0.811107105653813,907865-FS1-2,A clinical comparison between glipizide (Glibenese ����渇�膩��臂�申�鰹申鐃順����鐃初���申���紮�申羝�申鐃緒申��LIBENCLAMIDEnclamide (Daonil ����渇�膩��臂�申�鰹申鐃順����鐃初���申���紮�申羝�申鐃緒申�渇�膩������括�鐃順�����鰹申鐃� tMATURITY ONSET DIABETESy onset diabetes: a controlled double-blind cross-over study,MATURITY ONSET DIABETES,GLIBENCLAMIDE,RO-may_treat
498023367,7/4/2014 15:02:52,false,1314948428,7/4/2014 15:01:48,clixsense,0.7667,27969116,NLD,4,Veendam,185.12.216.74,no_relation,105,59,,128,72,treats,0.811107105653813,907865-FS1-2,A clinical comparison between glipizide (Glibenese ����渇�膩��臂�申�鰹申鐃順����鐃初���申���紮�申羝�申鐃緒申��LIBENCLAMIDEnclamide (Daonil ����渇�膩��臂�申�鰹申鐃順����鐃初���申���紮�申羝�申鐃緒申�渇�膩������括�鐃順�����鰹申鐃� tMATURITY ONSET DIABETESy onset diabetes: a controlled double-blind cross-over study,MATURITY ONSET DIABETES,GLIBENCLAMIDE,RO-may_treat
498023367,7/4/2014 15:30:13,false,1314970357,7/4/2014 15:30:01,prodege,0.6637,14848125,GBR,V2,Glasgow,86.130.194.252,GLIBENCLAMIDE treats MATURITY ONSET DIABETES,105,59,,128,72,treats,0.811107105653813,907865-FS1-2,A clinical comparison between glipizide (Glibenese ����渇�膩��臂�申�鰹申鐃順����鐃初���申���紮�申羝�申鐃緒申��LIBENCLAMIDEnclamide (Daonil ����渇�膩��臂�申�鰹申鐃順����鐃初���申���紮�申羝�申鐃緒申�渇�膩������括�鐃順�����鰹申鐃� tMATURITY ONSET DIABETESy onset diabetes: a controlled double-blind cross-over study,MATURITY ONSET DIABETES,GLIBENCLAMIDE,RO-may_treat
498023367,7/4/2014 15:30:19,false,1314970531,7/4/2014 15:30:13,gptbanks,0.4263,18496428,USA,CA,Newhall,199.244.112.44,GLIBENCLAMIDE treats MATURITY ONSET DIABETES,105,59,,128,72,treats,0.811107105653813,907865-FS1-2,A clinical comparison between glipizide (Glibenese ����渇�膩��臂�申�鰹申鐃順����鐃初���申���紮�申羝�申鐃緒申��LIBENCLAMIDEnclamide (Daonil ����渇�膩��臂�申�鰹申鐃順����鐃初���申���紮�申羝�申鐃緒申�渇�膩������括�鐃順�����鰹申鐃� tMATURITY ONSET DIABETESy onset diabetes: a controlled double-blind cross-over study,MATURITY ONSET DIABETES,GLIBENCLAMIDE,RO-may_treat
498023368,7/4/2014 14:45:18,false,1314933494,7/4/2014 14:45:01,clixsense,0.8625,19803139,NLD,6,Veldhoven,212.61.84.196,no_relation,115,77,,134,87,treats,0.997054485501582,907088-FS1-2,"These areas include rubella virus as a cause of congenital rubella syndrome, FOLIC ACID as a preventive factor for NEURAL TUBE DEFECTS, cytomegalovirus infection as a cause of birth defects and developmental disabilities, and alcohol as a cause of fetal alcohol spectrum disorders",NEURAL TUBE DEFECTS,FOLIC ACID,RO-may_prevent
498023368,7/4/2014 14:50:10,false,1314938002,7/4/2014 14:49:59,prodege,0.8625,14890188,GBR,I2,Manchester,151.230.18.68,FOLIC ACID treats NEURAL TUBE DEFECTS,115,77,,134,87,treats,0.997054485501582,907088-FS1-2,"These areas include rubella virus as a cause of congenital rubella syndrome, FOLIC ACID as a preventive factor for NEURAL TUBE DEFECTS, cytomegalovirus infection as a cause of birth defects and developmental disabilities, and alcohol as a cause of fetal alcohol spectrum disorders",NEURAL TUBE DEFECTS,FOLIC ACID,RO-may_prevent
498023368,7/4/2014 15:31:39,false,1314971883,7/4/2014 15:31:30,gptbanks,0.4263,18496428,USA,CA,Newhall,199.244.112.44,NEURAL TUBE DEFECTS treats FOLIC ACID,115,77,,134,87,treats,0.997054485501582,907088-FS1-2,"These areas include rubella virus as a cause of congenital rubella syndrome, FOLIC ACID as a preventive factor for NEURAL TUBE DEFECTS, cytomegalovirus infection as a cause of birth defects and developmental disabilities, and alcohol as a cause of fetal alcohol spectrum disorders",NEURAL TUBE DEFECTS,FOLIC ACID,RO-may_prevent
498023368,7/4/2014 15:33:00,false,1314973029,7/4/2014 15:32:38,prodege,0.6637,14848125,GBR,V2,Glasgow,86.130.194.252,no_relation,115,77,,134,87,treats,0.997054485501582,907088-FS1-2,"These areas include rubella virus as a cause of congenital rubella syndrome, FOLIC ACID as a preventive factor for NEURAL TUBE DEFECTS, cytomegalovirus infection as a cause of birth defects and developmental disabilities, and alcohol as a cause of fetal alcohol spectrum disorders",NEURAL TUBE DEFECTS,FOLIC ACID,RO-may_prevent
498023368,7/4/2014 15:42:34,false,1314979818,7/4/2014 15:42:12,bitcoinget,0.6363,21490602,USA,NJ,Dunellen,68.193.37.224,no_relation,115,77,,134,87,treats,0.997054485501582,907088-FS1-2,"These areas include rubella virus as a cause of congenital rubella syndrome, FOLIC ACID as a preventive factor for NEURAL TUBE DEFECTS, cytomegalovirus infection as a cause of birth defects and developmental disabilities, and alcohol as a cause of fetal alcohol spectrum disorders",NEURAL TUBE DEFECTS,FOLIC ACID,RO-may_prevent
498023369,7/4/2014 14:48:19,false,1314936442,7/4/2014 14:47:57,clixsense,0.8625,19803139,NLD,6,Veldhoven,212.61.84.196,no_relation,163,120,,174,134,treats,0.848528137423857,907509-FS1-2,"Ayestaran A, Lopez R, Montoro JB et al. Pharmacokinetics of conventional formulation versus fat emulsion formulation of AMPHOTERICIN B in a group of patients with NEUTROPENIA",NEUTROPENIA,AMPHOTERICIN B,RO-may_treat
498023369,7/4/2014 14:48:22,false,1314936533,7/4/2014 14:48:01,prodege,0.8625,14890188,GBR,I2,Manchester,151.230.18.68,AMPHOTERICIN B treats NEUTROPENIA,163,120,,174,134,treats,0.848528137423857,907509-FS1-2,"Ayestaran A, Lopez R, Montoro JB et al. Pharmacokinetics of conventional formulation versus fat emulsion formulation of AMPHOTERICIN B in a group of patients with NEUTROPENIA",NEUTROPENIA,AMPHOTERICIN B,RO-may_treat
498023369,7/4/2014 15:21:04,false,1314962752,7/4/2014 15:20:38,clixsense,0.6246,15189335,GBR,I9,Dereham,86.157.163.112,AMPHOTERICIN B treats NEUTROPENIA,163,120,,174,134,treats,0.848528137423857,907509-FS1-2,"Ayestaran A, Lopez R, Montoro JB et al. Pharmacokinetics of conventional formulation versus fat emulsion formulation of AMPHOTERICIN B in a group of patients with NEUTROPENIA",NEUTROPENIA,AMPHOTERICIN B,RO-may_treat
498023369,7/4/2014 15:33:00,false,1314973024,7/4/2014 15:32:38,prodege,0.6637,14848125,GBR,V2,Glasgow,86.130.194.252,AMPHOTERICIN B treats NEUTROPENIA,163,120,,174,134,treats,0.848528137423857,907509-FS1-2,"Ayestaran A, Lopez R, Montoro JB et al. Pharmacokinetics of conventional formulation versus fat emulsion formulation of AMPHOTERICIN B in a group of patients with NEUTROPENIA",NEUTROPENIA,AMPHOTERICIN B,RO-may_treat
498023369,7/4/2014 15:45:54,false,1314982155,7/4/2014 15:45:13,bitcoinget,0.6363,21490602,USA,NJ,Dunellen,68.193.37.224,AMPHOTERICIN B treats NEUTROPENIA,163,120,,174,134,treats,0.848528137423857,907509-FS1-2,"Ayestaran A, Lopez R, Montoro JB et al. Pharmacokinetics of conventional formulation versus fat emulsion formulation of AMPHOTERICIN B in a group of patients with NEUTROPENIA",NEUTROPENIA,AMPHOTERICIN B,RO-may_treat
498023370,7/4/2014 14:54:12,false,1314941176,7/4/2014 14:53:35,clixsense,0.7667,27969116,NLD,4,Veendam,185.12.216.74,BONE METASTASES causes PATHOLOGIC FRACTURE,189,100,,208,115,causes,0.904534033733291,902668-FS1-4,"Bone is a preferred site of metastasis for many solid tumors, and the complications associated with BONE METASTASES can result in significant skeletal morbidity including severe bone pain, PATHOLOGIC FRACTURE, spinal cord compression, and hypercalcemia of malignancy (HCM",PATHOLOGIC FRACTURE,BONE METASTASES,RO-disease_may_have_finding
498023370,7/4/2014 15:33:10,false,1314973187,7/4/2014 15:32:46,gptbanks,0.4263,18496428,USA,CA,Newhall,199.244.112.44,BONE METASTASES causes PATHOLOGIC FRACTURE,189,100,,208,115,causes,0.904534033733291,902668-FS1-4,"Bone is a preferred site of metastasis for many solid tumors, and the complications associated with BONE METASTASES can result in significant skeletal morbidity including severe bone pain, PATHOLOGIC FRACTURE, spinal cord compression, and hypercalcemia of malignancy (HCM",PATHOLOGIC FRACTURE,BONE METASTASES,RO-disease_may_have_finding
498023370,7/4/2014 15:40:58,false,1314978746,7/4/2014 15:40:14,bitcoinget,0.6363,21490602,USA,NJ,Dunellen,68.193.37.224,BONE METASTASES causes PATHOLOGIC FRACTURE,189,100,,208,115,causes,0.904534033733291,902668-FS1-4,"Bone is a preferred site of metastasis for many solid tumors, and the complications associated with BONE METASTASES can result in significant skeletal morbidity including severe bone pain, PATHOLOGIC FRACTURE, spinal cord compression, and hypercalcemia of malignancy (HCM",PATHOLOGIC FRACTURE,BONE METASTASES,RO-disease_may_have_finding
498023370,7/4/2014 15:50:44,false,1314986179,7/4/2014 15:50:10,rewardsspot,0.6639,24482174,GBR,H9,London,146.185.23.27,PATHOLOGIC FRACTURE causes BONE METASTASES,189,100,,208,115,causes,0.904534033733291,902668-FS1-4,"Bone is a preferred site of metastasis for many solid tumors, and the complications associated with BONE METASTASES can result in significant skeletal morbidity including severe bone pain, PATHOLOGIC FRACTURE, spinal cord compression, and hypercalcemia of malignancy (HCM",PATHOLOGIC FRACTURE,BONE METASTASES,RO-disease_may_have_finding
498023370,7/4/2014 15:52:34,false,1314987647,7/4/2014 15:52:24,neodev,0.5875,25804244,USA,IL,Chicago,99.198.108.116,BONE METASTASES causes PATHOLOGIC FRACTURE,189,100,,208,115,causes,0.904534033733291,902668-FS1-4,"Bone is a preferred site of metastasis for many solid tumors, and the complications associated with BONE METASTASES can result in significant skeletal morbidity including severe bone pain, PATHOLOGIC FRACTURE, spinal cord compression, and hypercalcemia of malignancy (HCM",PATHOLOGIC FRACTURE,BONE METASTASES,RO-disease_may_have_finding
498023371,7/4/2014 14:48:38,false,1314936755,7/4/2014 14:48:23,prodege,0.8625,14890188,GBR,I2,Manchester,151.230.18.68,no_relation,84,66,,100,79,is diagnosed by,0.609994281330419,906631-FS1-13,"We tried to detect salivary cortisol level with drug loading test(DEXAMETHASONE for CUSHING SYNDROME, and ACTH for adrenal insufficiency) with time interval",CUSHING SYNDROME,DEXAMETHASONE,RO-may_diagnose
498023371,7/4/2014 14:51:01,false,1314938604,7/4/2014 14:50:41,clixsense,0.8625,19803139,NLD,6,Veldhoven,212.61.84.196,no_relation,84,66,,100,79,is diagnosed by,0.609994281330419,906631-FS1-13,"We tried to detect salivary cortisol level with drug loading test(DEXAMETHASONE for CUSHING SYNDROME, and ACTH for adrenal insufficiency) with time interval",CUSHING SYNDROME,DEXAMETHASONE,RO-may_diagnose
498023371,7/4/2014 15:01:18,false,1314946965,7/4/2014 15:00:38,clixsense,0.7667,27969116,NLD,4,Veendam,185.12.216.74,DEXAMETHASONE is diagnosed by CUSHING SYNDROME,84,66,,100,79,is diagnosed by,0.609994281330419,906631-FS1-13,"We tried to detect salivary cortisol level with drug loading test(DEXAMETHASONE for CUSHING SYNDROME, and ACTH for adrenal insufficiency) with time interval",CUSHING SYNDROME,DEXAMETHASONE,RO-may_diagnose
498023371,7/4/2014 15:13:33,false,1314956751,7/4/2014 15:13:08,clixsense,0.6479,6394333,GBR,,,86.29.240.182,no_relation,84,66,,100,79,is diagnosed by,0.609994281330419,906631-FS1-13,"We tried to detect salivary cortisol level with drug loading test(DEXAMETHASONE for CUSHING SYNDROME, and ACTH for adrenal insufficiency) with time interval",CUSHING SYNDROME,DEXAMETHASONE,RO-may_diagnose
498023371,7/4/2014 15:45:54,false,1314982154,7/4/2014 15:45:13,bitcoinget,0.6363,21490602,USA,NJ,Dunellen,68.193.37.224,CUSHING SYNDROME is diagnosed by DEXAMETHASONE,84,66,,100,79,is diagnosed by,0.609994281330419,906631-FS1-13,"We tried to detect salivary cortisol level with drug loading test(DEXAMETHASONE for CUSHING SYNDROME, and ACTH for adrenal insufficiency) with time interval",CUSHING SYNDROME,DEXAMETHASONE,RO-may_diagnose
498023372,7/4/2014 14:48:38,false,1314936749,7/4/2014 14:48:23,prodege,0.8625,14890188,GBR,I2,Manchester,151.230.18.68,PANCYTOPENIA causes HEMOPHAGOCYTIC SYNDROME,78,0,,90,23,causes,0.991836598134176,902642-FS1-4,HEMOPHAGOCYTIC SYNDROME (HPS) is a life-threatening disorder characterized by PANCYTOPENIA and activation of macrophages,PANCYTOPENIA,HEMOPHAGOCYTIC SYNDROME,RO-disease_may_have_finding
498023372,7/4/2014 14:51:01,false,1314938603,7/4/2014 14:50:41,clixsense,0.8625,19803139,NLD,6,Veldhoven,212.61.84.196,no_relation,78,0,,90,23,causes,0.991836598134176,902642-FS1-4,HEMOPHAGOCYTIC SYNDROME (HPS) is a life-threatening disorder characterized by PANCYTOPENIA and activation of macrophages,PANCYTOPENIA,HEMOPHAGOCYTIC SYNDROME,RO-disease_may_have_finding
498023372,7/4/2014 14:55:14,false,1314941952,7/4/2014 14:54:13,clixsense,0.7667,27969116,NLD,4,Veendam,185.12.216.74,no_relation,78,0,,90,23,causes,0.991836598134176,902642-FS1-4,HEMOPHAGOCYTIC SYNDROME (HPS) is a life-threatening disorder characterized by PANCYTOPENIA and activation of macrophages,PANCYTOPENIA,HEMOPHAGOCYTIC SYNDROME,RO-disease_may_have_finding
498023372,7/4/2014 15:12:55,false,1314956324,7/4/2014 15:12:35,clixsense,0.6479,6394333,GBR,,,86.29.240.182,no_relation,78,0,,90,23,causes,0.991836598134176,902642-FS1-4,HEMOPHAGOCYTIC SYNDROME (HPS) is a life-threatening disorder characterized by PANCYTOPENIA and activation of macrophages,PANCYTOPENIA,HEMOPHAGOCYTIC SYNDROME,RO-disease_may_have_finding
498023372,7/4/2014 15:30:57,false,1314971223,7/4/2014 15:30:21,gptbanks,0.4263,18496428,USA,CA,Newhall,199.244.112.44,PANCYTOPENIA causes HEMOPHAGOCYTIC SYNDROME,78,0,,90,23,causes,0.991836598134176,902642-FS1-4,HEMOPHAGOCYTIC SYNDROME (HPS) is a life-threatening disorder characterized by PANCYTOPENIA and activation of macrophages,PANCYTOPENIA,HEMOPHAGOCYTIC SYNDROME,RO-disease_may_have_finding
498023373,7/4/2014 15:12:18,false,1314955974,7/4/2014 15:11:48,clixsense,0.6479,6394333,GBR,,,86.29.240.182,no_relation,116,172,,120,182,treats,0.995893206467704,907183-FS1-2,When administered intravenously in the dorsum of the hand the pain score and the number of patients who experienced PAIN was reduced significantly by mixing the agent with LIGNOCAINE when compared with a bolus injection,PAIN,LIGNOCAINE,RO-may_prevent
498023373,7/4/2014 15:21:04,false,1314962753,7/4/2014 15:20:38,clixsense,0.6246,15189335,GBR,I9,Dereham,86.157.163.112,LIGNOCAINE treats PAIN,116,172,,120,182,treats,0.995893206467704,907183-FS1-2,When administered intravenously in the dorsum of the hand the pain score and the number of patients who experienced PAIN was reduced significantly by mixing the agent with LIGNOCAINE when compared with a bolus injection,PAIN,LIGNOCAINE,RO-may_prevent
498023373,7/4/2014 15:31:04,false,1314971331,7/4/2014 15:30:59,gptbanks,0.4263,18496428,USA,CA,Newhall,199.244.112.44,LIGNOCAINE treats PAIN,116,172,,120,182,treats,0.995893206467704,907183-FS1-2,When administered intravenously in the dorsum of the hand the pain score and the number of patients who experienced PAIN was reduced significantly by mixing the agent with LIGNOCAINE when compared with a bolus injection,PAIN,LIGNOCAINE,RO-may_prevent
498023373,7/4/2014 15:44:13,false,1314980860,7/4/2014 15:43:35,bitcoinget,0.6363,21490602,USA,NJ,Dunellen,68.193.37.224,LIGNOCAINE treats PAIN,116,172,,120,182,treats,0.995893206467704,907183-FS1-2,When administered intravenously in the dorsum of the hand the pain score and the number of patients who experienced PAIN was reduced significantly by mixing the agent with LIGNOCAINE when compared with a bolus injection,PAIN,LIGNOCAINE,RO-may_prevent
498023373,7/4/2014 15:47:22,false,1314983332,7/4/2014 15:46:36,rewardsspot,0.6639,24482174,GBR,H9,London,146.185.23.27,LIGNOCAINE treats PAIN,116,172,,120,182,treats,0.995893206467704,907183-FS1-2,When administered intravenously in the dorsum of the hand the pain score and the number of patients who experienced PAIN was reduced significantly by mixing the agent with LIGNOCAINE when compared with a bolus injection,PAIN,LIGNOCAINE,RO-may_prevent
498023374,7/4/2014 14:49:08,false,1314937082,7/4/2014 14:48:42,clixsense,0.8625,19803139,NLD,6,Veldhoven,212.61.84.196,no_relation,80,138,,97,154,is diagnosed by,0.940720868383597,906871-FS1-13,"The commonly used laboratory investigations for the diagnosis and management of THYROID DISORDERS are the thyroid hormones, thyroxine and TRIIODOTHYRONINE and the pituitary hormone, thyrotrophin (TSH",THYROID DISORDERS,TRIIODOTHYRONINE,RO-may_diagnose
498023374,7/4/2014 15:02:52,false,1314948431,7/4/2014 15:01:48,clixsense,0.7667,27969116,NLD,4,Veendam,185.12.216.74,THYROID DISORDERS is diagnosed by TRIIODOTHYRONINE,80,138,,97,154,is diagnosed by,0.940720868383597,906871-FS1-13,"The commonly used laboratory investigations for the diagnosis and management of THYROID DISORDERS are the thyroid hormones, thyroxine and TRIIODOTHYRONINE and the pituitary hormone, thyrotrophin (TSH",THYROID DISORDERS,TRIIODOTHYRONINE,RO-may_diagnose
498023374,7/4/2014 15:10:34,false,1314954771,7/4/2014 15:10:12,clixsense,0.6479,6394333,GBR,,,86.29.240.182,no_relation,80,138,,97,154,is diagnosed by,0.940720868383597,906871-FS1-13,"The commonly used laboratory investigations for the diagnosis and management of THYROID DISORDERS are the thyroid hormones, thyroxine and TRIIODOTHYRONINE and the pituitary hormone, thyrotrophin (TSH",THYROID DISORDERS,TRIIODOTHYRONINE,RO-may_diagnose
498023374,7/4/2014 15:30:19,false,1314970532,7/4/2014 15:30:13,gptbanks,0.4263,18496428,USA,CA,Newhall,199.244.112.44,THYROID DISORDERS is diagnosed by TRIIODOTHYRONINE,80,138,,97,154,is diagnosed by,0.940720868383597,906871-FS1-13,"The commonly used laboratory investigations for the diagnosis and management of THYROID DISORDERS are the thyroid hormones, thyroxine and TRIIODOTHYRONINE and the pituitary hormone, thyrotrophin (TSH",THYROID DISORDERS,TRIIODOTHYRONINE,RO-may_diagnose
498023374,7/4/2014 15:30:42,false,1314970986,7/4/2014 15:30:14,prodege,0.6637,14848125,GBR,V2,Glasgow,86.130.194.252,no_relation,80,138,,97,154,is diagnosed by,0.940720868383597,906871-FS1-13,"The commonly used laboratory investigations for the diagnosis and management of THYROID DISORDERS are the thyroid hormones, thyroxine and TRIIODOTHYRONINE and the pituitary hormone, thyrotrophin (TSH",THYROID DISORDERS,TRIIODOTHYRONINE,RO-may_diagnose
498023375,7/4/2014 14:46:31,false,1314934669,7/4/2014 14:46:15,clixsense,0.8625,19803139,NLD,6,Veldhoven,212.61.84.196,no_relation,73,106,,97,114,treats,0.979795897113271,907345-FS1-2,"In order to evaluate the preventive effect of estrogen and vitamin D3 on POSTMENOPAUSAL BONE LOSS, either ESTROGEN (Premarin 0.625 mg/day) or vitamin D3 (Onealfa 1.0 micrograms/day) was administered to postmenopausal women",POSTMENOPAUSAL BONE LOSS,ESTROGEN,RO-may_prevent
498023375,7/4/2014 15:33:31,false,1314973420,7/4/2014 15:33:01,prodege,0.6637,14848125,GBR,V2,Glasgow,86.130.194.252,ESTROGEN treats POSTMENOPAUSAL BONE LOSS,73,106,,97,114,treats,0.979795897113271,907345-FS1-2,"In order to evaluate the preventive effect of estrogen and vitamin D3 on POSTMENOPAUSAL BONE LOSS, either ESTROGEN (Premarin 0.625 mg/day) or vitamin D3 (Onealfa 1.0 micrograms/day) was administered to postmenopausal women",POSTMENOPAUSAL BONE LOSS,ESTROGEN,RO-may_prevent
498023375,7/4/2014 15:35:43,false,1314974988,7/4/2014 15:35:37,gptbanks,0.4263,18496428,USA,CA,Newhall,199.244.112.44,ESTROGEN treats POSTMENOPAUSAL BONE LOSS,73,106,,97,114,treats,0.979795897113271,907345-FS1-2,"In order to evaluate the preventive effect of estrogen and vitamin D3 on POSTMENOPAUSAL BONE LOSS, either ESTROGEN (Premarin 0.625 mg/day) or vitamin D3 (Onealfa 1.0 micrograms/day) was administered to postmenopausal women",POSTMENOPAUSAL BONE LOSS,ESTROGEN,RO-may_prevent
498023375,7/4/2014 15:39:39,false,1314977845,7/4/2014 15:39:04,bitcoinget,0.6363,21490602,USA,NJ,Dunellen,68.193.37.224,ESTROGEN treats POSTMENOPAUSAL BONE LOSS,73,106,,97,114,treats,0.979795897113271,907345-FS1-2,"In order to evaluate the preventive effect of estrogen and vitamin D3 on POSTMENOPAUSAL BONE LOSS, either ESTROGEN (Premarin 0.625 mg/day) or vitamin D3 (Onealfa 1.0 micrograms/day) was administered to postmenopausal women",POSTMENOPAUSAL BONE LOSS,ESTROGEN,RO-may_prevent
498023375,7/4/2014 15:46:31,false,1314982635,7/4/2014 15:45:57,rewardsspot,0.6639,24482174,GBR,H9,London,146.185.23.27,ESTROGEN treats POSTMENOPAUSAL BONE LOSS,73,106,,97,114,treats,0.979795897113271,907345-FS1-2,"In order to evaluate the preventive effect of estrogen and vitamin D3 on POSTMENOPAUSAL BONE LOSS, either ESTROGEN (Premarin 0.625 mg/day) or vitamin D3 (Onealfa 1.0 micrograms/day) was administered to postmenopausal women",POSTMENOPAUSAL BONE LOSS,ESTROGEN,RO-may_prevent
498023376,7/4/2014 14:48:22,false,1314936515,7/4/2014 14:48:01,prodege,0.8625,14890188,GBR,I2,Manchester,151.230.18.68,DEXAMETHASONE treats HYPERCORTISOLISM,48,104,,64,117,treats,0.78086880944303,906657-FS1-2,"Very high plasma androgen levels or evidence of HYPERCORTISOLISM, which is not normally suppressible by DEXAMETHASONE, should lead to the search for a tumor or Cushing's syndrome",HYPERCORTISOLISM,DEXAMETHASONE,RO-may_diagnose
498023376,7/4/2014 15:12:55,false,1314956340,7/4/2014 15:12:35,clixsense,0.6479,6394333,GBR,,,86.29.240.182,no_relation,48,104,,64,117,treats,0.78086880944303,906657-FS1-2,"Very high plasma androgen levels or evidence of HYPERCORTISOLISM, which is not normally suppressible by DEXAMETHASONE, should lead to the search for a tumor or Cushing's syndrome",HYPERCORTISOLISM,DEXAMETHASONE,RO-may_diagnose
498023376,7/4/2014 15:21:36,false,1314963059,7/4/2014 15:21:19,clixsense,0.6246,15189335,GBR,I9,Dereham,86.157.163.112,DEXAMETHASONE treats HYPERCORTISOLISM,48,104,,64,117,treats,0.78086880944303,906657-FS1-2,"Very high plasma androgen levels or evidence of HYPERCORTISOLISM, which is not normally suppressible by DEXAMETHASONE, should lead to the search for a tumor or Cushing's syndrome",HYPERCORTISOLISM,DEXAMETHASONE,RO-may_diagnose
498023376,7/4/2014 15:31:11,false,1314971434,7/4/2014 15:31:06,gptbanks,0.4263,18496428,USA,CA,Newhall,199.244.112.44,DEXAMETHASONE treats HYPERCORTISOLISM,48,104,,64,117,treats,0.78086880944303,906657-FS1-2,"Very high plasma androgen levels or evidence of HYPERCORTISOLISM, which is not normally suppressible by DEXAMETHASONE, should lead to the search for a tumor or Cushing's syndrome",HYPERCORTISOLISM,DEXAMETHASONE,RO-may_diagnose
498023376,7/4/2014 15:33:44,false,1314973745,7/4/2014 15:33:32,prodege,0.6637,14848125,GBR,V2,Glasgow,86.130.194.252,DEXAMETHASONE treats HYPERCORTISOLISM,48,104,,64,117,treats,0.78086880944303,906657-FS1-2,"Very high plasma androgen levels or evidence of HYPERCORTISOLISM, which is not normally suppressible by DEXAMETHASONE, should lead to the search for a tumor or Cushing's syndrome",HYPERCORTISOLISM,DEXAMETHASONE,RO-may_diagnose
498023377,7/4/2014 14:49:41,false,1314937649,7/4/2014 14:49:29,prodege,0.8625,14890188,GBR,I2,Manchester,151.230.18.68,no_relation,48,104,,64,117,causes,0.312347523777212,906657-FS1-4,"Very high plasma androgen levels or evidence of HYPERCORTISOLISM, which is not normally suppressible by DEXAMETHASONE, should lead to the search for a tumor or Cushing's syndrome",HYPERCORTISOLISM,DEXAMETHASONE,RO-may_diagnose
498023377,7/4/2014 14:52:30,false,1314939760,7/4/2014 14:52:07,clixsense,0.8625,19803139,NLD,6,Veldhoven,212.61.84.196,no_relation,48,104,,64,117,causes,0.312347523777212,906657-FS1-4,"Very high plasma androgen levels or evidence of HYPERCORTISOLISM, which is not normally suppressible by DEXAMETHASONE, should lead to the search for a tumor or Cushing's syndrome",HYPERCORTISOLISM,DEXAMETHASONE,RO-may_diagnose
498023377,7/4/2014 15:23:43,false,1314964710,7/4/2014 15:23:16,clixsense,0.6246,15189335,GBR,I9,Dereham,86.157.163.112,DEXAMETHASONE causes HYPERCORTISOLISM,48,104,,64,117,causes,0.312347523777212,906657-FS1-4,"Very high plasma androgen levels or evidence of HYPERCORTISOLISM, which is not normally suppressible by DEXAMETHASONE, should lead to the search for a tumor or Cushing's syndrome",HYPERCORTISOLISM,DEXAMETHASONE,RO-may_diagnose
498023377,7/4/2014 15:30:42,false,1314970993,7/4/2014 15:30:14,prodege,0.6637,14848125,GBR,V2,Glasgow,86.130.194.252,no_relation,48,104,,64,117,causes,0.312347523777212,906657-FS1-4,"Very high plasma androgen levels or evidence of HYPERCORTISOLISM, which is not normally suppressible by DEXAMETHASONE, should lead to the search for a tumor or Cushing's syndrome",HYPERCORTISOLISM,DEXAMETHASONE,RO-may_diagnose
498023377,7/4/2014 15:31:53,false,1314972112,7/4/2014 15:31:42,gptbanks,0.4263,18496428,USA,CA,Newhall,199.244.112.44,HYPERCORTISOLISM causes DEXAMETHASONE,48,104,,64,117,causes,0.312347523777212,906657-FS1-4,"Very high plasma androgen levels or evidence of HYPERCORTISOLISM, which is not normally suppressible by DEXAMETHASONE, should lead to the search for a tumor or Cushing's syndrome",HYPERCORTISOLISM,DEXAMETHASONE,RO-may_diagnose
498023378,7/4/2014 14:46:15,false,1314934397,7/4/2014 14:46:01,prodege,0.8625,14890188,GBR,I2,Manchester,151.230.18.68,ISOTRETINOIN treats ACNE,37,61,,41,73,treats,0.983869910099907,907655-FS1-2,Association of suicide attempts with ACNE and treatment with ISOTRETINOIN: retrospective Swedish cohort study,ACNE,ISOTRETINOIN,RO-may_treat
498023378,7/4/2014 14:50:17,false,1314938069,7/4/2014 14:49:52,clixsense,0.8625,19803139,NLD,6,Veldhoven,212.61.84.196,ISOTRETINOIN treats ACNE,37,61,,41,73,treats,0.983869910099907,907655-FS1-2,Association of suicide attempts with ACNE and treatment with ISOTRETINOIN: retrospective Swedish cohort study,ACNE,ISOTRETINOIN,RO-may_treat
498023378,7/4/2014 15:14:48,false,1314957594,7/4/2014 15:14:26,clixsense,0.6479,6394333,GBR,,,86.29.240.182,no_relation,37,61,,41,73,treats,0.983869910099907,907655-FS1-2,Association of suicide attempts with ACNE and treatment with ISOTRETINOIN: retrospective Swedish cohort study,ACNE,ISOTRETINOIN,RO-may_treat
498023378,7/4/2014 15:25:58,false,1314966501,7/4/2014 15:25:18,clixsense,0.6246,15189335,GBR,I9,Dereham,86.157.163.112,ISOTRETINOIN treats ACNE,37,61,,41,73,treats,0.983869910099907,907655-FS1-2,Association of suicide attempts with ACNE and treatment with ISOTRETINOIN: retrospective Swedish cohort study,ACNE,ISOTRETINOIN,RO-may_treat
498023378,7/4/2014 15:31:31,false,1314971795,7/4/2014 15:31:16,prodege,0.6637,14848125,GBR,V2,Glasgow,86.130.194.252,ISOTRETINOIN treats ACNE,37,61,,41,73,treats,0.983869910099907,907655-FS1-2,Association of suicide attempts with ACNE and treatment with ISOTRETINOIN: retrospective Swedish cohort study,ACNE,ISOTRETINOIN,RO-may_treat
498023379,7/4/2014 14:49:51,false,1314937757,7/4/2014 14:49:35,clixsense,0.8625,19803139,NLD,6,Veldhoven,212.61.84.196,BUPIVACAINE causes PAIN,94,124,,98,135,causes,0.919145030018058,907397-FS1-4,There was no difference in the rate of regression of sensory anesthesia or the development of PAIN among patients receiving BUPIVACAINE alone or bupivacaine with fentanyl,PAIN,BUPIVACAINE,RO-may_prevent
498023379,7/4/2014 15:03:32,false,1314949047,7/4/2014 15:02:53,clixsense,0.7667,27969116,NLD,4,Veendam,185.12.216.74,no_relation,94,124,,98,135,causes,0.919145030018058,907397-FS1-4,There was no difference in the rate of regression of sensory anesthesia or the development of PAIN among patients receiving BUPIVACAINE alone or bupivacaine with fentanyl,PAIN,BUPIVACAINE,RO-may_prevent
498023379,7/4/2014 15:09:27,false,1314953978,7/4/2014 15:08:52,clixsense,0.6479,6394333,GBR,,,86.29.240.182,no_relation,94,124,,98,135,causes,0.919145030018058,907397-FS1-4,There was no difference in the rate of regression of sensory anesthesia or the development of PAIN among patients receiving BUPIVACAINE alone or bupivacaine with fentanyl,PAIN,BUPIVACAINE,RO-may_prevent
498023379,7/4/2014 15:27:17,false,1314967604,7/4/2014 15:27:05,clixsense,0.6246,15189335,GBR,I9,Dereham,86.157.163.112,BUPIVACAINE causes PAIN,94,124,,98,135,causes,0.919145030018058,907397-FS1-4,There was no difference in the rate of regression of sensory anesthesia or the development of PAIN among patients receiving BUPIVACAINE alone or bupivacaine with fentanyl,PAIN,BUPIVACAINE,RO-may_prevent
498023379,7/4/2014 15:28:47,false,1314969138,7/4/2014 15:28:22,prodege,0.6637,14848125,GBR,V2,Glasgow,86.130.194.252,no_relation,94,124,,98,135,causes,0.919145030018058,907397-FS1-4,There was no difference in the rate of regression of sensory anesthesia or the development of PAIN among patients receiving BUPIVACAINE alone or bupivacaine with fentanyl,PAIN,BUPIVACAINE,RO-may_prevent
498023380,7/4/2014 14:45:01,false,1314933240,7/4/2014 14:44:28,prodege,0.8625,14890188,GBR,I2,Manchester,151.230.18.68,no_relation,35,68,,50,81,causes,0.970494958830946,902649-FS1-4,We do not recommend observation of SPLENIC RUPTURE in patients with MONONUCLEOSIS because of the danger of delayed hemorrhage,SPLENIC RUPTURE,MONONUCLEOSIS,RO-disease_may_have_finding
498023380,7/4/2014 14:45:18,false,1314933503,7/4/2014 14:45:01,clixsense,0.8625,19803139,NLD,6,Veldhoven,212.61.84.196,no_relation,35,68,,50,81,causes,0.970494958830946,902649-FS1-4,We do not recommend observation of SPLENIC RUPTURE in patients with MONONUCLEOSIS because of the danger of delayed hemorrhage,SPLENIC RUPTURE,MONONUCLEOSIS,RO-disease_may_have_finding
498023380,7/4/2014 15:15:45,false,1314958259,7/4/2014 15:15:34,clixsense,0.6479,6394333,GBR,,,86.29.240.182,no_relation,35,68,,50,81,causes,0.970494958830946,902649-FS1-4,We do not recommend observation of SPLENIC RUPTURE in patients with MONONUCLEOSIS because of the danger of delayed hemorrhage,SPLENIC RUPTURE,MONONUCLEOSIS,RO-disease_may_have_finding
498023380,7/4/2014 15:32:44,false,1314972828,7/4/2014 15:31:54,gptbanks,0.4263,18496428,USA,CA,Newhall,199.244.112.44,MONONUCLEOSIS causes SPLENIC RUPTURE,35,68,,50,81,causes,0.970494958830946,902649-FS1-4,We do not recommend observation of SPLENIC RUPTURE in patients with MONONUCLEOSIS because of the danger of delayed hemorrhage,SPLENIC RUPTURE,MONONUCLEOSIS,RO-disease_may_have_finding
498023380,7/4/2014 15:43:00,false,1314980119,7/4/2014 15:42:35,bitcoinget,0.6363,21490602,USA,NJ,Dunellen,68.193.37.224,MONONUCLEOSIS causes SPLENIC RUPTURE,35,68,,50,81,causes,0.970494958830946,902649-FS1-4,We do not recommend observation of SPLENIC RUPTURE in patients with MONONUCLEOSIS because of the danger of delayed hemorrhage,SPLENIC RUPTURE,MONONUCLEOSIS,RO-disease_may_have_finding
498023381,7/4/2014 15:12:34,false,1314956113,7/4/2014 15:12:20,clixsense,0.6479,6394333,GBR,,,86.29.240.182,no_relation,39,4,,52,29,causes,0.975900072948533,902666-FS1-4,"The INVASIVE DUCTAL CARCINOMA showed a SOLID PATTERN, high nuclear and structural atypia and frequent mitotic figures, while the tubular adenoma consisted of a proliferation of small ducts lined by single layers of epithelial and myoepithelial cells with bland nuclei and inconspicuous nucleoli",SOLID PATTERN,INVASIVE DUCTAL CARCINOMA,RO-disease_may_have_finding
498023381,7/4/2014 15:31:53,false,1314972109,7/4/2014 15:31:42,gptbanks,0.4263,18496428,USA,CA,Newhall,199.244.112.44,INVASIVE DUCTAL CARCINOMA causes SOLID PATTERN,39,4,,52,29,causes,0.975900072948533,902666-FS1-4,"The INVASIVE DUCTAL CARCINOMA showed a SOLID PATTERN, high nuclear and structural atypia and frequent mitotic figures, while the tubular adenoma consisted of a proliferation of small ducts lined by single layers of epithelial and myoepithelial cells with bland nuclei and inconspicuous nucleoli",SOLID PATTERN,INVASIVE DUCTAL CARCINOMA,RO-disease_may_have_finding
498023381,7/4/2014 15:43:34,false,1314980418,7/4/2014 15:43:01,bitcoinget,0.6363,21490602,USA,NJ,Dunellen,68.193.37.224,no_relation,39,4,,52,29,causes,0.975900072948533,902666-FS1-4,"The INVASIVE DUCTAL CARCINOMA showed a SOLID PATTERN, high nuclear and structural atypia and frequent mitotic figures, while the tubular adenoma consisted of a proliferation of small ducts lined by single layers of epithelial and myoepithelial cells with bland nuclei and inconspicuous nucleoli",SOLID PATTERN,INVASIVE DUCTAL CARCINOMA,RO-disease_may_have_finding
498023381,7/4/2014 15:51:31,false,1314986806,7/4/2014 15:50:49,rewardsspot,0.6639,24482174,GBR,H9,London,146.185.23.27,SOLID PATTERN causes INVASIVE DUCTAL CARCINOMA,39,4,,52,29,causes,0.975900072948533,902666-FS1-4,"The INVASIVE DUCTAL CARCINOMA showed a SOLID PATTERN, high nuclear and structural atypia and frequent mitotic figures, while the tubular adenoma consisted of a proliferation of small ducts lined by single layers of epithelial and myoepithelial cells with bland nuclei and inconspicuous nucleoli",SOLID PATTERN,INVASIVE DUCTAL CARCINOMA,RO-disease_may_have_finding
498023381,7/4/2014 15:52:22,false,1314987469,7/4/2014 15:52:07,neodev,0.5875,25804244,USA,IL,Chicago,99.198.108.116,INVASIVE DUCTAL CARCINOMA causes SOLID PATTERN,39,4,,52,29,causes,0.975900072948533,902666-FS1-4,"The INVASIVE DUCTAL CARCINOMA showed a SOLID PATTERN, high nuclear and structural atypia and frequent mitotic figures, while the tubular adenoma consisted of a proliferation of small ducts lined by single layers of epithelial and myoepithelial cells with bland nuclei and inconspicuous nucleoli",SOLID PATTERN,INVASIVE DUCTAL CARCINOMA,RO-disease_may_have_finding
498023382,7/4/2014 14:45:01,false,1314933246,7/4/2014 14:44:28,prodege,0.8625,14890188,GBR,I2,Manchester,151.230.18.68,PAPAVERINE treats ERECTILE DYSFUNCTION,118,87,,138,97,treats,0.983869910099907,906513-FS1-2,"In our experience, E1-PG intracavernous injection has proven to be more effective than PAPAVERINE in the treatment of ERECTILE DYSFUNCTION and therefore, added to its safety and degree of acceptance, we consider it a first choice approach in the diagnosis and treatment of erectile dysfunction in males",ERECTILE DYSFUNCTION,PAPAVERINE,RO-may_diagnose
498023382,7/4/2014 14:57:48,false,1314944021,7/4/2014 14:57:29,clixsense,0.7667,27969116,NLD,4,Veendam,185.12.216.74,PAPAVERINE treats ERECTILE DYSFUNCTION,118,87,,138,97,treats,0.983869910099907,906513-FS1-2,"In our experience, E1-PG intracavernous injection has proven to be more effective than PAPAVERINE in the treatment of ERECTILE DYSFUNCTION and therefore, added to its safety and degree of acceptance, we consider it a first choice approach in the diagnosis and treatment of erectile dysfunction in males",ERECTILE DYSFUNCTION,PAPAVERINE,RO-may_diagnose
498023382,7/4/2014 15:11:31,false,1314955468,7/4/2014 15:11:17,clixsense,0.6479,6394333,GBR,,,86.29.240.182,no_relation,118,87,,138,97,treats,0.983869910099907,906513-FS1-2,"In our experience, E1-PG intracavernous injection has proven to be more effective than PAPAVERINE in the treatment of ERECTILE DYSFUNCTION and therefore, added to its safety and degree of acceptance, we consider it a first choice approach in the diagnosis and treatment of erectile dysfunction in males",ERECTILE DYSFUNCTION,PAPAVERINE,RO-may_diagnose
498023382,7/4/2014 15:21:54,false,1314963329,7/4/2014 15:21:39,clixsense,0.6246,15189335,GBR,I9,Dereham,86.157.163.112,PAPAVERINE treats ERECTILE DYSFUNCTION,118,87,,138,97,treats,0.983869910099907,906513-FS1-2,"In our experience, E1-PG intracavernous injection has proven to be more effective than PAPAVERINE in the treatment of ERECTILE DYSFUNCTION and therefore, added to its safety and degree of acceptance, we consider it a first choice approach in the diagnosis and treatment of erectile dysfunction in males",ERECTILE DYSFUNCTION,PAPAVERINE,RO-may_diagnose
498023382,7/4/2014 15:31:04,false,1314971312,7/4/2014 15:30:59,gptbanks,0.4263,18496428,USA,CA,Newhall,199.244.112.44,ERECTILE DYSFUNCTION treats PAPAVERINE,118,87,,138,97,treats,0.983869910099907,906513-FS1-2,"In our experience, E1-PG intracavernous injection has proven to be more effective than PAPAVERINE in the treatment of ERECTILE DYSFUNCTION and therefore, added to its safety and degree of acceptance, we consider it a first choice approach in the diagnosis and treatment of erectile dysfunction in males",ERECTILE DYSFUNCTION,PAPAVERINE,RO-may_diagnose
498023383,7/4/2014 14:46:48,false,1314934905,7/4/2014 14:46:33,prodege,0.8625,14890188,GBR,I2,Manchester,151.230.18.68,INSULIN treats HYPERGLYCEMIA,82,138,,95,145,treats,0.98058067569092,907915-FS1-2,"Beta cells are nonetheless destroyed (by unknown means), and the patient develops HYPERGLYCEMIA or ketoacidosis unless he or she receives INSULIN",HYPERGLYCEMIA,INSULIN,RO-may_treat
498023383,7/4/2014 14:49:33,false,1314937571,7/4/2014 14:49:09,clixsense,0.8625,19803139,NLD,6,Veldhoven,212.61.84.196,INSULIN treats HYPERGLYCEMIA,82,138,,95,145,treats,0.98058067569092,907915-FS1-2,"Beta cells are nonetheless destroyed (by unknown means), and the patient develops HYPERGLYCEMIA or ketoacidosis unless he or she receives INSULIN",HYPERGLYCEMIA,INSULIN,RO-may_treat
498023383,7/4/2014 15:14:24,false,1314957301,7/4/2014 15:14:06,clixsense,0.6479,6394333,GBR,,,86.29.240.182,no_relation,82,138,,95,145,treats,0.98058067569092,907915-FS1-2,"Beta cells are nonetheless destroyed (by unknown means), and the patient develops HYPERGLYCEMIA or ketoacidosis unless he or she receives INSULIN",HYPERGLYCEMIA,INSULIN,RO-may_treat
498023383,7/4/2014 15:21:54,false,1314963328,7/4/2014 15:21:39,clixsense,0.6246,15189335,GBR,I9,Dereham,86.157.163.112,INSULIN treats HYPERGLYCEMIA,82,138,,95,145,treats,0.98058067569092,907915-FS1-2,"Beta cells are nonetheless destroyed (by unknown means), and the patient develops HYPERGLYCEMIA or ketoacidosis unless he or she receives INSULIN",HYPERGLYCEMIA,INSULIN,RO-may_treat
498023383,7/4/2014 15:31:47,false,1314972049,7/4/2014 15:31:32,prodege,0.6637,14848125,GBR,V2,Glasgow,86.130.194.252,INSULIN treats HYPERGLYCEMIA,82,138,,95,145,treats,0.98058067569092,907915-FS1-2,"Beta cells are nonetheless destroyed (by unknown means), and the patient develops HYPERGLYCEMIA or ketoacidosis unless he or she receives INSULIN",HYPERGLYCEMIA,INSULIN,RO-may_treat
498023384,7/4/2014 14:45:46,false,1314933870,7/4/2014 14:45:17,prodege,0.8625,14890188,GBR,I2,Manchester,151.230.18.68,IMIPRAMINE treats DEPRESSION,102,71,,112,81,treats,1,907634-FS1-2,A double-blind comparison of the efficacy and safety of paroxetine and IMIPRAMINE in the treatment of DEPRESSION with dementia,DEPRESSION,IMIPRAMINE,RO-may_treat
498023384,7/4/2014 14:56:21,false,1314942899,7/4/2014 14:56:01,clixsense,0.7667,27969116,NLD,4,Veendam,185.12.216.74,IMIPRAMINE treats DEPRESSION,102,71,,112,81,treats,1,907634-FS1-2,A double-blind comparison of the efficacy and safety of paroxetine and IMIPRAMINE in the treatment of DEPRESSION with dementia,DEPRESSION,IMIPRAMINE,RO-may_treat
498023384,7/4/2014 15:15:14,false,1314957885,7/4/2014 15:14:50,clixsense,0.6479,6394333,GBR,,,86.29.240.182,no_relation,102,71,,112,81,treats,1,907634-FS1-2,A double-blind comparison of the efficacy and safety of paroxetine and IMIPRAMINE in the treatment of DEPRESSION with dementia,DEPRESSION,IMIPRAMINE,RO-may_treat
498023384,7/4/2014 15:26:33,false,1314967019,7/4/2014 15:26:02,clixsense,0.6246,15189335,GBR,I9,Dereham,86.157.163.112,IMIPRAMINE treats DEPRESSION,102,71,,112,81,treats,1,907634-FS1-2,A double-blind comparison of the efficacy and safety of paroxetine and IMIPRAMINE in the treatment of DEPRESSION with dementia,DEPRESSION,IMIPRAMINE,RO-may_treat
498023384,7/4/2014 15:33:10,false,1314973220,7/4/2014 15:32:46,gptbanks,0.4263,18496428,USA,CA,Newhall,199.244.112.44,DEPRESSION treats IMIPRAMINE,102,71,,112,81,treats,1,907634-FS1-2,A double-blind comparison of the efficacy and safety of paroxetine and IMIPRAMINE in the treatment of DEPRESSION with dementia,DEPRESSION,IMIPRAMINE,RO-may_treat
498023385,7/4/2014 14:47:13,false,1314935370,7/4/2014 14:46:54,clixsense,0.8625,19803139,NLD,6,Veldhoven,212.61.84.196,no_relation,289,369,,297,381,treats,0.981980506061966,907548-FS1-2,"b  Class:  Antihistamines 56:22.08; First Generation Antihistamines 4:04; A04AD (ATC)  Synonyms:  dimenhy DRINATE ; Anti-nauseant; Anti-nausee; Dimenhydrinate; Dinate; Gravergol; Gravol; Nauseatol; Travel  Uses  Motion Sickness  Used principally in the prevention and treatment of nausea, VOMITING, and/or vertigo associated with motion sickness, although scopolamine, PROMETHAZINE, or meclizine may be more effective",VOMITING,PROMETHAZINE,RO-may_treat
498023385,7/4/2014 15:03:32,false,1314949053,7/4/2014 15:02:53,clixsense,0.7667,27969116,NLD,4,Veendam,185.12.216.74,no_relation,289,369,,297,381,treats,0.981980506061966,907548-FS1-2,"b  Class:  Antihistamines 56:22.08; First Generation Antihistamines 4:04; A04AD (ATC)  Synonyms:  dimenhy DRINATE ; Anti-nauseant; Anti-nausee; Dimenhydrinate; Dinate; Gravergol; Gravol; Nauseatol; Travel  Uses  Motion Sickness  Used principally in the prevention and treatment of nausea, VOMITING, and/or vertigo associated with motion sickness, although scopolamine, PROMETHAZINE, or meclizine may be more effective",VOMITING,PROMETHAZINE,RO-may_treat
498023385,7/4/2014 15:36:34,false,1314975649,7/4/2014 15:36:18,gptbanks,0.4263,18496428,USA,CA,Newhall,199.244.112.44,VOMITING treats PROMETHAZINE,289,369,,297,381,treats,0.981980506061966,907548-FS1-2,"b  Class:  Antihistamines 56:22.08; First Generation Antihistamines 4:04; A04AD (ATC)  Synonyms:  dimenhy DRINATE ; Anti-nauseant; Anti-nausee; Dimenhydrinate; Dinate; Gravergol; Gravol; Nauseatol; Travel  Uses  Motion Sickness  Used principally in the prevention and treatment of nausea, VOMITING, and/or vertigo associated with motion sickness, although scopolamine, PROMETHAZINE, or meclizine may be more effective",VOMITING,PROMETHAZINE,RO-may_treat
498023385,7/4/2014 15:47:52,false,1314983767,7/4/2014 15:47:19,bitcoinget,0.6363,21490602,USA,NJ,Dunellen,68.193.37.224,PROMETHAZINE treats VOMITING,289,369,,297,381,treats,0.981980506061966,907548-FS1-2,"b  Class:  Antihistamines 56:22.08; First Generation Antihistamines 4:04; A04AD (ATC)  Synonyms:  dimenhy DRINATE ; Anti-nauseant; Anti-nausee; Dimenhydrinate; Dinate; Gravergol; Gravol; Nauseatol; Travel  Uses  Motion Sickness  Used principally in the prevention and treatment of nausea, VOMITING, and/or vertigo associated with motion sickness, although scopolamine, PROMETHAZINE, or meclizine may be more effective",VOMITING,PROMETHAZINE,RO-may_treat
498023385,7/4/2014 15:50:02,false,1314985555,7/4/2014 15:49:29,rewardsspot,0.6639,24482174,GBR,H9,London,146.185.23.27,PROMETHAZINE treats VOMITING,289,369,,297,381,treats,0.981980506061966,907548-FS1-2,"b  Class:  Antihistamines 56:22.08; First Generation Antihistamines 4:04; A04AD (ATC)  Synonyms:  dimenhy DRINATE ; Anti-nauseant; Anti-nausee; Dimenhydrinate; Dinate; Gravergol; Gravol; Nauseatol; Travel  Uses  Motion Sickness  Used principally in the prevention and treatment of nausea, VOMITING, and/or vertigo associated with motion sickness, although scopolamine, PROMETHAZINE, or meclizine may be more effective",VOMITING,PROMETHAZINE,RO-may_treat
498023386,7/4/2014 14:47:34,false,1314935648,7/4/2014 14:47:14,prodege,0.8625,14890188,GBR,I2,Manchester,151.230.18.68,VASOSPASTIC ANGINA is diagnosed by ERGONOVINE,156,103,,174,113,is diagnosed by,0.975900072948533,906650-FS1-13,"These results suggest that the two provocative tests for coronary spasm that involve acetylcholine and ERGONOVINE are clinically useful in the diagnosis of VASOSPASTIC ANGINA, but testing with intracoronary ergonovine is needed when a spontaneous focal coronary spasm is relieved by the intracoronary injection of acetylcholine",VASOSPASTIC ANGINA,ERGONOVINE,RO-may_diagnose
498023386,7/4/2014 14:49:08,false,1314937081,7/4/2014 14:48:42,clixsense,0.8625,19803139,NLD,6,Veldhoven,212.61.84.196,ERGONOVINE is diagnosed by VASOSPASTIC ANGINA,156,103,,174,113,is diagnosed by,0.975900072948533,906650-FS1-13,"These results suggest that the two provocative tests for coronary spasm that involve acetylcholine and ERGONOVINE are clinically useful in the diagnosis of VASOSPASTIC ANGINA, but testing with intracoronary ergonovine is needed when a spontaneous focal coronary spasm is relieved by the intracoronary injection of acetylcholine",VASOSPASTIC ANGINA,ERGONOVINE,RO-may_diagnose
498023386,7/4/2014 14:56:00,false,1314942581,7/4/2014 14:55:15,clixsense,0.7667,27969116,NLD,4,Veendam,185.12.216.74,VASOSPASTIC ANGINA is diagnosed by ERGONOVINE,156,103,,174,113,is diagnosed by,0.975900072948533,906650-FS1-13,"These results suggest that the two provocative tests for coronary spasm that involve acetylcholine and ERGONOVINE are clinically useful in the diagnosis of VASOSPASTIC ANGINA, but testing with intracoronary ergonovine is needed when a spontaneous focal coronary spasm is relieved by the intracoronary injection of acetylcholine",VASOSPASTIC ANGINA,ERGONOVINE,RO-may_diagnose
498023386,7/4/2014 15:24:06,false,1314964992,7/4/2014 15:23:47,clixsense,0.6246,15189335,GBR,I9,Dereham,86.157.163.112,ERGONOVINE is diagnosed by VASOSPASTIC ANGINA,156,103,,174,113,is diagnosed by,0.975900072948533,906650-FS1-13,"These results suggest that the two provocative tests for coronary spasm that involve acetylcholine and ERGONOVINE are clinically useful in the diagnosis of VASOSPASTIC ANGINA, but testing with intracoronary ergonovine is needed when a spontaneous focal coronary spasm is relieved by the intracoronary injection of acetylcholine",VASOSPASTIC ANGINA,ERGONOVINE,RO-may_diagnose
498023386,7/4/2014 15:36:07,false,1314975314,7/4/2014 15:36:00,gptbanks,0.4263,18496428,USA,CA,Newhall,199.244.112.44,VASOSPASTIC ANGINA is diagnosed by ERGONOVINE,156,103,,174,113,is diagnosed by,0.975900072948533,906650-FS1-13,"These results suggest that the two provocative tests for coronary spasm that involve acetylcholine and ERGONOVINE are clinically useful in the diagnosis of VASOSPASTIC ANGINA, but testing with intracoronary ergonovine is needed when a spontaneous focal coronary spasm is relieved by the intracoronary injection of acetylcholine",VASOSPASTIC ANGINA,ERGONOVINE,RO-may_diagnose
498023387,7/4/2014 15:00:37,false,1314946284,7/4/2014 15:00:11,clixsense,0.7667,27969116,NLD,4,Veendam,185.12.216.74,CHOLECALCIFEROL treats OSTEOPOROSIS,103,55,,115,70,treats,1,907503-FS1-2,Alendronate is used alone or in fixed combination with CHOLECALCIFEROL (vitamin D 3 ) for treatment of OSTEOPOROSIS in postmenopausal women,OSTEOPOROSIS,CHOLECALCIFEROL,RO-may_treat
498023387,7/4/2014 15:09:49,false,1314954236,7/4/2014 15:09:29,clixsense,0.6479,6394333,GBR,,,86.29.240.182,no_relation,103,55,,115,70,treats,1,907503-FS1-2,Alendronate is used alone or in fixed combination with CHOLECALCIFEROL (vitamin D 3 ) for treatment of OSTEOPOROSIS in postmenopausal women,OSTEOPOROSIS,CHOLECALCIFEROL,RO-may_treat
498023387,7/4/2014 15:22:19,false,1314963712,7/4/2014 15:21:55,clixsense,0.6246,15189335,GBR,I9,Dereham,86.157.163.112,CHOLECALCIFEROL treats OSTEOPOROSIS,103,55,,115,70,treats,1,907503-FS1-2,Alendronate is used alone or in fixed combination with CHOLECALCIFEROL (vitamin D 3 ) for treatment of OSTEOPOROSIS in postmenopausal women,OSTEOPOROSIS,CHOLECALCIFEROL,RO-may_treat
498023387,7/4/2014 15:30:00,false,1314970181,7/4/2014 15:29:49,prodege,0.6637,14848125,GBR,V2,Glasgow,86.130.194.252,CHOLECALCIFEROL treats OSTEOPOROSIS,103,55,,115,70,treats,1,907503-FS1-2,Alendronate is used alone or in fixed combination with CHOLECALCIFEROL (vitamin D 3 ) for treatment of OSTEOPOROSIS in postmenopausal women,OSTEOPOROSIS,CHOLECALCIFEROL,RO-may_treat
498023387,7/4/2014 15:31:28,false,1314971772,7/4/2014 15:31:14,gptbanks,0.4263,18496428,USA,CA,Newhall,199.244.112.44,OSTEOPOROSIS treats CHOLECALCIFEROL,103,55,,115,70,treats,1,907503-FS1-2,Alendronate is used alone or in fixed combination with CHOLECALCIFEROL (vitamin D 3 ) for treatment of OSTEOPOROSIS in postmenopausal women,OSTEOPOROSIS,CHOLECALCIFEROL,RO-may_treat
498023388,7/4/2014 14:46:00,false,1314934132,7/4/2014 14:45:47,prodege,0.8625,14890188,GBR,I2,Manchester,151.230.18.68,FUROSEMIDE treats CHRONIC RENAL FAILURE,115,76,,136,86,treats,0.929981109950554,907701-FS1-2,"1]  Knauf H, Mutschler E. Diuretic effectiveness of hydrochlorothiazide and FUROSEMIDE alone and in combination in CHRONIC RENAL FAILURE",CHRONIC RENAL FAILURE,FUROSEMIDE,RO-may_treat
498023388,7/4/2014 14:49:51,false,1314937758,7/4/2014 14:49:35,clixsense,0.8625,19803139,NLD,6,Veldhoven,212.61.84.196,no_relation,115,76,,136,86,treats,0.929981109950554,907701-FS1-2,"1]  Knauf H, Mutschler E. Diuretic effectiveness of hydrochlorothiazide and FUROSEMIDE alone and in combination in CHRONIC RENAL FAILURE",CHRONIC RENAL FAILURE,FUROSEMIDE,RO-may_treat
498023388,7/4/2014 14:53:34,false,1314940648,7/4/2014 14:52:47,clixsense,0.7667,27969116,NLD,4,Veendam,185.12.216.74,no_relation,115,76,,136,86,treats,0.929981109950554,907701-FS1-2,"1]  Knauf H, Mutschler E. Diuretic effectiveness of hydrochlorothiazide and FUROSEMIDE alone and in combination in CHRONIC RENAL FAILURE",CHRONIC RENAL FAILURE,FUROSEMIDE,RO-may_treat
498023388,7/4/2014 15:10:34,false,1314954775,7/4/2014 15:10:12,clixsense,0.6479,6394333,GBR,,,86.29.240.182,no_relation,115,76,,136,86,treats,0.929981109950554,907701-FS1-2,"1]  Knauf H, Mutschler E. Diuretic effectiveness of hydrochlorothiazide and FUROSEMIDE alone and in combination in CHRONIC RENAL FAILURE",CHRONIC RENAL FAILURE,FUROSEMIDE,RO-may_treat
498023388,7/4/2014 15:22:19,false,1314963713,7/4/2014 15:21:55,clixsense,0.6246,15189335,GBR,I9,Dereham,86.157.163.112,FUROSEMIDE treats CHRONIC RENAL FAILURE,115,76,,136,86,treats,0.929981109950554,907701-FS1-2,"1]  Knauf H, Mutschler E. Diuretic effectiveness of hydrochlorothiazide and FUROSEMIDE alone and in combination in CHRONIC RENAL FAILURE",CHRONIC RENAL FAILURE,FUROSEMIDE,RO-may_treat
498023389,7/4/2014 15:12:18,false,1314955971,7/4/2014 15:11:48,clixsense,0.6479,6394333,GBR,,,86.29.240.182,no_relation,49,17,,67,45,treats,0.371390676354104,907785-FS1-2,Urokinase versus TISSUE PLASMINOGEN ACTIVATOR in PULMONARY EMBOLISM,PULMONARY EMBOLISM,TISSUE PLASMINOGEN ACTIVATOR,RO-may_treat
498023389,7/4/2014 15:28:09,false,1314968592,7/4/2014 15:27:46,prodege,0.6637,14848125,GBR,V2,Glasgow,86.130.194.252,no_relation,49,17,,67,45,treats,0.371390676354104,907785-FS1-2,Urokinase versus TISSUE PLASMINOGEN ACTIVATOR in PULMONARY EMBOLISM,PULMONARY EMBOLISM,TISSUE PLASMINOGEN ACTIVATOR,RO-may_treat
498023389,7/4/2014 15:36:17,false,1314975383,7/4/2014 15:36:09,gptbanks,0.4263,18496428,USA,CA,Newhall,199.244.112.44,PULMONARY EMBOLISM treats TISSUE PLASMINOGEN ACTIVATOR,49,17,,67,45,treats,0.371390676354104,907785-FS1-2,Urokinase versus TISSUE PLASMINOGEN ACTIVATOR in PULMONARY EMBOLISM,PULMONARY EMBOLISM,TISSUE PLASMINOGEN ACTIVATOR,RO-may_treat
498023389,7/4/2014 15:44:38,false,1314981199,7/4/2014 15:44:14,bitcoinget,0.6363,21490602,USA,NJ,Dunellen,68.193.37.224,TISSUE PLASMINOGEN ACTIVATOR treats PULMONARY EMBOLISM,49,17,,67,45,treats,0.371390676354104,907785-FS1-2,Urokinase versus TISSUE PLASMINOGEN ACTIVATOR in PULMONARY EMBOLISM,PULMONARY EMBOLISM,TISSUE PLASMINOGEN ACTIVATOR,RO-may_treat
498023389,7/4/2014 15:50:02,false,1314985554,7/4/2014 15:49:29,rewardsspot,0.6639,24482174,GBR,H9,London,146.185.23.27,no_relation,49,17,,67,45,treats,0.371390676354104,907785-FS1-2,Urokinase versus TISSUE PLASMINOGEN ACTIVATOR in PULMONARY EMBOLISM,PULMONARY EMBOLISM,TISSUE PLASMINOGEN ACTIVATOR,RO-may_treat
498023390,7/4/2014 14:46:13,false,1314934380,7/4/2014 14:45:48,clixsense,0.8625,19803139,NLD,6,Veldhoven,212.61.84.196,no_relation,180,126,,198,135,treats,0.635000635000953,907209-FS1-2,"In developing PTU-treated rats, the abnormalities completely disappeared after therapy with increasing physiological doses of THYROXINE; consequently they were directly related to THYROID DEFICIENCY and not to toxic effects of PTU",THYROID DEFICIENCY,THYROXINE,RO-may_prevent
498023390,7/4/2014 14:59:43,false,1314945442,7/4/2014 14:59:04,clixsense,0.7667,27969116,NLD,4,Veendam,185.12.216.74,THYROXINE treats THYROID DEFICIENCY,180,126,,198,135,treats,0.635000635000953,907209-FS1-2,"In developing PTU-treated rats, the abnormalities completely disappeared after therapy with increasing physiological doses of THYROXINE; consequently they were directly related to THYROID DEFICIENCY and not to toxic effects of PTU",THYROID DEFICIENCY,THYROXINE,RO-may_prevent
498023390,7/4/2014 15:12:34,false,1314956107,7/4/2014 15:12:20,clixsense,0.6479,6394333,GBR,,,86.29.240.182,no_relation,180,126,,198,135,treats,0.635000635000953,907209-FS1-2,"In developing PTU-treated rats, the abnormalities completely disappeared after therapy with increasing physiological doses of THYROXINE; consequently they were directly related to THYROID DEFICIENCY and not to toxic effects of PTU",THYROID DEFICIENCY,THYROXINE,RO-may_prevent
498023390,7/4/2014 15:30:58,false,1314971231,7/4/2014 15:30:44,prodege,0.6637,14848125,GBR,V2,Glasgow,86.130.194.252,THYROXINE treats THYROID DEFICIENCY,180,126,,198,135,treats,0.635000635000953,907209-FS1-2,"In developing PTU-treated rats, the abnormalities completely disappeared after therapy with increasing physiological doses of THYROXINE; consequently they were directly related to THYROID DEFICIENCY and not to toxic effects of PTU",THYROID DEFICIENCY,THYROXINE,RO-may_prevent
498023390,7/4/2014 15:36:17,false,1314975385,7/4/2014 15:36:09,gptbanks,0.4263,18496428,USA,CA,Newhall,199.244.112.44,THYROXINE treats THYROID DEFICIENCY,180,126,,198,135,treats,0.635000635000953,907209-FS1-2,"In developing PTU-treated rats, the abnormalities completely disappeared after therapy with increasing physiological doses of THYROXINE; consequently they were directly related to THYROID DEFICIENCY and not to toxic effects of PTU",THYROID DEFICIENCY,THYROXINE,RO-may_prevent
498023392,7/4/2014 14:45:47,false,1314933879,7/4/2014 14:45:19,clixsense,0.8625,19803139,NLD,6,Veldhoven,212.61.84.196,no_relation,106,76,,113,84,treats,0.957826285221151,907616-FS1-2,"James WP, Avenell A, Broom J et al. A one-year trial to assess the value of ORLISTAT in the management of OBESITY",OBESITY,ORLISTAT,RO-may_treat
498023392,7/4/2014 14:58:16,false,1314944395,7/4/2014 14:57:49,clixsense,0.7667,27969116,NLD,4,Veendam,185.12.216.74,ORLISTAT treats OBESITY,106,76,,113,84,treats,0.957826285221151,907616-FS1-2,"James WP, Avenell A, Broom J et al. A one-year trial to assess the value of ORLISTAT in the management of OBESITY",OBESITY,ORLISTAT,RO-may_treat
498023392,7/4/2014 15:28:21,false,1314968768,7/4/2014 15:28:10,prodege,0.6637,14848125,GBR,V2,Glasgow,86.130.194.252,ORLISTAT treats OBESITY,106,76,,113,84,treats,0.957826285221151,907616-FS1-2,"James WP, Avenell A, Broom J et al. A one-year trial to assess the value of ORLISTAT in the management of OBESITY",OBESITY,ORLISTAT,RO-may_treat
498023392,7/4/2014 15:40:13,false,1314978260,7/4/2014 15:39:41,bitcoinget,0.6363,21490602,USA,NJ,Dunellen,68.193.37.224,ORLISTAT treats OBESITY,106,76,,113,84,treats,0.957826285221151,907616-FS1-2,"James WP, Avenell A, Broom J et al. A one-year trial to assess the value of ORLISTAT in the management of OBESITY",OBESITY,ORLISTAT,RO-may_treat
498023392,7/4/2014 15:49:23,false,1314985082,7/4/2014 15:48:50,rewardsspot,0.6639,24482174,GBR,H9,London,146.185.23.27,ORLISTAT treats OBESITY,106,76,,113,84,treats,0.957826285221151,907616-FS1-2,"James WP, Avenell A, Broom J et al. A one-year trial to assess the value of ORLISTAT in the management of OBESITY",OBESITY,ORLISTAT,RO-may_treat
498023393,7/4/2014 14:47:13,false,1314935360,7/4/2014 14:46:54,clixsense,0.8625,19803139,NLD,6,Veldhoven,212.61.84.196,PRAVASTATIN treats HYPERCHOLESTEROLEMIA,87,71,,107,82,treats,0.991836598134176,907624-FS1-2,"Comparison of the efficacy, safety and tolerability of simvastatin and PRAVASTATIN for HYPERCHOLESTEROLEMIA",HYPERCHOLESTEROLEMIA,PRAVASTATIN,RO-may_treat
498023393,7/4/2014 14:48:53,false,1314936921,7/4/2014 14:48:40,prodege,0.8625,14890188,GBR,I2,Manchester,151.230.18.68,no_relation,87,71,,107,82,treats,0.991836598134176,907624-FS1-2,"Comparison of the efficacy, safety and tolerability of simvastatin and PRAVASTATIN for HYPERCHOLESTEROLEMIA",HYPERCHOLESTEROLEMIA,PRAVASTATIN,RO-may_treat
498023393,7/4/2014 15:35:58,false,1314975211,7/4/2014 15:35:52,gptbanks,0.4263,18496428,USA,CA,Newhall,199.244.112.44,HYPERCHOLESTEROLEMIA treats PRAVASTATIN,87,71,,107,82,treats,0.991836598134176,907624-FS1-2,"Comparison of the efficacy, safety and tolerability of simvastatin and PRAVASTATIN for HYPERCHOLESTEROLEMIA",HYPERCHOLESTEROLEMIA,PRAVASTATIN,RO-may_treat
498023393,7/4/2014 15:41:19,false,1314978984,7/4/2014 15:40:59,bitcoinget,0.6363,21490602,USA,NJ,Dunellen,68.193.37.224,PRAVASTATIN treats HYPERCHOLESTEROLEMIA,87,71,,107,82,treats,0.991836598134176,907624-FS1-2,"Comparison of the efficacy, safety and tolerability of simvastatin and PRAVASTATIN for HYPERCHOLESTEROLEMIA",HYPERCHOLESTEROLEMIA,PRAVASTATIN,RO-may_treat
498023393,7/4/2014 15:52:22,false,1314987464,7/4/2014 15:51:38,rewardsspot,0.6639,24482174,GBR,H9,London,146.185.23.27,PRAVASTATIN treats HYPERCHOLESTEROLEMIA,87,71,,107,82,treats,0.991836598134176,907624-FS1-2,"Comparison of the efficacy, safety and tolerability of simvastatin and PRAVASTATIN for HYPERCHOLESTEROLEMIA",HYPERCHOLESTEROLEMIA,PRAVASTATIN,RO-may_treat
498023394,7/4/2014 14:45:17,false,1314933501,7/4/2014 14:45:02,prodege,0.8625,14890188,GBR,I2,Manchester,151.230.18.68,KETOPROFEN treats RHEUMATOID ARTHRITIS,130,82,,150,92,treats,1,907589-FS1-2,"El-Ghobarey AF, Rennie JAN, Hadidi T et al. A comparative trial of large doses of KETOPROFEN and indomethacin in the treatment of RHEUMATOID ARTHRITIS",RHEUMATOID ARTHRITIS,KETOPROFEN,RO-may_treat
498023394,7/4/2014 15:13:33,false,1314956742,7/4/2014 15:13:08,clixsense,0.6479,6394333,GBR,,,86.29.240.182,no_relation,130,82,,150,92,treats,1,907589-FS1-2,"El-Ghobarey AF, Rennie JAN, Hadidi T et al. A comparative trial of large doses of KETOPROFEN and indomethacin in the treatment of RHEUMATOID ARTHRITIS",RHEUMATOID ARTHRITIS,KETOPROFEN,RO-may_treat
498023394,7/4/2014 15:27:17,false,1314967608,7/4/2014 15:27:05,clixsense,0.6246,15189335,GBR,I9,Dereham,86.157.163.112,KETOPROFEN treats RHEUMATOID ARTHRITIS,130,82,,150,92,treats,1,907589-FS1-2,"El-Ghobarey AF, Rennie JAN, Hadidi T et al. A comparative trial of large doses of KETOPROFEN and indomethacin in the treatment of RHEUMATOID ARTHRITIS",RHEUMATOID ARTHRITIS,KETOPROFEN,RO-may_treat
498023394,7/4/2014 15:33:44,false,1314973725,7/4/2014 15:33:32,prodege,0.6637,14848125,GBR,V2,Glasgow,86.130.194.252,KETOPROFEN treats RHEUMATOID ARTHRITIS,130,82,,150,92,treats,1,907589-FS1-2,"El-Ghobarey AF, Rennie JAN, Hadidi T et al. A comparative trial of large doses of KETOPROFEN and indomethacin in the treatment of RHEUMATOID ARTHRITIS",RHEUMATOID ARTHRITIS,KETOPROFEN,RO-may_treat
498023394,7/4/2014 15:47:22,false,1314983333,7/4/2014 15:46:36,rewardsspot,0.6639,24482174,GBR,H9,London,146.185.23.27,KETOPROFEN treats RHEUMATOID ARTHRITIS,130,82,,150,92,treats,1,907589-FS1-2,"El-Ghobarey AF, Rennie JAN, Hadidi T et al. A comparative trial of large doses of KETOPROFEN and indomethacin in the treatment of RHEUMATOID ARTHRITIS",RHEUMATOID ARTHRITIS,KETOPROFEN,RO-may_treat
498023395,7/4/2014 14:49:28,false,1314937458,7/4/2014 14:49:11,prodege,0.8625,14890188,GBR,I2,Manchester,151.230.18.68,PHEOCHROMOCYTOMA causes HYPERTENSION,50,96,,62,112,causes,0.348155311911396,902671-FS1-4,Evidence: ? Vigilant intraoperative management of HYPERTENSION is essential during resection of PHEOCHROMOCYTOMA,HYPERTENSION,PHEOCHROMOCYTOMA,RO-disease_may_have_finding
498023395,7/4/2014 14:59:03,false,1314944962,7/4/2014 14:58:40,clixsense,0.7667,27969116,NLD,4,Veendam,185.12.216.74,no_relation,50,96,,62,112,causes,0.348155311911396,902671-FS1-4,Evidence: ? Vigilant intraoperative management of HYPERTENSION is essential during resection of PHEOCHROMOCYTOMA,HYPERTENSION,PHEOCHROMOCYTOMA,RO-disease_may_have_finding
498023395,7/4/2014 15:13:06,false,1314956486,7/4/2014 15:12:56,clixsense,0.6479,6394333,GBR,,,86.29.240.182,no_relation,50,96,,62,112,causes,0.348155311911396,902671-FS1-4,Evidence: ? Vigilant intraoperative management of HYPERTENSION is essential during resection of PHEOCHROMOCYTOMA,HYPERTENSION,PHEOCHROMOCYTOMA,RO-disease_may_have_finding
498023395,7/4/2014 15:25:58,false,1314966479,7/4/2014 15:25:18,clixsense,0.6246,15189335,GBR,I9,Dereham,86.157.163.112,PHEOCHROMOCYTOMA causes HYPERTENSION,50,96,,62,112,causes,0.348155311911396,902671-FS1-4,Evidence: ? Vigilant intraoperative management of HYPERTENSION is essential during resection of PHEOCHROMOCYTOMA,HYPERTENSION,PHEOCHROMOCYTOMA,RO-disease_may_have_finding
498023395,7/4/2014 15:27:45,false,1314968044,7/4/2014 15:27:14,prodege,0.6637,14848125,GBR,V2,Glasgow,86.130.194.252,no_relation,50,96,,62,112,causes,0.348155311911396,902671-FS1-4,Evidence: ? Vigilant intraoperative management of HYPERTENSION is essential during resection of PHEOCHROMOCYTOMA,HYPERTENSION,PHEOCHROMOCYTOMA,RO-disease_may_have_finding
498023396,7/4/2014 14:46:13,false,1314934379,7/4/2014 14:45:48,clixsense,0.8625,19803139,NLD,6,Veldhoven,212.61.84.196,no_relation,5,30,,28,51,causes,0.771516749810459,902767-FS1-4,"With POSTMENOPAUSAL BLEEDING, ENDOMETRIAL CARCINOMA must always be ruled out",POSTMENOPAUSAL BLEEDING,ENDOMETRIAL CARCINOMA,RO-disease_may_have_finding
498023396,7/4/2014 15:01:18,false,1314946967,7/4/2014 15:00:38,clixsense,0.7667,27969116,NLD,4,Veendam,185.12.216.74,no_relation,5,30,,28,51,causes,0.771516749810459,902767-FS1-4,"With POSTMENOPAUSAL BLEEDING, ENDOMETRIAL CARCINOMA must always be ruled out",POSTMENOPAUSAL BLEEDING,ENDOMETRIAL CARCINOMA,RO-disease_may_have_finding
498023396,7/4/2014 15:48:15,false,1314984096,7/4/2014 15:47:54,bitcoinget,0.6363,21490602,USA,NJ,Dunellen,68.193.37.224,ENDOMETRIAL CARCINOMA causes POSTMENOPAUSAL BLEEDING,5,30,,28,51,causes,0.771516749810459,902767-FS1-4,"With POSTMENOPAUSAL BLEEDING, ENDOMETRIAL CARCINOMA must always be ruled out",POSTMENOPAUSAL BLEEDING,ENDOMETRIAL CARCINOMA,RO-disease_may_have_finding
498023396,7/4/2014 15:49:23,false,1314985076,7/4/2014 15:48:50,rewardsspot,0.6639,24482174,GBR,H9,London,146.185.23.27,no_relation,5,30,,28,51,causes,0.771516749810459,902767-FS1-4,"With POSTMENOPAUSAL BLEEDING, ENDOMETRIAL CARCINOMA must always be ruled out",POSTMENOPAUSAL BLEEDING,ENDOMETRIAL CARCINOMA,RO-disease_may_have_finding
498023396,7/4/2014 15:51:57,false,1314987118,7/4/2014 15:51:47,neodev,0.5875,25804244,USA,IL,Chicago,99.198.108.116,ENDOMETRIAL CARCINOMA causes POSTMENOPAUSAL BLEEDING,5,30,,28,51,causes,0.771516749810459,902767-FS1-4,"With POSTMENOPAUSAL BLEEDING, ENDOMETRIAL CARCINOMA must always be ruled out",POSTMENOPAUSAL BLEEDING,ENDOMETRIAL CARCINOMA,RO-disease_may_have_finding
498023397,7/4/2014 14:55:14,false,1314941951,7/4/2014 14:54:13,clixsense,0.7667,27969116,NLD,4,Veendam,185.12.216.74,ERGOMETRINE treats VARIANT ANGINA,214,128,,228,139,treats,0.964901281354015,906931-FS1-2,"Studies were performed on isolated canine coronary artery segments to characterize the mechanism of the constrictor response of ERGOMETRINE (ergonovine), an agent used to induce coronary vasospasm in patients with VARIANT ANGINA",VARIANT ANGINA,ERGOMETRINE,RO-may_diagnose
498023397,7/4/2014 15:15:33,false,1314958170,7/4/2014 15:15:15,clixsense,0.6479,6394333,GBR,,,86.29.240.182,no_relation,214,128,,228,139,treats,0.964901281354015,906931-FS1-2,"Studies were performed on isolated canine coronary artery segments to characterize the mechanism of the constrictor response of ERGOMETRINE (ergonovine), an agent used to induce coronary vasospasm in patients with VARIANT ANGINA",VARIANT ANGINA,ERGOMETRINE,RO-may_diagnose
498023397,7/4/2014 15:25:02,false,1314965712,7/4/2014 15:24:37,clixsense,0.6246,15189335,GBR,I9,Dereham,86.157.163.112,ERGOMETRINE treats VARIANT ANGINA,214,128,,228,139,treats,0.964901281354015,906931-FS1-2,"Studies were performed on isolated canine coronary artery segments to characterize the mechanism of the constrictor response of ERGOMETRINE (ergonovine), an agent used to induce coronary vasospasm in patients with VARIANT ANGINA",VARIANT ANGINA,ERGOMETRINE,RO-may_diagnose
498023397,7/4/2014 15:31:31,false,1314971797,7/4/2014 15:31:16,prodege,0.6637,14848125,GBR,V2,Glasgow,86.130.194.252,ERGOMETRINE treats VARIANT ANGINA,214,128,,228,139,treats,0.964901281354015,906931-FS1-2,"Studies were performed on isolated canine coronary artery segments to characterize the mechanism of the constrictor response of ERGOMETRINE (ergonovine), an agent used to induce coronary vasospasm in patients with VARIANT ANGINA",VARIANT ANGINA,ERGOMETRINE,RO-may_diagnose
498023397,7/4/2014 15:42:10,false,1314979517,7/4/2014 15:41:20,bitcoinget,0.6363,21490602,USA,NJ,Dunellen,68.193.37.224,no_relation,214,128,,228,139,treats,0.964901281354015,906931-FS1-2,"Studies were performed on isolated canine coronary artery segments to characterize the mechanism of the constrictor response of ERGOMETRINE (ergonovine), an agent used to induce coronary vasospasm in patients with VARIANT ANGINA",VARIANT ANGINA,ERGOMETRINE,RO-may_diagnose
498023398,7/4/2014 14:51:45,false,1314939324,7/4/2014 14:51:28,clixsense,0.8625,19803139,NLD,6,Veldhoven,212.61.84.196,INTERFERON treats MULTIPLE MYELOMA,42,11,,58,21,treats,1,907873-FS1-2,The use of INTERFERON in the treatment of MULTIPLE MYELOMA,MULTIPLE MYELOMA,INTERFERON,RO-may_treat
498023398,7/4/2014 14:57:48,false,1314944026,7/4/2014 14:57:29,clixsense,0.7667,27969116,NLD,4,Veendam,185.12.216.74,INTERFERON treats MULTIPLE MYELOMA,42,11,,58,21,treats,1,907873-FS1-2,The use of INTERFERON in the treatment of MULTIPLE MYELOMA,MULTIPLE MYELOMA,INTERFERON,RO-may_treat
498023398,7/4/2014 15:30:00,false,1314970186,7/4/2014 15:29:49,prodege,0.6637,14848125,GBR,V2,Glasgow,86.130.194.252,INTERFERON treats MULTIPLE MYELOMA,42,11,,58,21,treats,1,907873-FS1-2,The use of INTERFERON in the treatment of MULTIPLE MYELOMA,MULTIPLE MYELOMA,INTERFERON,RO-may_treat
498023398,7/4/2014 15:32:44,false,1314972852,7/4/2014 15:31:54,gptbanks,0.4263,18496428,USA,CA,Newhall,199.244.112.44,MULTIPLE MYELOMA treats INTERFERON,42,11,,58,21,treats,1,907873-FS1-2,The use of INTERFERON in the treatment of MULTIPLE MYELOMA,MULTIPLE MYELOMA,INTERFERON,RO-may_treat
498023398,7/4/2014 15:42:34,false,1314979819,7/4/2014 15:42:12,bitcoinget,0.6363,21490602,USA,NJ,Dunellen,68.193.37.224,INTERFERON treats MULTIPLE MYELOMA,42,11,,58,21,treats,1,907873-FS1-2,The use of INTERFERON in the treatment of MULTIPLE MYELOMA,MULTIPLE MYELOMA,INTERFERON,RO-may_treat
498023399,7/4/2014 14:46:15,false,1314934399,7/4/2014 14:46:01,prodege,0.8625,14890188,GBR,I2,Manchester,151.230.18.68,ITRACONAZOLE treats BLASTOMYCOSIS,14,51,,27,63,treats,1,907822-FS1-2,"Children with BLASTOMYCOSIS should be treated with ITRACONAZOLE, 5 to 7 mg/kg/day",BLASTOMYCOSIS,ITRACONAZOLE,RO-may_treat
498023399,7/4/2014 14:47:56,false,1314936112,7/4/2014 14:47:31,clixsense,0.8625,19803139,NLD,6,Veldhoven,212.61.84.196,ITRACONAZOLE treats BLASTOMYCOSIS,14,51,,27,63,treats,1,907822-FS1-2,"Children with BLASTOMYCOSIS should be treated with ITRACONAZOLE, 5 to 7 mg/kg/day",BLASTOMYCOSIS,ITRACONAZOLE,RO-may_treat
498023399,7/4/2014 14:56:45,false,1314943227,7/4/2014 14:56:22,clixsense,0.7667,27969116,NLD,4,Veendam,185.12.216.74,ITRACONAZOLE treats BLASTOMYCOSIS,14,51,,27,63,treats,1,907822-FS1-2,"Children with BLASTOMYCOSIS should be treated with ITRACONAZOLE, 5 to 7 mg/kg/day",BLASTOMYCOSIS,ITRACONAZOLE,RO-may_treat
498023399,7/4/2014 15:14:04,false,1314957094,7/4/2014 15:13:34,clixsense,0.6479,6394333,GBR,,,86.29.240.182,no_relation,14,51,,27,63,treats,1,907822-FS1-2,"Children with BLASTOMYCOSIS should be treated with ITRACONAZOLE, 5 to 7 mg/kg/day",BLASTOMYCOSIS,ITRACONAZOLE,RO-may_treat
498023399,7/4/2014 15:25:15,false,1314965953,7/4/2014 15:25:04,clixsense,0.6246,15189335,GBR,I9,Dereham,86.157.163.112,ITRACONAZOLE treats BLASTOMYCOSIS,14,51,,27,63,treats,1,907822-FS1-2,"Children with BLASTOMYCOSIS should be treated with ITRACONAZOLE, 5 to 7 mg/kg/day",BLASTOMYCOSIS,ITRACONAZOLE,RO-may_treat
498023400,7/4/2014 14:47:29,false,1314935573,7/4/2014 14:47:15,clixsense,0.8625,19803139,NLD,6,Veldhoven,212.61.84.196,no_relation,125,110,,129,120,treats,0.995893206467704,907864-FS1-2,"20 ,   21 ,   22 ,   23 ,   24 ,   25 ,   40 ,   41 ,   42 ,   43 ,   44 ,   45   40% of patients who receive GABAPENTIN for PAIN associated with diabetic neuropathy obtain good pain relief",PAIN,GABAPENTIN,RO-may_treat
498023400,7/4/2014 14:48:53,false,1314936914,7/4/2014 14:48:40,prodege,0.8625,14890188,GBR,I2,Manchester,151.230.18.68,GABAPENTIN treats PAIN,125,110,,129,120,treats,0.995893206467704,907864-FS1-2,"20 ,   21 ,   22 ,   23 ,   24 ,   25 ,   40 ,   41 ,   42 ,   43 ,   44 ,   45   40% of patients who receive GABAPENTIN for PAIN associated with diabetic neuropathy obtain good pain relief",PAIN,GABAPENTIN,RO-may_treat
498023400,7/4/2014 15:04:34,false,1314949841,7/4/2014 15:04:07,clixsense,0.7667,27969116,NLD,4,Veendam,185.12.216.74,GABAPENTIN treats PAIN,125,110,,129,120,treats,0.995893206467704,907864-FS1-2,"20 ,   21 ,   22 ,   23 ,   24 ,   25 ,   40 ,   41 ,   42 ,   43 ,   44 ,   45   40% of patients who receive GABAPENTIN for PAIN associated with diabetic neuropathy obtain good pain relief",PAIN,GABAPENTIN,RO-may_treat
498023400,7/4/2014 15:24:20,false,1314965188,7/4/2014 15:24:09,clixsense,0.6246,15189335,GBR,I9,Dereham,86.157.163.112,GABAPENTIN treats PAIN,125,110,,129,120,treats,0.995893206467704,907864-FS1-2,"20 ,   21 ,   22 ,   23 ,   24 ,   25 ,   40 ,   41 ,   42 ,   43 ,   44 ,   45   40% of patients who receive GABAPENTIN for PAIN associated with diabetic neuropathy obtain good pain relief",PAIN,GABAPENTIN,RO-may_treat
498023400,7/4/2014 15:35:51,false,1314975130,7/4/2014 15:35:45,gptbanks,0.4263,18496428,USA,CA,Newhall,199.244.112.44,PAIN treats GABAPENTIN,125,110,,129,120,treats,0.995893206467704,907864-FS1-2,"20 ,   21 ,   22 ,   23 ,   24 ,   25 ,   40 ,   41 ,   42 ,   43 ,   44 ,   45   40% of patients who receive GABAPENTIN for PAIN associated with diabetic neuropathy obtain good pain relief",PAIN,GABAPENTIN,RO-may_treat
498023401,7/4/2014 14:47:00,false,1314935137,7/4/2014 14:46:49,prodege,0.8625,14890188,GBR,I2,Manchester,151.230.18.68,TERBINAFINE treats TINEA CAPITIS,140,108,,153,119,treats,0.995037190209989,907640-FS1-2,"Kullavanijaya P, Reangchainam S, Ungpakorn R. Randomized single-blind study of efficacy and tolerability of TERBINAFINE in the treatment of TINEA CAPITIS",TINEA CAPITIS,TERBINAFINE,RO-may_treat
498023401,7/4/2014 14:57:27,false,1314943772,7/4/2014 14:56:46,clixsense,0.7667,27969116,NLD,4,Veendam,185.12.216.74,TERBINAFINE treats TINEA CAPITIS,140,108,,153,119,treats,0.995037190209989,907640-FS1-2,"Kullavanijaya P, Reangchainam S, Ungpakorn R. Randomized single-blind study of efficacy and tolerability of TERBINAFINE in the treatment of TINEA CAPITIS",TINEA CAPITIS,TERBINAFINE,RO-may_treat
498023401,7/4/2014 15:23:43,false,1314964726,7/4/2014 15:23:16,clixsense,0.6246,15189335,GBR,I9,Dereham,86.157.163.112,TERBINAFINE treats TINEA CAPITIS,140,108,,153,119,treats,0.995037190209989,907640-FS1-2,"Kullavanijaya P, Reangchainam S, Ungpakorn R. Randomized single-blind study of efficacy and tolerability of TERBINAFINE in the treatment of TINEA CAPITIS",TINEA CAPITIS,TERBINAFINE,RO-may_treat
498023401,7/4/2014 15:35:34,false,1314974891,7/4/2014 15:35:29,gptbanks,0.4263,18496428,USA,CA,Newhall,199.244.112.44,TINEA CAPITIS treats TERBINAFINE,140,108,,153,119,treats,0.995037190209989,907640-FS1-2,"Kullavanijaya P, Reangchainam S, Ungpakorn R. Randomized single-blind study of efficacy and tolerability of TERBINAFINE in the treatment of TINEA CAPITIS",TINEA CAPITIS,TERBINAFINE,RO-may_treat
498023401,7/4/2014 15:45:11,false,1314981640,7/4/2014 15:44:40,bitcoinget,0.6363,21490602,USA,NJ,Dunellen,68.193.37.224,TERBINAFINE treats TINEA CAPITIS,140,108,,153,119,treats,0.995037190209989,907640-FS1-2,"Kullavanijaya P, Reangchainam S, Ungpakorn R. Randomized single-blind study of efficacy and tolerability of TERBINAFINE in the treatment of TINEA CAPITIS",TINEA CAPITIS,TERBINAFINE,RO-may_treat
498023402,7/4/2014 14:45:46,false,1314933869,7/4/2014 14:45:17,prodege,0.8625,14890188,GBR,I2,Manchester,151.230.18.68,ONDANSETRON treats EMESIS,51,109,,57,120,treats,0.964901281354015,907273-FS1-2,Eight patients achieved good control of nausea and EMESIS with ondansetron alone while two patients required ONDANSETRON and diphenhydramine,EMESIS,ONDANSETRON,RO-may_prevent
498023402,7/4/2014 14:46:52,false,1314934982,7/4/2014 14:46:32,clixsense,0.8625,19803139,NLD,6,Veldhoven,212.61.84.196,ONDANSETRON treats EMESIS,51,109,,57,120,treats,0.964901281354015,907273-FS1-2,Eight patients achieved good control of nausea and EMESIS with ondansetron alone while two patients required ONDANSETRON and diphenhydramine,EMESIS,ONDANSETRON,RO-may_prevent
498023402,7/4/2014 14:56:45,false,1314943223,7/4/2014 14:56:22,clixsense,0.7667,27969116,NLD,4,Veendam,185.12.216.74,no_relation,51,109,,57,120,treats,0.964901281354015,907273-FS1-2,Eight patients achieved good control of nausea and EMESIS with ondansetron alone while two patients required ONDANSETRON and diphenhydramine,EMESIS,ONDANSETRON,RO-may_prevent
498023402,7/4/2014 15:23:15,false,1314964405,7/4/2014 15:22:51,clixsense,0.6246,15189335,GBR,I9,Dereham,86.157.163.112,ONDANSETRON treats EMESIS,51,109,,57,120,treats,0.964901281354015,907273-FS1-2,Eight patients achieved good control of nausea and EMESIS with ondansetron alone while two patients required ONDANSETRON and diphenhydramine,EMESIS,ONDANSETRON,RO-may_prevent
498023402,7/4/2014 15:30:58,false,1314971220,7/4/2014 15:30:44,prodege,0.6637,14848125,GBR,V2,Glasgow,86.130.194.252,ONDANSETRON treats EMESIS,51,109,,57,120,treats,0.964901281354015,907273-FS1-2,Eight patients achieved good control of nausea and EMESIS with ondansetron alone while two patients required ONDANSETRON and diphenhydramine,EMESIS,ONDANSETRON,RO-may_prevent
498023403,7/4/2014 14:49:58,false,1314937825,7/4/2014 14:49:42,prodege,0.8625,14890188,GBR,I2,Manchester,151.230.18.68,DCIS is diagnosed by MICROCALCIFICATION,43,14,,61,18,is diagnosed by,0.635000635000953,902739-FS1-13,Many cases of DCIS are detected because of MICROCALCIFICATION on mammograms; 20% of screen-detected cancers are of this type,MICROCALCIFICATION,DCIS,RO-disease_may_have_finding
498023403,7/4/2014 14:59:43,false,1314945441,7/4/2014 14:59:04,clixsense,0.7667,27969116,NLD,4,Veendam,185.12.216.74,DCIS is diagnosed by MICROCALCIFICATION,43,14,,61,18,is diagnosed by,0.635000635000953,902739-FS1-13,Many cases of DCIS are detected because of MICROCALCIFICATION on mammograms; 20% of screen-detected cancers are of this type,MICROCALCIFICATION,DCIS,RO-disease_may_have_finding
498023403,7/4/2014 15:10:10,false,1314954450,7/4/2014 15:09:50,clixsense,0.6479,6394333,GBR,,,86.29.240.182,no_relation,43,14,,61,18,is diagnosed by,0.635000635000953,902739-FS1-13,Many cases of DCIS are detected because of MICROCALCIFICATION on mammograms; 20% of screen-detected cancers are of this type,MICROCALCIFICATION,DCIS,RO-disease_may_have_finding
498023403,7/4/2014 15:37:00,false,1314975970,7/4/2014 15:36:36,gptbanks,0.4263,18496428,USA,CA,Newhall,199.244.112.44,MICROCALCIFICATION is diagnosed by DCIS,43,14,,61,18,is diagnosed by,0.635000635000953,902739-FS1-13,Many cases of DCIS are detected because of MICROCALCIFICATION on mammograms; 20% of screen-detected cancers are of this type,MICROCALCIFICATION,DCIS,RO-disease_may_have_finding
498023403,7/4/2014 15:44:13,false,1314980861,7/4/2014 15:43:35,bitcoinget,0.6363,21490602,USA,NJ,Dunellen,68.193.37.224,DCIS is diagnosed by MICROCALCIFICATION,43,14,,61,18,is diagnosed by,0.635000635000953,902739-FS1-13,Many cases of DCIS are detected because of MICROCALCIFICATION on mammograms; 20% of screen-detected cancers are of this type,MICROCALCIFICATION,DCIS,RO-disease_may_have_finding
498023404,7/4/2014 14:47:34,false,1314935635,7/4/2014 14:47:14,prodege,0.8625,14890188,GBR,I2,Manchester,151.230.18.68,ANTIARRHYTHMIC AGENTS treats DYSRHYTHMIA,0,45,,11,66,treats,1,907097-FS1-2,"DYSRHYTHMIA should be treated with atropine, ANTIARRHYTHMIC AGENTS, and a temporary pacemaker, in order to avoid lethal results",DYSRHYTHMIA,ANTIARRHYTHMIC AGENTS,RO-may_prevent
498023404,7/4/2014 14:48:41,false,1314936792,7/4/2014 14:48:20,clixsense,0.8625,19803139,NLD,6,Veldhoven,212.61.84.196,ANTIARRHYTHMIC AGENTS treats DYSRHYTHMIA,0,45,,11,66,treats,1,907097-FS1-2,"DYSRHYTHMIA should be treated with atropine, ANTIARRHYTHMIC AGENTS, and a temporary pacemaker, in order to avoid lethal results",DYSRHYTHMIA,ANTIARRHYTHMIC AGENTS,RO-may_prevent
498023404,7/4/2014 14:58:16,false,1314944386,7/4/2014 14:57:49,clixsense,0.7667,27969116,NLD,4,Veendam,185.12.216.74,DYSRHYTHMIA treats ANTIARRHYTHMIC AGENTS,0,45,,11,66,treats,1,907097-FS1-2,"DYSRHYTHMIA should be treated with atropine, ANTIARRHYTHMIC AGENTS, and a temporary pacemaker, in order to avoid lethal results",DYSRHYTHMIA,ANTIARRHYTHMIC AGENTS,RO-may_prevent
498023404,7/4/2014 15:26:55,false,1314967302,7/4/2014 15:26:34,clixsense,0.6246,15189335,GBR,I9,Dereham,86.157.163.112,ANTIARRHYTHMIC AGENTS treats DYSRHYTHMIA,0,45,,11,66,treats,1,907097-FS1-2,"DYSRHYTHMIA should be treated with atropine, ANTIARRHYTHMIC AGENTS, and a temporary pacemaker, in order to avoid lethal results",DYSRHYTHMIA,ANTIARRHYTHMIC AGENTS,RO-may_prevent
498023404,7/4/2014 15:27:12,false,1314967532,7/4/2014 15:26:49,prodege,0.6637,14848125,GBR,V2,Glasgow,86.130.194.252,ANTIARRHYTHMIC AGENTS treats DYSRHYTHMIA,0,45,,11,66,treats,1,907097-FS1-2,"DYSRHYTHMIA should be treated with atropine, ANTIARRHYTHMIC AGENTS, and a temporary pacemaker, in order to avoid lethal results",DYSRHYTHMIA,ANTIARRHYTHMIC AGENTS,RO-may_prevent
498023405,7/4/2014 14:46:00,false,1314934151,7/4/2014 14:45:47,prodege,0.8625,14890188,GBR,I2,Manchester,151.230.18.68,PENTAMIDINE ISETHIONATE treats PNEUMOCYSTIS PNEUMONIA,101,68,,123,91,treats,0.953462589245592,907179-FS1-2,"In 1984, three patients died of severe hypoglycemia after receiving PENTAMIDINE ISETHIONATE to treat PNEUMOCYSTIS PNEUMONIA",PNEUMOCYSTIS PNEUMONIA,PENTAMIDINE ISETHIONATE,RO-may_prevent
498023405,7/4/2014 14:49:33,false,1314937569,7/4/2014 14:49:09,clixsense,0.8625,19803139,NLD,6,Veldhoven,212.61.84.196,PENTAMIDINE ISETHIONATE treats PNEUMOCYSTIS PNEUMONIA,101,68,,123,91,treats,0.953462589245592,907179-FS1-2,"In 1984, three patients died of severe hypoglycemia after receiving PENTAMIDINE ISETHIONATE to treat PNEUMOCYSTIS PNEUMONIA",PNEUMOCYSTIS PNEUMONIA,PENTAMIDINE ISETHIONATE,RO-may_prevent
498023405,7/4/2014 15:28:21,false,1314968767,7/4/2014 15:28:10,prodege,0.6637,14848125,GBR,V2,Glasgow,86.130.194.252,PENTAMIDINE ISETHIONATE treats PNEUMOCYSTIS PNEUMONIA,101,68,,123,91,treats,0.953462589245592,907179-FS1-2,"In 1984, three patients died of severe hypoglycemia after receiving PENTAMIDINE ISETHIONATE to treat PNEUMOCYSTIS PNEUMONIA",PNEUMOCYSTIS PNEUMONIA,PENTAMIDINE ISETHIONATE,RO-may_prevent
498023405,7/4/2014 15:39:39,false,1314977832,7/4/2014 15:39:04,bitcoinget,0.6363,21490602,USA,NJ,Dunellen,68.193.37.224,PENTAMIDINE ISETHIONATE treats PNEUMOCYSTIS PNEUMONIA,101,68,,123,91,treats,0.953462589245592,907179-FS1-2,"In 1984, three patients died of severe hypoglycemia after receiving PENTAMIDINE ISETHIONATE to treat PNEUMOCYSTIS PNEUMONIA",PNEUMOCYSTIS PNEUMONIA,PENTAMIDINE ISETHIONATE,RO-may_prevent
498023405,7/4/2014 15:52:22,false,1314987462,7/4/2014 15:51:38,rewardsspot,0.6639,24482174,GBR,H9,London,146.185.23.27,PENTAMIDINE ISETHIONATE treats PNEUMOCYSTIS PNEUMONIA,101,68,,123,91,treats,0.953462589245592,907179-FS1-2,"In 1984, three patients died of severe hypoglycemia after receiving PENTAMIDINE ISETHIONATE to treat PNEUMOCYSTIS PNEUMONIA",PNEUMOCYSTIS PNEUMONIA,PENTAMIDINE ISETHIONATE,RO-may_prevent
498023406,7/4/2014 14:46:48,false,1314934904,7/4/2014 14:46:33,prodege,0.8625,14890188,GBR,I2,Manchester,151.230.18.68,DEXAMETHASONE contraindicates HYPERCORTISOLISM,48,104,,64,117,contraindicates,0.468521285665818,906657-FS1-10,"Very high plasma androgen levels or evidence of HYPERCORTISOLISM, which is not normally suppressible by DEXAMETHASONE, should lead to the search for a tumor or Cushing's syndrome",HYPERCORTISOLISM,DEXAMETHASONE,RO-may_diagnose
498023406,7/4/2014 14:47:56,false,1314936115,7/4/2014 14:47:31,clixsense,0.8625,19803139,NLD,6,Veldhoven,212.61.84.196,HYPERCORTISOLISM contraindicates DEXAMETHASONE,48,104,,64,117,contraindicates,0.468521285665818,906657-FS1-10,"Very high plasma androgen levels or evidence of HYPERCORTISOLISM, which is not normally suppressible by DEXAMETHASONE, should lead to the search for a tumor or Cushing's syndrome",HYPERCORTISOLISM,DEXAMETHASONE,RO-may_diagnose
498023406,7/4/2014 15:19:51,false,1314961724,7/4/2014 15:19:30,clixsense,0.6246,15189335,GBR,I9,Dereham,86.157.163.112,HYPERCORTISOLISM contraindicates DEXAMETHASONE,48,104,,64,117,contraindicates,0.468521285665818,906657-FS1-10,"Very high plasma androgen levels or evidence of HYPERCORTISOLISM, which is not normally suppressible by DEXAMETHASONE, should lead to the search for a tumor or Cushing's syndrome",HYPERCORTISOLISM,DEXAMETHASONE,RO-may_diagnose
498023406,7/4/2014 15:31:28,false,1314971740,7/4/2014 15:31:14,gptbanks,0.4263,18496428,USA,CA,Newhall,199.244.112.44,DEXAMETHASONE contraindicates HYPERCORTISOLISM,48,104,,64,117,contraindicates,0.468521285665818,906657-FS1-10,"Very high plasma androgen levels or evidence of HYPERCORTISOLISM, which is not normally suppressible by DEXAMETHASONE, should lead to the search for a tumor or Cushing's syndrome",HYPERCORTISOLISM,DEXAMETHASONE,RO-may_diagnose
498023406,7/4/2014 15:34:12,false,1314974134,7/4/2014 15:33:45,prodege,0.6637,14848125,GBR,V2,Glasgow,86.130.194.252,no_relation,48,104,,64,117,contraindicates,0.468521285665818,906657-FS1-10,"Very high plasma androgen levels or evidence of HYPERCORTISOLISM, which is not normally suppressible by DEXAMETHASONE, should lead to the search for a tumor or Cushing's syndrome",HYPERCORTISOLISM,DEXAMETHASONE,RO-may_diagnose
498023407,7/4/2014 14:46:31,false,1314934673,7/4/2014 14:46:15,clixsense,0.8625,19803139,NLD,6,Veldhoven,212.61.84.196,no_relation,53,107,,73,118,treats,1,907900-FS1-2,"Tikkanen MJ, Laakso M, Ilmonen M et al. Treatment of HYPERCHOLESTEROLEMIA and combined hyperlipidemia with SIMVASTATIN and gemfibrozil in patients with NIDDM",HYPERCHOLESTEROLEMIA,SIMVASTATIN,RO-may_treat
498023407,7/4/2014 15:22:47,false,1314964007,7/4/2014 15:22:20,clixsense,0.6246,15189335,GBR,I9,Dereham,86.157.163.112,SIMVASTATIN treats HYPERCHOLESTEROLEMIA,53,107,,73,118,treats,1,907900-FS1-2,"Tikkanen MJ, Laakso M, Ilmonen M et al. Treatment of HYPERCHOLESTEROLEMIA and combined hyperlipidemia with SIMVASTATIN and gemfibrozil in patients with NIDDM",HYPERCHOLESTEROLEMIA,SIMVASTATIN,RO-may_treat
498023407,7/4/2014 15:32:37,false,1314972774,7/4/2014 15:32:24,prodege,0.6637,14848125,GBR,V2,Glasgow,86.130.194.252,SIMVASTATIN treats HYPERCHOLESTEROLEMIA,53,107,,73,118,treats,1,907900-FS1-2,"Tikkanen MJ, Laakso M, Ilmonen M et al. Treatment of HYPERCHOLESTEROLEMIA and combined hyperlipidemia with SIMVASTATIN and gemfibrozil in patients with NIDDM",HYPERCHOLESTEROLEMIA,SIMVASTATIN,RO-may_treat
498023407,7/4/2014 15:39:03,false,1314977311,7/4/2014 15:38:30,bitcoinget,0.6363,21490602,USA,NJ,Dunellen,68.193.37.224,SIMVASTATIN treats HYPERCHOLESTEROLEMIA,53,107,,73,118,treats,1,907900-FS1-2,"Tikkanen MJ, Laakso M, Ilmonen M et al. Treatment of HYPERCHOLESTEROLEMIA and combined hyperlipidemia with SIMVASTATIN and gemfibrozil in patients with NIDDM",HYPERCHOLESTEROLEMIA,SIMVASTATIN,RO-may_treat
498023407,7/4/2014 15:50:44,false,1314986180,7/4/2014 15:50:10,rewardsspot,0.6639,24482174,GBR,H9,London,146.185.23.27,SIMVASTATIN treats HYPERCHOLESTEROLEMIA,53,107,,73,118,treats,1,907900-FS1-2,"Tikkanen MJ, Laakso M, Ilmonen M et al. Treatment of HYPERCHOLESTEROLEMIA and combined hyperlipidemia with SIMVASTATIN and gemfibrozil in patients with NIDDM",HYPERCHOLESTEROLEMIA,SIMVASTATIN,RO-may_treat
498023408,7/4/2014 15:13:06,false,1314956476,7/4/2014 15:12:56,clixsense,0.6479,6394333,GBR,,,86.29.240.182,no_relation,67,53,,87,63,treats,0.929981109950554,907638-FS1-2,"Palmer DG, Ferry DG, Gibbins BL et al. Ibuprofen and DIFLUNISAL in RHEUMATOID ARTHRITIS: a double-blind comparative trial",RHEUMATOID ARTHRITIS,DIFLUNISAL,RO-may_treat
498023408,7/4/2014 15:31:39,false,1314971854,7/4/2014 15:31:30,gptbanks,0.4263,18496428,USA,CA,Newhall,199.244.112.44,DIFLUNISAL treats RHEUMATOID ARTHRITIS,67,53,,87,63,treats,0.929981109950554,907638-FS1-2,"Palmer DG, Ferry DG, Gibbins BL et al. Ibuprofen and DIFLUNISAL in RHEUMATOID ARTHRITIS: a double-blind comparative trial",RHEUMATOID ARTHRITIS,DIFLUNISAL,RO-may_treat
498023408,7/4/2014 15:43:00,false,1314980124,7/4/2014 15:42:35,bitcoinget,0.6363,21490602,USA,NJ,Dunellen,68.193.37.224,DIFLUNISAL treats RHEUMATOID ARTHRITIS,67,53,,87,63,treats,0.929981109950554,907638-FS1-2,"Palmer DG, Ferry DG, Gibbins BL et al. Ibuprofen and DIFLUNISAL in RHEUMATOID ARTHRITIS: a double-blind comparative trial",RHEUMATOID ARTHRITIS,DIFLUNISAL,RO-may_treat
498023408,7/4/2014 15:51:31,false,1314986805,7/4/2014 15:50:49,rewardsspot,0.6639,24482174,GBR,H9,London,146.185.23.27,DIFLUNISAL treats RHEUMATOID ARTHRITIS,67,53,,87,63,treats,0.929981109950554,907638-FS1-2,"Palmer DG, Ferry DG, Gibbins BL et al. Ibuprofen and DIFLUNISAL in RHEUMATOID ARTHRITIS: a double-blind comparative trial",RHEUMATOID ARTHRITIS,DIFLUNISAL,RO-may_treat
498023408,7/4/2014 15:52:34,false,1314987646,7/4/2014 15:52:24,neodev,0.5875,25804244,USA,IL,Chicago,99.198.108.116,DIFLUNISAL treats RHEUMATOID ARTHRITIS,67,53,,87,63,treats,0.929981109950554,907638-FS1-2,"Palmer DG, Ferry DG, Gibbins BL et al. Ibuprofen and DIFLUNISAL in RHEUMATOID ARTHRITIS: a double-blind comparative trial",RHEUMATOID ARTHRITIS,DIFLUNISAL,RO-may_treat
498023409,7/4/2014 14:47:48,false,1314935978,7/4/2014 14:47:34,prodege,0.8625,14890188,GBR,I2,Manchester,151.230.18.68,no_relation,90,0,,102,5,causes,0.416025147168922,906474-FS1-4,"SMMCI has also been found as an isolated finding or together with other anomalies such as MICROCEPHALY, short stature, endocrine pathology, and choanal atresia",MICROCEPHALY,SMMCI,RO-has_manifestation
498023409,7/4/2014 14:48:41,false,1314936798,7/4/2014 14:48:20,clixsense,0.8625,19803139,NLD,6,Veldhoven,212.61.84.196,no_relation,90,0,,102,5,causes,0.416025147168922,906474-FS1-4,"SMMCI has also been found as an isolated finding or together with other anomalies such as MICROCEPHALY, short stature, endocrine pathology, and choanal atresia",MICROCEPHALY,SMMCI,RO-has_manifestation
498023409,7/4/2014 14:53:34,false,1314940647,7/4/2014 14:52:47,clixsense,0.7667,27969116,NLD,4,Veendam,185.12.216.74,SMMCI causes MICROCEPHALY,90,0,,102,5,causes,0.416025147168922,906474-FS1-4,"SMMCI has also been found as an isolated finding or together with other anomalies such as MICROCEPHALY, short stature, endocrine pathology, and choanal atresia",MICROCEPHALY,SMMCI,RO-has_manifestation
498023409,7/4/2014 15:09:27,false,1314953979,7/4/2014 15:08:52,clixsense,0.6479,6394333,GBR,,,86.29.240.182,no_relation,90,0,,102,5,causes,0.416025147168922,906474-FS1-4,"SMMCI has also been found as an isolated finding or together with other anomalies such as MICROCEPHALY, short stature, endocrine pathology, and choanal atresia",MICROCEPHALY,SMMCI,RO-has_manifestation
498023409,7/4/2014 15:24:06,false,1314965007,7/4/2014 15:23:47,clixsense,0.6246,15189335,GBR,I9,Dereham,86.157.163.112,SMMCI causes MICROCEPHALY,90,0,,102,5,causes,0.416025147168922,906474-FS1-4,"SMMCI has also been found as an isolated finding or together with other anomalies such as MICROCEPHALY, short stature, endocrine pathology, and choanal atresia",MICROCEPHALY,SMMCI,RO-has_manifestation
498023410,7/4/2014 15:15:14,false,1314957894,7/4/2014 15:14:50,clixsense,0.6479,6394333,GBR,,,86.29.240.182,no_relation,46,74,,60,86,treats,0.917662935482247,907805-FS1-2,"cOmeprazole and lansoprazole are approved for GASTRIC ULCERS; omeprazole, LANSOPRAZOLE, and rabeprazole are approved for duodenal ulcers",GASTRIC ULCERS,LANSOPRAZOLE,RO-may_treat
498023410,7/4/2014 15:27:12,false,1314967513,7/4/2014 15:26:49,prodege,0.6637,14848125,GBR,V2,Glasgow,86.130.194.252,LANSOPRAZOLE treats GASTRIC ULCERS,46,74,,60,86,treats,0.917662935482247,907805-FS1-2,"cOmeprazole and lansoprazole are approved for GASTRIC ULCERS; omeprazole, LANSOPRAZOLE, and rabeprazole are approved for duodenal ulcers",GASTRIC ULCERS,LANSOPRAZOLE,RO-may_treat
498023410,7/4/2014 15:35:34,false,1314974892,7/4/2014 15:35:29,gptbanks,0.4263,18496428,USA,CA,Newhall,199.244.112.44,LANSOPRAZOLE treats GASTRIC ULCERS,46,74,,60,86,treats,0.917662935482247,907805-FS1-2,"cOmeprazole and lansoprazole are approved for GASTRIC ULCERS; omeprazole, LANSOPRAZOLE, and rabeprazole are approved for duodenal ulcers",GASTRIC ULCERS,LANSOPRAZOLE,RO-may_treat
498023410,7/4/2014 15:39:03,false,1314977310,7/4/2014 15:38:30,bitcoinget,0.6363,21490602,USA,NJ,Dunellen,68.193.37.224,LANSOPRAZOLE treats GASTRIC ULCERS,46,74,,60,86,treats,0.917662935482247,907805-FS1-2,"cOmeprazole and lansoprazole are approved for GASTRIC ULCERS; omeprazole, LANSOPRAZOLE, and rabeprazole are approved for duodenal ulcers",GASTRIC ULCERS,LANSOPRAZOLE,RO-may_treat
498023410,7/4/2014 15:46:31,false,1314982639,7/4/2014 15:45:57,rewardsspot,0.6639,24482174,GBR,H9,London,146.185.23.27,LANSOPRAZOLE treats GASTRIC ULCERS,46,74,,60,86,treats,0.917662935482247,907805-FS1-2,"cOmeprazole and lansoprazole are approved for GASTRIC ULCERS; omeprazole, LANSOPRAZOLE, and rabeprazole are approved for duodenal ulcers",GASTRIC ULCERS,LANSOPRAZOLE,RO-may_treat
